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Neurons do not exist in isolation in the central nervous system, and there is a growing appreciation 
that the interactions between neuronal and non-neuronal cells are fundamentally important for 
nervous system function. A major family of non-neuronal cells are the astrocytes, with a surge of 
recent work suggesting the relationship between neurons and astrocytes is bidirectional and highly 
complex. In my thesis I seek to further uncover the nature of this intimate relationship between 
neurons and astrocytes of the cortex. One well-established role of astrocytes is the collection of 
neuronal glutamate via their high affinity excitatory amino acid transporters, with dysfunctions in 
this system being linked to numerous neurological diseases. Previous reports suggest that neurons 
may regulate the expression of these astrocytic glutamate transporters, through an as yet unknown 
pathway. In my thesis I first investigate the nature of this non-cell-autonomous neuronal control of 
astrocytes. I begin by using results from the lab’s novel mixed-species RNA-sequencing dataset to 
explore how neurons regulate astrocytic gene expression, finding that they upregulated the 
astrocytic glutamate transporters. By electrophysiological recording I show a corresponding 
functional increase in the astrocytes’ ability to collect glutamate, before demonstrating that neurons 
upregulate the astrocytic transporters through Notch signalling. I then investigate whether 
continuous Notch signalling is required to maintain these transporters’ expression and function, 
finding that removal of Notch signalling after the establishment of transporter expression 
significantly reduces the transporters’ activity. For the remainder of my thesis I explore how cortical 
astrocytes may in turn control cortical neuronal function. Using RNA-seq data generated in the lab 
I discover a host of neuronal genes that are regulated by astrocytes. Amongst these genes were the 
functionally important K+ inward rectifying channel family, which were strongly downregulated in 
neurons by astrocytes, an observation hitherto unseen. I hypothesise that this downregulation will 
result in alterations to neuronal membrane properties which will enhance neuronal excitability, and 
that this may in turn have down-stream consequences on neuronal activity and synaptogenesis. I 
find that cortical neurons are rendered more excitable by astrocytes, leading to an enhancement of 
neuronal activity, driven by the astrocyte-induced decrease in K+ inward rectifiers. Although I do 
not see an increase in baseline synaptogenesis, I show a range of homeostatic neuronal responses 
emerge in the presence of astrocytes. This work suggests that astrocytes play a central role in 




There are many different cell types in the brain aside from the more widely known neurons. These 
different cell types are in constant communication with each other and neurons, and neural 
function depends on these interactions. One of the largest families of these cells in humans are called 
astrocytes, named after their complex “star-like” morphology. A number of important 
housekeeping functions are carried out by astrocytes, including clearance of the excitatory 
neurotransmitter glutamate from the external environment surrounding neurons. This clearance is 
important as glutamate outside of neurons is toxic and can lead to neuronal death. Furthermore, 
astrocytes form close associations with the information transfer points, called synapses, between 
neurons, and are able to detect and respond to neuronal information passing through these points. 
This has led to the suggestion that astrocytes may play a direct role in neuronal communication on 
top of their housekeeping duties. However, the extent of the communication between astrocytes 
and neurons, and the functional consequences of this, are only just beginning to be explored. 
My thesis addresses this gap in knowledge, revealing how neurons control astrocyte properties, and 
how astrocytes in turn control neuronal properties. First, I show that neurons send signals to 
astrocytes through a contact-mediated pathway that gives astrocytes the ability to clear glutamate. I 
show that this neuronal signalling is required to maintain astrocytic glutamate clearance, which has 
consequences for neurodegenerative disease, where contact between neurons and astrocytes is lost. 
I then reveal a list of neuronal genes whose expression is controlled by astrocytes. I find that a group 
of genes for the functionally important potassium channels are reduced in neurons by a factor 
secreted by astrocytes. I show that this reduction in potassium channels alters neuronal membrane 
properties, making neurons more excitable and active. These potassium channels and neuronal 
excitability are regulated in response to abnormal stimulation in order to maintain correct neuronal 
activity, in a process known as homeostasis. Importantly, I show that without astrocytes, neurons 
are not capable of this homeostatic response that is essential in order to mitigate pathological activity 
levels and maintain brain function. 
v 
 
Table of Contents 
Declaration ............................................................................................................................... i 
Acknowledgements................................................................................................................. ii 
Abstract .................................................................................................................................. iii 
Lay Summary ......................................................................................................................... iv 
Table of Contents ................................................................................................................... v 
Abbreviations ........................................................................................................................ xii 
Chapter 1 - Introduction ........................................................................................................ 2 
1.1 An introduction to the interplay of neurons and astrocytes .................................................... 2 
1.1.1 Passive astrocyte-neuron interactions ................................................................................................ 3 
1.1.2 Active astrocyte-neuron communication .......................................................................................... 7 
1.2 Neuron-to-astrocyte communication ....................................................................................... 8 
Figure 1.1: Cortical rat neuronal control of cortical mouse astrocytic transcriptome ............................... 9 
1.3 Astrocytic glutamate clearance and recycling ......................................................................... 10 
Figure 1.2: The glutamine-glutamate cycle ................................................................................................ 11 
1.4 Glutamate transport within the brain ..................................................................................... 12 
1.4.1 The excitatory amino acid transporters ........................................................................................... 12 
Figure 1.3: Excitatory amino acid transporter family .............................................................................. 13 
1.4.2 Impairments in astrocytic glutamate clearance are features of disease ........................................... 18 
1.5 Glutamate transporter regulation ............................................................................................ 21 
1.5.1 Regulation of astrocytic EAAT1 and EAAT2 by soluble factors ................................................. 22 
Figure 1.4: The cyclic AMP signalling pathway ........................................................................................ 23 
1.5.2 Contact dependent regulation of EAAT1 and EAAT2 ................................................................. 24 
Figure 1.5: The Notch signalling pathway .................................................................................................. 25 
vi 
 
1.6 Astrocyte-to-neuron communication ..................................................................................... 27 
1.7 Astrocytic involvement in neuronal development ................................................................. 27 
1.7.1 Morphology and cell type development .......................................................................................... 28 
1.7.2 Synaptogenesis .................................................................................................................................. 28 
Figure 1.6 Astrocytic proteins associated with excitatory synaptogenesis .................................................. 31 
Figure 1.7 Retinal cell network .................................................................................................................... 44 
1.8 Astrocyte involvement in neuronal activity ............................................................................ 46 
1.8.1 Synaptic plasticity ............................................................................................................................. 47 
1.8.2 Neuronal KIR channels ..................................................................................................................... 51 
1.9 Thesis summary ........................................................................................................................ 53 
1.9.1 Aims ................................................................................................................................................... 55 
Chapter 2 – Materials and Methods ..................................................................................... 57 
2.1 Cell culture: cortical tissue ....................................................................................................... 57 
2.2 Cell culture: retinal ganglion cells ........................................................................................... 59 
2.3 Transfections and plasmids ..................................................................................................... 60 
2.4 Electrophysiological recordings ............................................................................................... 61 
2.4.1 Solutions ............................................................................................................................................ 61 
2.4.2 General recording set-up .................................................................................................................. 61 
2.4.3 Astrocyte recordings ......................................................................................................................... 62 
2.4.4 Neuronal recordings: intrinsic properties and excitability ............................................................. 63 
2.4.5 Neuronal recordings: spontaneous activity and mEPSC ............................................................... 63 
2.5 Western blotting ....................................................................................................................... 63 
2.6 Conditioned media experiments ............................................................................................. 64 
2.7 Immunohistochemistry and confocal imaging ....................................................................... 65 
2.8 RNA-sequencing ..................................................................................................................... 66 
vii 
 
2.9 Mass spectrometry .................................................................................................................... 67 
2.10 Data analysis and statistics ..................................................................................................... 68 
2.11 Ethics ....................................................................................................................................... 69 
Chapter 3 – Neuron to astrocyte signalling: Neurons control functional expression of 
astrocytic glutamate transporters EAAT1 and EAAT2 ..................................................... 71 
3.1 Introduction ............................................................................................................................. 71 
3.2 Neurons alter astrocyte morphology ....................................................................................... 72 
Figure 3.1: Neurons alter astrocyte morphology, increasing astrocytic complexity .................................. 73 
3.3 Neurons do not alter the basic membrane properties of astrocytes ....................................... 73 
Figure 3.2: Neurons do not significantly alter the intrinsic properties of astrocytes ............................... 74 
3.4 Neurons increase EAAT currents in astrocytes, which is prevented by inhibition of the Notch 
signalling pathway .......................................................................................................................... 75 
Figure 3.3: Neurons increase astrocytic EAAT currents, which is prevented by inhibition of Notch 
signalling ........................................................................................................................................................ 76 
3.5 Activating Notch signalling in mono-culture astrocytes is sufficient to boost EAAT function
 ......................................................................................................................................................... 77 
Figure 3.4: Activating Notch signalling in MC astrocytes is sufficient to boost EAAT activity............ 77 
3.6 Neuronal Notch signalling is needed throughout life to maintain EAAT expression ......... 78 
Figure 3.5: Notch signalling is needed to maintain astrocytic EAAT function ...................................... 79 
3.7 Discussion ................................................................................................................................. 80 
3.7.1 Summary of findings ......................................................................................................................... 80 
3.7.2 Neurons control astrocytic EAAT1 and EAAT2 through Notch signalling ............................... 80 
3.7.3 Notch signalling is needed to maintain astrocytic EAAT function ............................................... 82 
3.7.4 Conclusions ....................................................................................................................................... 85 
Chapter 4 – Astrocytes alter neuronal gene expression and physiological properties ....... 87 
4.1 Introduction ............................................................................................................................. 87 
viii 
 
4.2 AraC treatment prevents astrocyte growth and proliferation ............................................... 88 
Figure 4.1: Rat neurons cultured in the absence and presence of mouse astrocytes, treated with AraC 89 
4.3 Investigating the effect of astrocytes on the neuronal transcriptome using mixed-species 
RNA-sequencing ........................................................................................................................... 90 
Figure 4.2: Change in neuronal gene expression due to astrocytes ............................................................ 90 
4.4 Neuronal membrane properties are altered in co-cultured neurons, consistent with a decrease 
in KIR expression ............................................................................................................................. 91 
Figure 4.3: The presence of astrocytes alters the membrane properties of cortical neurons at DIV8 ..... 92 
4.5 Neuronal excitability is increased by the presence of astrocytes ............................................ 92 
Figure 4.4: Neuronal excitability is increased in the presence of astrocytes ............................................. 93 
4.5.1 Effects of astrocytes on neurons are not specific to species ............................................................ 94 
4.6 Blocking KIR in mono-culture mimics the effects of astrocytes on intrinsic neuronal 
properties ........................................................................................................................................ 94 
Figure 4.5: Specific KIR3.1 and KIR2.3 antagonism of MC neurons increases excitability ................... 96 
Figure 4.6: Non-specific KIR block with low-dose Ba2+ increases excitability of MC neurons ................ 97 
4.7 Homeostatic mechanisms mask effects at DIV15, but are recovered by inhibition of activity
 ......................................................................................................................................................... 98 
Figure 4.7: At DIV15 the intrinsic properties of CC neurons, but not MC neurons, are activity 
regulated, masking the effect of astrocytes ................................................................................................... 99 
4.9 Protein levels of KIR3.1 are decreased in CC neurons .......................................................... 101 
Figure 4.8: Neuronal KIR3.1 protein levels decrease with astrocyte co-culture ...................................... 102 
4.10 An astrocyte secreted molecule is responsible for the change intrinsic properties ........... 103 
Figure 4.9: Change in mono-cultured cortical neuronal gene expression after three days of astrocyte 
conditioned media treatment ..................................................................................................................... 103 
Figure 4.10: Resting membrane potential and membrane resistance of MC rat neurons are affected by 
ACM treatment ........................................................................................................................................... 104 
Figure 4.11: Neuronal excitability in DIV8 cells is increased by ACM treatment ............................. 105 
ix 
 
4.11 Secretomics of ACM reveals list of astrocyte released proteins ......................................... 106 
Figure 4.12: Enrichment of proteins detected in astrocyte conditioned media compared to their 
enrichment in neuronal conditioned media ............................................................................................ 107 
4.12 Discussion ............................................................................................................................. 108 
4.12.1 Summary of findings .................................................................................................................... 108 
4.12.2 Cortical neurons can survive in the absence of astrocytes .......................................................... 108 
4.12.3 Astrocytes control cortical neuronal gene expression, including the KIR channels................... 109 
4.12.4 Astrocytes control neuronal membrane properties and excitability, purportedly by KIR 
regulation .................................................................................................................................................. 110 
4.12.5 An astrocyte secreted protein is responsible for cortical neuronal KIR regulation .................... 111 
4.12.6 Neurons require astrocytes for activity-dependent homeostatic plasticity of excitability ........ 112 
4.12.7 Limitations and future work ........................................................................................................ 113 
4.12.8 Conclusion .................................................................................................................................... 115 
Figure 4.13: Model of astrocytic control of neuronal KIR ....................................................................... 116 
Chapter 5 – Cortical neurons do not need cues from astrocytes to form synapses; astrocytes 
instead enhance network activity and plasticity ................................................................ 119 
5.1 Introduction ........................................................................................................................... 119 
5.2 KIR overexpression blocks spontaneous activity in cortical neurons ................................... 120 
Figure 5.1: KIR2.1 overexpression reduces spontaneous activity in co-cultured cortical neurons ......... 121 
5.3 Spontaneous activity is higher in co-cultured cortical neurons ........................................... 122 
Figure 5.2: Spontaneous activity is greater in co-cultured cortical neurons at DIV8 .......................... 122 
5.4 There is no difference in TTX-insensitive (miniature EPSCs) event properties between 
mono- and co-cultured neurons .................................................................................................. 123 
Figure 5.3: TTX-insensitive currents (mEPSCs) in DIV8 cortical neurons are unaltered by astrocytes
 ....................................................................................................................................................................... 124 
Figure 5.4: TTX-insensitive currents (mEPSCs) in DIV15 cortical neurons are unaltered by astrocytes
 ....................................................................................................................................................................... 125 
x 
 
5.5 There is no difference in synapse numbers between mono- and co-cultured cortical neurons
 ....................................................................................................................................................... 126 
Figure 5.5: Co-localised pre- and post-synaptic markers appear with the same frequency in mono- and 
co-cultured cortical neurons ........................................................................................................................ 127 
5.6 Lack of astrocytic influence on synaptogenesis not due to an inefficiency of our cortical 
astrocytes; synaptogenesis can be induced in RGCs .................................................................. 128 
Figure 5.6: Spontaneous activity in retinal ganglion cells cultured alone or with mouse astrocytes ... 129 
Figure 5.7: Astrocytes increase the proportion of retinal ganglion cells with synaptic activity and the 
frequency of mEPSC events......................................................................................................................... 130 
5.7 Homeostatic increases in synaptic strength after activity deprivation are only seen in co-
culture ........................................................................................................................................... 131 
Figure 5.8: Blocking activity in DIV15 co-cultured neurons increases mEPSC frequency, but has no 
effect on mono-cultured neurons ................................................................................................................ 132 
5.8 Homeostatic regulation of neuronal activity only seen in co-cultured neurons ................. 133 
Figure 5.9: There is still a difference in spontaneous activity between MC and CC neurons by DIV15
 ....................................................................................................................................................................... 134 
Figure 5.10: Removing TTX after 48hrs of activity inhibition induces robust neuronal network activity 
in co-culture, with limited effect in the absence of astrocytes ................................................................... 136 
5.9 Discussion ............................................................................................................................... 137 
5.9.1 Summary of findings ...................................................................................................................... 137 
5.9.2 Astrocytes increase the activity of neurons in a way consistent with an enhancement of excitability 
due to downregulation of KIR ................................................................................................................. 137 
5.9.3 Cortical neurons do not need astrocytes for the formation of excitatory synapses under baseline 
conditions ................................................................................................................................................. 138 
5.9.4 Astrocyte induced synaptogenesis is still observed in RGCs: RGC synaptogenesis is separate to 
cortical synaptogenesis ............................................................................................................................. 139 
5.9.5Astrocytes do regulate excitatory cortical synapses in an activity-dependent manner ................. 140 
xi 
 
5.9.6 The combined ability to regulate excitability and synaptic strength gives astrocytes significant 
control over the activity-dependent homeostasis of neurons ................................................................ 141 
5.9.7 Limitations and future work .......................................................................................................... 142 
5.9.8 Conclusion ...................................................................................................................................... 143 
Chapter 6 – Concluding remarks ...................................................................................... 145 
Figure 6.1: Proposed astrocyte signalling mechanisms leading to the repression of neuronal Kcnj ... 146 
References ........................................................................................................................... 149 
Appendix ............................................................................................................................. 167 
Figure A1: Involvement of the Notch signalling pathway between neurons and astrocytes ................ 167 
Figure A2: Tubulin expression in MC and CC cortical neurons (DIV8) ............................................ 168 
Figure A3: Gene expression of excitatory synapse associated genes for MC and CC cortical neurons at 
DIV8 and DIV15 as assessed from RNA-sequencing ............................................................................ 169 
Figure A4: RNA-sequencing data of KIR gene expression in cortical rat neurons is decreased in the 
presence of mouse astrocytes ........................................................................................................................ 170 
Figure A5: Activity dependent changes in KIR expression in DIV15 cortical rat neurons .................. 171 
Figure A6: Activity regulation of KIR channels in pure mouse neurons vs mixed mouse cells ............. 172 
Figure A7: Regulation of KIR genes in DIV3 rat neurons by ACM treatment ................................... 173 
Figure A8: Relative expression of proteins enriched >2-fold in ACM over NCM .............................. 177 
Figure A9: Astrocytes alter the membrane properties of mouse neurons at DIV8, appearing similar to 
rat neurons at DIV15 ................................................................................................................................. 178 
Figure A10: Both Notch pathway and astrocytic EAAT transporter genes are downregulated with age 






ACM  Astrocyte conditioned media 
aCSF   Artificial cerebrospinal fluid 
AD  Alzheimer’s disease 
ALS  Amyotrophic lateral sclerosis 
AMP  Adenosine monophosphate 
AMPA  α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hydrobromide 
apoE  Apolipoprotein E 
AraC  Cytosine arabinoside 
CAM  Cell adhesion molecule 
cAMP  Cyclic AMP 
CC  Co-culture 
Chrdl1  Chordin-like 1 
CNS  Central nervous system 
DAPT  N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester 
DIV  Day in vitro 
EAAT  Excitatory amino acid transporter 
EF-GFP  Enhanced fluorescence GFP 
EM  Electron microscopy 
EPSC  Excitatory post-synaptic current 
FI  Frequency-current 
GABA  γ-Aminobutyric acid 
GFP  Green fluorescent protein 
GPCR  G-protein coupled receptor 
GS  Glutamine synthetase 
GP  Glypican 
IV  Current-voltage 
KIR  K+ inward rectifier channel 
L-Asp  L-Aspartate 
LTD  Long-term depression 
LTP  Long-term potentiation 
mAChR Muscarinic receptor 
MAPK  Mitogen-activated protein kinases 
MC  Mono-culture 
mEPSC  Miniature EPSC 
mGluR  Metabotropic glutamate receptor  
mRNA  Messenger RNA 
NCM  Neuron conditioned media 
xiii 
 
NICD  Notch intracellular domain 
NL  Neuroligin 
NMDA  N-Methyl-D-aspartic acid 
PAG  Phosphate-activated glutaminase 
PCR  Polymerase chain reaction 
PTX  Picrotoxin 
RGC  Retinal ganglion cell 
RM  Membrane resistance 
RMP  Resting membrane potential 
RNA-seq RNA-sequencing 
ROS  Reactive oxygen species 
RT-qPCR Quantitative reverse transcription PCR 
TFB-TBOA (3S)-3-[[3-[[4-(Trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-aspartic 
acid 
TLE Temporal lobe epilepsy 
t-LTD Spike-timing dependent LTD 
TQ Tertiapin Q 
TSP Thrombospondin 

















Chapter 1 - Introduction 
1.1 An introduction to the interplay of neurons and astrocytes 
For many years the study of the brain focused almost solely on the communication between one 
family of cells in the brain, the neurons. Despite being aware of other central nervous system (CNS) 
cell types for over a century, the pronounced electrical responses of the neurons made them the 
focus of study, whilst the other cell types were side-lined, with the belief they provided little more 
than structural support (Kettenmann and Verkhratsky, 2008, Weigert, 1895, Ramon-y-Cajal et al., 
1996). This historical bias is reflected today with non-neuronal cells still collectively termed glia, 
meaning glue, whereas neurons have become the emblem for our field: neuroscience.    
Recently this bias has begun to be addressed, with research into the different glial cells, including 
the oligodendrocytes, microglia, astrocytes and NG2+ cells, rapidly gaining momentum. It is 
increasingly clear that all of the CNS cell types play an important role in nervous system function, 
with the interactions between the different glia types and neurons being fundamental to successful 
neuronal development, health, information processing and storage.  
An abundant and formerly overlooked cell family in the nervous system are the astrocytes. In the 
human cortex astrocytes represent an estimated 10-12% of all cells present, although most attempts 
to count cell numbers have not thought it necessary to differentiate between glial cell types, so it is 
still uncertain the exact proportion of astrocytes in different regions of the brain (von Bartheld et 
al., 2016, Pelvig et al., 2008). Astrocytes are derived from the same neural precursor cell population, 
radial glia, as neurons. Developmentally, in the early embryonic stages radial glia precursor cells are 
derived from basal neuroepithelium cells, and generate neurons from around embryonic day 10 
(E10) to E18 (in rodents) (Haubensak et al., 2004, Miller and Gauthier, 2007). Around this point 
there is a “gliogenic switch” triggered by various signalling cascades, including neuron to radial glia 
Notch signalling, whereupon radial glia begin producing astrocytes (and oligodendrocytes) instead 
of neurons (Miller and Gauthier, 2007, Rowitch and Kriegstein, 2010). During maturation 
astrocytes develop bushy protrusions enveloping large volumes, which extend and connect with 
their neighbouring astrocytes’ protrusions through gap junctions to create a “tiled” astrocyte 
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network throughout the brain, as well as extending their processes out to neuronal synapses 
(Bushong et al., 2004, Ventura and Harris, 1999).  
1.1.1 Passive astrocyte-neuron interactions 
Given astrocytes’ abundance, complex structures and close associations with synapses, you would 
expect these cells to play an important role in the brain. Indeed, from the 1960s it was observed and 
subsequently confirmed that astrocytes play an important role in K+ buffering, and from the 1990s 
that they are the primary collectors of neuronally released glutamate (Orkand et al., 1966, Hertz, 
1965, Walz, 2000, Rothstein et al., 1996, Danbolt, 2001, Brown, 2017). As either elevated 
extracellular K+ or glutamate concentrations can lead to neuronal hyperexcitability and death, this 
was the first work demonstrating an important role of astrocytes for neuronal health and function. 
Additionally, astrocytes are now established players in antioxidant defence, producing glutathione 
for the reduction of peroxides, and there is strong debate whether astrocytes provide metabolic 
substrates, such as lactate, to sustain high neuronal energy requirements (Calì et al., 2019, Dienel, 
2018, Dringen et al., 2005, Hirrlinger et al., 2002, Baxter and Hardingham, 2016). From this work 
astrocytes are now well established as providers of homeostatic support for neurons. 
1.1.1.1 Control of extracellular environment 
Today, the most well-established function of astrocytes remains their buffering of K+ and their 
clearance of extracellular glutamate, which maintains the concentrations of these stimulating factors 
throughout the extracellular environment. During an action potential, K+ is released from neurons, 
increasing the extracellular K+ concentration (Frankenhaeuser and Hodgkin, 1956). Due to the 
expression of numerous K+ channels in cellular membranes, increases in extracellular K+ can further 
depolarise membrane potentials, which can lead to aberrant neuronal activity. As such, extracellular 
K+ concentration is tightly regulated, typically increasing by less than 1 mM following normal 
activity, with the astrocyte network being a central component for this maintenance (Syková, 1983, 
Larsen et al., 2016). Although the exact mechanism is still debated, astrocytes respond to increases 
in extracellular K+ by first collecting it through both astrocytic Na+, K+-ATPase transporters and 
their extensively expressed K+ inward rectifier channel, KIR4.1 (Larsen et al., 2014). This sequestered 
K+ spreads throughout the astrocyte network, at least partially through astrocytic gap junctions, and 
is then released back out again into areas of low K+ concentration through KIR4.1 channels (Wallraff 
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et al., 2006, Hertz and Chen, 2016). As well as their regulation of K+ concentration, astrocytes are 
also responsible for maintaining the exceptionally low extracellular levels of glutamate in the brain 
required to prevent neuronal excitotoxicity, through their high affinity glutamate transporters 
(Danbolt, 2001). I expand on this subject matter in detail throughout Chapter 1.3-1.5 of the 
introduction, but it appears that the expression of these functionally crucial transporters in 
astrocytes is regulated by neurons (Schlag et al., 1998).  
1.1.1.2 Antioxidant provision 
One of the first observations of astrocytic influence on neurons was the enhanced survival of 
neurons grown in the presence of astrocytes. As well as the astrocytes’ role in preventing 
excitotoxicity by their buffering of K+ and removal of glutamate via their glutamate transporters, 
they are further involved in neuroprotection via the provision of antioxidants. The brain, and in 
particular the neurons within, is a highly metabolically active organ, using 20% of the total body 
energy and O2 consumption despite making up only 2% of total body mass (Dienel, 2018). This 
oxygen consumption results in the generation of peroxides and other derived reactive oxygen species 
(ROS), which can cause DNA damage, initiate faulty cell signalling and induce apoptotic pathways 
if not sufficiently neutralised (Barnham et al., 2004, Dringen et al., 2005). There are several 
antioxidant pathways responsible for clearing up these reactive species, including glutathione, 
catalase, superoxide dismutase and thioredoxin, and it has become apparent that astrocytes are 
heavily involved in this process (Baxter and Hardingham, 2016).    
One of the major pathways for peroxide neutralisation in the brain is the glutathione system. In this 
pathway, H2O2 is reduced with glutathione by glutathione peroxidase into water and glutathione 
disulphide, which can then be converted back to glutathione via glutathione reductase (Dringen et 
al., 2005). Using neuron or astrocyte cultures it was observed that this pathway is endogenously 
active in astrocytes rather than neurons (Dringen et al., 1999). Furthermore, the glutathione 
required for this detoxification pathway is the product of nuclear factor erythroid-2-related factor 2 
(Nrf2) activation of the antioxidant response element (ARE), with genes for this glutathione 
pathway being specifically upregulated in astrocytes rather than neurons following oxidative stress 
(Bell et al., 2011, Vargas and Johnson, 2009).  
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As neurons are the major consumers of oxygen, and hence producers of ROS, glutathione is greatly 
needed in neurons themselves to prevent peroxide mediated toxicity. Astrocytes therefore would 
need to send this glutathione across to neurons. Indeed, evidence suggests that astrocytes export 
glutathione into the extracellular environment, where it is converted into cysteine, and this cysteine 
can then be taken up by neuronal xCT transporters where it is used (along with astrocyte-derived 
glutamine) as a precursor for neuronal glutathione production (Hirrlinger et al., 2002, Shih et al., 
2003, Vargas and Johnson, 2009). In this way astrocytes not only provide neuroprotection via 
clearance of K+ and glutamate, they also respond to oxidative stress, producing antioxidants that 
neurons can then use for their protection. 
1.1.1.3 Metabolic support of activity 
Neuronal activity has one of the largest energy requirements in the body, most of which goes 
towards supporting synaptic transmission (Harris et al., 2012, Dienel, 2018). Unlike other tissues, 
the brain is almost solely dependent on glucose to support this activity under normal conditions, 
with the human brain requiring approximately 90 g of glucose per day (Chugani et al., 1987, 
Madsen et al., 1995). Over two decades ago it was proposed that in response to neuronal activity 
astrocytes increase their uptake of glucose  from blood vessels and convert it into lactate, which they 
then shuttle to neurons to use as fuel, in what was termed the astrocyte-neuron lactate shuttle 
(Pellerin et al., 1998). This proposal has been widely debated and the extent to which neurons use 
astrocyte provided lactate as a metabolic substrate is under question (Bélanger et al., 2011, 
Boumezbeur et al., 2010, Dienel, 2017). It is likely that neurons preferentially metabolise glucose 
under basal conditions, but under higher metabolic demands astrocytes are able to increase lactate 
production and release as an alternative energy source for neurons. 
A second key way in which astrocytes support the high energetic demands of neurons is by 
providing them with amino acid precursors such as glutamine for the production of both glutamate 
and γ-aminobutyric acid (GABA), a key feature of the glutamate-glutamine cycle which will be 
discussed in greater detail later in this chapter. Surprisingly, neurons express little of the enzyme 
pyruvate carboxylase, giving them a limited capacity for the de novo synthesis of metabolic 
intermediates that are required for glutamate and GABA synthesis, whereas astrocytes express this 
enzyme in abundance rendering them capable of the anaplerotic reactions required (Bak et al., 2006, 
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Yu et al., 1983). As astrocytes are additionally the major clearers of glutamate, this would result in 
the run-down of pre-synaptic glutamate stores following excitatory transmission, as neurons neither 
uptake nor synthesise the neurotransmitter to a great extent. It follows that astrocytes must then 
supply neurons with the precursor glutamine and/or other metabolic intermediates generated 
through astrocytic anaplerosis in order for neuronal neurotransmitter stores to be replenished, 
allowing transmission to continue.  
The requirement of astrocytic glutamine for maintaining excitatory activity was nicely 
demonstrated several years ago by Reimer and colleagues (Tani et al., 2014). In hippocampal slices 
the authors showed that under a low stimulus paradigm (0.2 Hz activity bursts), preventing 
astrocytic conversion of glutamate to glutamine by inhibition of the enzyme glutamine synthetase 
(GS) had little effect on neuronal activity. In the hippocampus 20-30 Hz of activity can be observed 
in mice in vivo during exploration, so the authors then increased the stimulus to 2 Hz, still a 
submaximal stimulus, and this time found that there was a continual decrease in field amplitude 
when astrocytic GS was inhibited, that could be prevented by bath applying 500 μM of exogenous 
glutamine to the aCSF (Tani et al., 2014). When they increased to 20 Hz stimulation, they found a 
rapid run-down to near full abolishment of field responses when astrocytic glutamine production 
was inhibited, and exogenous glutamine could only partially prevent the effects. However, this 
continual high burst activity is un-physiological, so they moved to an intermittent 20 Hz followed 
by 200 s of low 0.2 Hz stimulation protocol, as well as a physiological protocol based on activity 
patterns recorded from an in vivo freely moving animal. Under these more physiological scenarios, 
without astrocytic glutamine supply there was an almost complete lack of induced field response 
after several high frequency events, but in the presence of exogenous glutamine this rundown was 
completely prevented (Tani et al., 2014). They further demonstrated this was also the case for 
excitatory pyramidal layer III cortical cells, with intermittent 20 Hz stimulation causing a decreasing 
field response without astrocytic glutamine, that was recovered by the application of exogenous 
glutamine (Tani et al., 2014).  
As yet, there is no conditional astrocytic glutamine transporter knock down to confirm the necessity 
of astrocytic glutamine release for maintaining activity, nor any drugs capable of specifically 
inhibiting the astrocytic glutamine transporter (SNAT3; Todd et al., 2017). A SNAT3 knockout 
mouse has been reported, but due to the importance of SNAT3 in the kidney this resulted in animal 
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death by post-natal day 20. However, by this stage the mice had significantly reduced glutamate and 
GABA, but increased glutamine, concentrations in the brain, as well as a form of ataxia, further 
supporting the requirement of astrocytic released glutamine for maintaining neuronal glutamate 
levels required for optimal transmission (Chan et al., 2016).  
1.1.2 Active astrocyte-neuron communication 
Beyond astrocytes’ important but arguably passive roles in homeostasis, astrocytes and neurons are 
also able to communicate with each other to actively modulate activity and function. The first 
evidence of neuronal communication to astrocytes came with the advent of Ca2+ imaging. 
Compared to neurons, astrocytes are relatively electrically quiet cells, a contributing factor to the 
former paucity of research into their function. However, with Ca2+ imaging it was shown that 
astrocytes are highly active cells, showing dynamic and varied Ca2+ signalling within their processes, 
particularly in response to neuronal activity (Porter and McCarthy, 1995, Khakh and McCarthy, 
2015). This confirmed that astrocytes both directly sensed and responded to neuronal 
communication. More recent work has additionally shown Na+ to be a second activity-regulated 
signalling mechanism within astrocytes (Verkhratsky et al., 2019, Kirischuk et al., 2012). 
A hot topic of research currently is how astrocytes may communicate back to neurons and alter 
neuronal function and activity. Evidence suggests that astrocyte to neuron signalling may be 
important in axon and dendrite growth and formation, as well as synapse formation (Le Roux and 
Esquenazi, 2002, Baldwin and Eroglu, 2017, Christopherson et al., 2005). Furthermore, the notion 
of a tripartite synapse has become commonplace, whereby astrocytes act as a third player along with 
the pre- and post-synapse, releasing neuro-modulatory factors to directly stimulate neuronal 
synapses (Perea et al., 2009, Parpura et al., 1994, Araque et al., 1998). This direct astrocyte to 
synapse signalling may be required for various forms of neuronal plasticity, including long-term 
potentiation (LTP) and long-term depression (LTD) (Henneberger et al., 2010, Min and Nevian, 
2012). 
Although there has been a rapid expansion in the knowledge of these more active forms of astrocyte-
neuron communication, the field is still in its relative infancy, with many gaps in knowledge still to 
be addressed. In my thesis I explore both sides of this bidirectional communication between 
neurons and astrocytes, seeking to answer some of the outstanding questions. First, I investigate 
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how cortical neurons signal to cortical astrocytes to control astrocytic function, particularly 
focussing on how neurons control the functionally important astrocytic glutamate clearance 
pathway. Secondly, I investigate how cortical astrocytes alter cortical neuronal gene expression, and 
what the functional outcomes of this control are. For the remainder of this introductory chapter I 
will elaborate on the background literature leading to the work in this thesis.  
1.2 Neuron-to-astrocyte communication 
It is clear that neurons signal to astrocytes, causing changes in astrocytic form and function. The 
earliest suggestions that neurons actively communicate to astrocytes came from the observation that 
astrocytes express a number of receptors for neurotransmitters, and that application of the 
neurotransmitters glutamate or GABA induced astrocytic depolarisations (Kettenmann and 
Schachner, 1985, Bowman and Kimelberg, 1984, Murphy and Pearce, 1987). One of the most 
striking examples of neuron-to-astrocyte signalling is the dramatic morphological changes in vitro 
astrocytes undergo when cultured with neurons, being transformed from flat “pancake” shaped 
cells into more complex “star” like structures, reminiscent of their in vivo forms (Hatten, 1985, 
Hasel et al., 2017). But despite these observations over three decades ago, the signalling cascades 
induced in astrocytes by neuronal input, and the functional outcomes, are still largely unknown. 
Up until recently, only a few astrocytic proteins were known to be regulated by neurons. In 1997 
Swanson and colleagues showed that the two astrocytic glutamate transporters, excitatory amino 
acid transporter 1 (EAAT1; Slc1a3) and EAAT2 (Slc1a2), were upregulated by neurons. In cortical 
astrocytes cultured alone they detected EAAT1 in most astrocytes but little to no EAAT2, but in 
the presence of neurons they saw a significant increase in EAAT1 along with a strong induction of 
EAAT2 expression (Swanson et al., 1997). A few years on the connexin 43 (Gja1) protein, which 
forms astrocytic gap functions, was also shown to be upregulated by neurons (Rouach et al., 2000). 
Additionally, in 1988 glutamine synthetase metabolic activity appeared to be increased in forebrain 
astrocytes grown in the presence of forebrain neurons, suggesting that the interaction between 
neurons and astrocytes may also regulate astrocytic glutamine synthetase (Hayashi et al., 1988). 
However, even for just these few known targets, the neuronal signals behind their regulation in 




Figure 1.1: Cortical rat neuronal control of cortical mouse astrocytic transcriptome 
Neurons regulate the expression of astrocytic genes, with approximately 16 % of cortical (mouse) astrocytic 
genes being significantly up or downregulated by ≥1.3-fold by rat neurons. Prominently amongst the 
upregulated mouse genes are those for glutamate uptake, Slc1a3 (EAAT1) and Slc1a2 (EAAT2), and 
glutamate metabolism, Glul (glutamine synthetase) and Glud (glutamate dehydrogenase). Commonly used 
astrocytic markers, such as S100β, Aldh1l1 and glial fibrillary acidic protein (Gfap) were unaffected by co-
culture with neurons, although the astrocytic water channel (Aqp4) was significantly upregulated. Figure 
adapted from Hasel et al., 2017. 
 
 
To address this gap in knowledge our laboratory recently undertook RNA-sequencing (RNA-seq) 
of cortical astrocytes grown alone or in the presence of cortical neurons (Hasel et al., 2017). We 
uncovered hundreds of previously unknown astrocytic genes that are regulated by neurons, for 
example the astrocytic water channel, aquaporin 4 (Aqp4; see Figure 1.1). However, one of the 
strongest effects of neurons on astrocytes that we saw was the induction of the already reported 
astrocytic glutamate transporters, Slc1a2 and Slc1a3, as well as genes for proteins involved in 
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glutamate metabolism, Glul (glutamine synthetase) and Glud (glutamate dehydrogenase). Given 
the functional importance of glutamate clearance and recycling, I chose to focus on exploring how 
neurons control astrocytic glutamate transporter function, and the signalling pathway involved.  
1.3 Astrocytic glutamate clearance and recycling 
Glutamate is the predominant neurotransmitter in the brain, activating post-synaptic ionotropic 
N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA)/kainate receptors. Co-activation of AMPA and NMDA receptors allows the influx of 
Na+ ions, depolarising the cell’s membrane potential, with sufficient depolarisation triggering an 
action potential. As well as being located on the post-synaptic density, NMDA receptors can be 
found in extrasynaptic locations. This is significant as NMDA receptors allow Ca2+ to pass through 
their channel pore as well as Na+, with this Ca2+ causing the induction of different signalling 
cascades depending on both the NMDA receptor location and subtype (Hardingham et al., 2002, 
Hardingham and Bading, 2010, Martel et al., 2012). As well as activating ionotropic receptors, 
glutamate also activates the metabotropic glutamate receptor family (mGluRs), which are G-
protein coupled receptors (GPCR), whose stimulation initiates various signalling cascades (Gerber 
et al., 2007).  
Once released it is important that glutamate is cleared away, as too much glutamate in the 
extracellular space becomes neurotoxic. Firstly, if it isn’t cleared away it will continue to stimulate 
the post-synaptic receptors after the initial signal has been sent, impairing the detection of the next 
signal that arrives and potentially leading to cell swelling due to ion influx (Danbolt, 2001). 
Secondly, if this glutamate escapes from the synaptic zone it was released into it could activate 
unintended synapses, triggering activity where it should not. But most significantly, if glutamate 
escapes the synaptic region it can activate extrasynaptic NMDA receptors: too much Ca2+ influx via 
these extrasynaptic NMDA receptors induces signalling cascades that initiate cell death programs 
(Hardingham and Bading, 2010).  
Astrocytes have long been known to be important in promoting the survival of neurons and for 
counteracting the toxic effects of glutamate (Lindsay, 1979, Banker, 1980, Rosenberg et al., 1992, 
Rosenberg and Aizenman, 1989). This protection is largely due to the fact they are predominantly 
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responsible for clearing away glutamate via transporters located on astrocytic membranes, 
preventing excitotoxicity. Once inside the astrocytes, the glutamate is then either converted into 
α-ketoglutarate by glutamate dehydrogenase (GDH) or transaminases and shunted into the 
astrocytic TCA cycle, or else converted into glutamine by the enzyme glutamine synthetase (GS) 
(Hertz and Rodrigues, 2014, Sonnewald and Schousboe, 2016). Glutamine is not toxic to neurons, 
and is extruded by the SNAT3 glutamine transporter into the extrasynaptic space, which can then 
be taken up by neurons and converted back into glutamate via the neuronally expressed 
phosphate-activated glutaminase (PAG), thus replenishing pre-synaptic glutamate stores (Billups et 
al., 2013, Tani et al., 2014, Todd et al., 2017, Uwechue et al., 2012). This cycle is referred to as the 
glutamine-glutamate cycle (Figure 1.2). 
 
Figure 1.2: The glutamine-glutamate cycle 
Glutamate (Glu-) released after excitatory transmission is collected by astrocytic EAAT transporters 1 & 2. 
The glutamate is then either converted into α-ketoglutarate (α-KG) via glutamate dehydrogenase (GDH) or 
transaminase reaction and enters the TCA cycle, or else is converted into glutamine (Gln) by glutamine 
synthetase (GS). Astrocytes excrete Gln back into the extracellular environment via the Na+ driven SNAT3 
transporter, which is then taken up by an as yet unconfirmed neuronal Gln transporter. Neurons then convert 
Gln back to Glu- via a phosphate-activated glutaminase (PAG) reaction to replenish their vesicular Glu- 




Astrocytic glutamate uptake and recycling is a vital part of CNS function, with impairments in this 
system associated with many nervous system diseases. Key within this machinery are the two 
glutamate transporters, excitatory amino acid transporters 1 and 2 (EAAT1 and EAAT2), that are 
responsible for the astrocytic uptake of glutamate.   
1.4 Glutamate transport within the brain 
Glutamate is found at high concentrations in the brain, at a concentration of approximately 
10 – 14 mM/L depending on region (Hädel et al., 2013, Schubert et al., 2004). However, most of 
this glutamate is kept within intracellular compartments, with only 3–4 μM/L found in the 
extracellular fluid (Lehmann et al., 1983, Hamberger and Nyström, 1984). Accordingly, there are 
numerous transporter proteins in the brain that are capable of facilitating glutamate transport to 
ensure that the right concentration of glutamate is maintained in the right compartments. These 
transporters first fall into two broad categories: those which are found in intracellular 
compartments, such as the three vesicular glutamate transporters (vGLUT1-3) which package 
glutamate into synaptic vesicles, and those located on the plasma membrane of cells that can 
transport glutamate into (or out of) the cell (see Danbolt, 2001, Erecińska and Silver, 1990, Helms 
et al., 2017, for reviews). The glutamate transporters that are found in the plasma membranes of 
brain cells consist of five sodium-dependent co-transporters, and one sodium-independent 
exchanger (Fotiadis et al., 2013, Grewer et al., 2014, Kanai et al., 2013). The sodium-independent 
exchanger, xCT, is found almost exclusively on astrocytes, but preferentially transports cysteine 
into the cell in exchange for extruding a glutamate molecule out of the astrocyte (Bridges et al., 2012, 
Ottestad-Hansen et al., 2018). Due to the need to transport glutamate into cells against its 
electrochemical gradient, it is therefore the sodium-dependent class of transporters that are 
responsible for quickly sequestering extracellular glutamate back into cells. There are five known 
members of this family of transporters, excitatory amino acid transporters 1 – 5.   
1.4.1 The excitatory amino acid transporters 
In the early 1970s a high affinity sodium-dependent uptake system for the negatively charged amino 
acids L-glutamate and L-aspartate was first described in synaptosomal preparations, which was 
hypothesised to be responsible for the accumulation of the putative excitatory neurotransmitter 
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glutamate into cells (Logan and Snyder, 1971, Balcar and Johnston, 1972). A few years later Balcar 
and colleagues went on to show that this glutamate uptake system was also present in glial cells, but 
not until 1992 were EAATs first purified, with four independent groups cloning three distinct 
EAAT family members: Glt-1 (EAAT2), GLAST (EAAT1), and EAAC (EAAT3) (Kanai and 
Hediger, 1992, Pines et al., 1992, Storck et al., 1992, Balcar et al., 1977, Tanaka, 1993). The final 




Figure 1.3: Excitatory amino acid transporter family 
A) Stoichiometry of EAAT family transporters. EAATs can function as an anion channel, with the associated 
Cl- conductance uncoupled to the transport of glutamate. B) Overview of the five EAAT family members. 
References: (Lehre et al., 1995, Dehnes et al., 1998, Lehre et al., 1997, Lehre and Danbolt, 1998, Holmseth 






All members of the EAAT family transport L-glutamate into cells under normal conditions using 
the electrochemical gradients of Na+ and K+ (Danbolt, 2001, Grewer et al., 2014). The different 
subtypes are found throughout the body, and within the brain they are found on different cell types 
and in different brain regions. Although they all transport glutamate into cells, each subtype 
possesses a different degree of chloride permeability, and it appears the function of each of these 
subtypes may vary. A summary of the five EAAT transporters is given in Figure 1.3. 
1.4.1.1 Location 
The two subtypes EAAT1 (analogous to GLAST) and EAAT2 (analogous to Glt-1) are referred to 
as the astrocytic glutamate transporters as they are the only EAAT subtypes expressed on astrocytes, 
where they are predominantly found on fine astrocytic processes opposed to glutamatergic synapses 
(Šerý et al., 2015, Zhou and Danbolt, 2013, Chaudhry et al., 1995). EAAT1 is found in astroglia 
(including the Bergmann and Müller glia) throughout the brain, on which they are exclusively 
expressed, and are the primary collectors of glutamate in both the cerebellum and retina (via 
Bergmann and Müller glia, respectively) (Lehre and Danbolt, 1998, Lehre et al., 1995, Schmitt et 
al., 1997, Rothstein et al., 1994, Derouiche and Rauen, 1995, Lehre et al., 1997, Pow and Barnett, 
1999). EAAT2, on the other hand, is the main glutamate transporter in other brain regions, but 
most prominently in the hippocampus and cortex (Lehre et al., 1995, Zhou and Danbolt, 2013). 
The location of EAAT2 is less astrocyte-exclusive, with some evidence suggesting it is also found to 
a small degree in neurons, particularly in the hippocampus and retina (see Zhou and Danbolt, 2013 
for discussion). Combined, EAAT1 and EAAT2 make up a significant proportion of the total 
protein in the brain, representing ~2.1% of protein in the molecular layer of the cerebellum, 1.6% in 
the hippocampal stratum radiatum, and 1% of protein in forebrain tissue, making them the most 
abundant EAATs found in the CNS, and clearly of functional importance (Lehre and Danbolt, 
1998).  
The EAAT3 subtype is exclusively neuronal, and is found on neurons throughout the brain 
(Holmseth et al., 2012, Shashidharan et al., 1997). It typically localises on dendritic spines, and not 
axon terminals, with its highest expression seen in the hippocampus, at a concentration of 
0.013 mg/g (Holmseth et al., 2012). This is 100 times less than the concentration of EAAT2 in the 
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same region, so even here is unlikely to significantly contribute to glutamate clearance. EAAT4 is 
another neuronally expressed glutamate transporter, however its expression profile is more 
restricted than that of EAAT3, being found primarily on Purkinje cells of the cerebellum, with 
some sparse expression in certain subregions of the forebrain and midbrain (Dehnes et al., 1998, 
Massie et al., 2008). It represents about 0.2% of protein in the molecular layer of the cerebellum, 
which is approximately 10 times less than the predominant astroglial subtype in this region, EAAT1 
(which represents 1.8% of total cerebellar protein), and about par with the EAAT2 subtype (sitting 
at 0.3%) (Dehnes et al., 1998, Lehre and Danbolt, 1998). The final member of the family, EAAT5, 
has only been found in the eye, where it is located on synaptic terminals of retinal rod bipolar cells 
as well as rod and cone photoreceptors (Arriza et al., 1997, Pow and Barnett, 2000). Again, the 
astrocytic EAAT1 subtype is expressed more strongly in the retina than EAAT5, and there is 
evidence that EAAT5 may physiologically act as a chloride channel rather than a glutamate 
transporter in these retinal neurons (Eliasof et al., 1998, Wersinger et al., 2006). 
1.4.1.2 Structure and function 
All EAATs support the transport of L-glutamate as well as D and L-Aspartate, displaying a relatively 
high affinity for L-glutamate, with reported KM for glutamate ranging from 10-100 μM (Arriza et 
al., 1997, Arriza et al., 1994, Gegelashvili and Schousboe, 1998). Given that the glutamate 
concentration within cells is many-fold higher than that in the extracellular space, combined with 
the fact that glutamate is an anion carrying -1 charge, the stoichiometry of the EAATs must be such 
that the transport cycle overcomes the electrochemical gradient of glutamate. The stoichiometry 
was debated for some time, with different groups arguing for whether the transporters couple two 
or three Na+ ions to the transport of one glutamate (Zerangue and Kavanaugh, 1996, Kanai et al., 
1995). It has since been established that the EAATs combine the transport of 1 glutamate molecule 
with the co-transport of 3 Na+ and 1 H+, whilst counter-transporting 1 K+, as shown in Figure 1.3 
(Levy et al., 1998). This has been supported by more recent studies using the homologous archaeal 
glutamate transporters GltPh and GltTk whose structures were crystallised in 2004 and 2013 (Yernool 
et al., 2004, Jensen et al., 2013, Arkhipova et al., 2019, Kortzak et al., 2019). As a result, the transport 
cycle is charged, with a net +2 charge per molecule of glutamate transported, facilitating the inward 
movement of the otherwise negatively charged glutamate, whilst using the Na+ and K+ 
concentration gradients to further drive transport into the cell. Importantly, this stoichiometry is 
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estimated to allow the internal glutamate concentration to be in the order of 106 times greater than 
the external concentration under physiological conditions, ensuring the transporters work to take 
up rather than extrude glutamate under normal conditions (Danbolt, 2001). 
Although this transporter stoichiometry is believed to be common to all members of the EAAT 
family, meaning all EAATs could help facilitate glutamate clearance, there is a difference between 
the EAATs. As well as functioning as a transporter, EAATs can also act as ligand-gated ion channels, 
with glutamate activation leading to an uncoupled conductance of Cl- through the channel 
(Wadiche et al., 1995, Wadiche and Kavanaugh, 1998, Fairman et al., 1995, Machtens et al., 2015). 
However, the level of anion conductance varies largely between the different subtypes (Fahlke et al., 
2016). EAAT4 and EAAT5 display the largest ion conductance, with their Cl- conductance being 
greater than that of their glutamate uptake, EAAT1 and EAAT3 have intermediate ion 
conductance, while EAAT2 displays very little conductance at all (Arriza et al., 1997, Fairman et al., 
1995, Kanai et al., 2013, Wadiche et al., 1995). Recent work has suggested that EAAT5 uses this 
anionic conductance to act as an “inhibitory” glutamate receptor in retinal cells, hyperpolarising 
these cells’ membrane potentials following glutamate activation (Schneider et al., 2014, Tse et al., 
2014, Wersinger et al., 2006). It is likely that both the EAAT4 and EAAT5 subtypes do not 
physiologically function as glutamate uptake systems, but instead act as Cl- channels.  
The first support for astrocytic glutamate transporters EAAT1 and EAAT2 being responsible for 
glutamate clearance rather than neuronal subtypes came from studies using autoradiographic 
localization, which found the bulk of cleared glutamate was seen in glial cells (McLennan, 1976, 
Wilkin et al., 1982). Electrophysiological recordings later went on to show that this astrocytic 
glutamate clearance was mediated by EAAT1 and EAAT2 (Bergles and Jahr, 1998, Bergles and Jahr, 
1997). Final evidence that it is the astrocytic EAAT1 and EAAT2 subtypes, and not the neuronal 
EAAT3, that are responsible for glutamate clearance comes from knockout studies.  
An EAAT2 knockout animal was generated in 1997, which developed lethal seizures resulting in an 
80% death rate by 13 weeks of age, compared to 100% survival in controls (Tanaka et al., 1997). It 
was found that there was a slower clearance of synaptically released glutamate in knockout animals, 
with neuronal degeneration appearing specifically in the hippocampal CA1 region (Tanaka et al., 
1997). In 1998 the group went on to generate an EAAT1 knockout animal (Watase et al., 1998). 
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Unlike the EAAT2 knockout, removal of EAAT1 did not appear to be lethal, and brain 
development appeared normal. The group focused on the cerebellum, given that is EAAT1’s 
prominent region of expression, and found that in EAAT1 knockouts glutamate uptake in this 
region was nearly half that of wild-types. Although finding no difference in basic motor tasks, they 
found a significant impairment in the knockouts’ ability to complete a more challenging rotor-rod 
experiment. Further, they found that mutant EAAT1 animals, but not wild-types, were susceptible 
to cerebellar edema following cold injury (Watase et al., 1998). Inevitably, in 2006 the group 
reported on a double EAAT1/EAAT2 knockout animal. Unlike the single mutants, the double 
knockout of EAAT1 and EAAT2 was embryonic lethal, with mice dying by E17-18, and brain-
wide abnormalities in structure observed (Matsugami et al., 2006). These studies highlight the vital 
importance of this system in the CNS. 
In 1997 a second group generated a mouse knockout for the neuronal glutamate uptake transporter, 
EAAT3 (Peghini et al., 1997). Contrary to the neurological deficits seen in EAAT1 or EAAT2 
knockout animals, removal of the neuronal glutamate uptake transporter, EAAT3, had no negative 
effect on brain formation or function over a period of >12 months. There was no impairment in 
motor skills, nor in memory, nor in susceptibility to induced seizures (Peghini et al., 1997). The 
group did observe that the mutant mice developed dicarboxylic aminoaciduria, although this is 
attributed to the fact that EAAT3 plays an important role in glutamate transport in the kidneys. A 
limitation of all these studies, particularly for the EAAT2 knockout, is in the fact they were global 
knockout models, and not astrocyte specific. As EAAT2 is reportedly expressed on neurons, this 
does not rule out neuronal EAAT2 glutamate uptake as being an important source of glutamate 
clearance to prevent excitotoxicity. Addressing this limitation, Rosenberg and colleagues produced 
conditional neuronal and conditional astrocytic EAAT2 knockout lines (Petr et al., 2015). Whilst 
neuronal knockouts showed no difference in growth and lifespan, astrocytic EAAT2 mutants had 
lower weight gain and significantly higher mortality rates compared to controls (Petr et al., 2015). 
In proteoliposome preparations from forebrains they found glutamate uptake in astrocytic mutants 
was 25% of that in controls, whereas there was no difference in glutamate uptake in these 
preparations between neuronal knockouts and controls. EEG recordings further showed astrocytic 
EAAT2 knockouts to have significantly more seizure events than controls, with no difference 
between the conditional neuronal knockouts and controls (Petr et al., 2015).  
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Altogether, the evidence shows that it is EAAT1 and EAAT2 expressed on astrocytes that are 
primarily responsible for clearing extracellular glutamate to prevent excitotoxicity. The 
stoichiometry of the EAAT transporters provides one explanation for why it is the role of astrocytes 
and not neurons: uptake can result in significant depolarisation (up to 2+ per molecule). If neurons 
were required to take up the bulk of released glutamate, this process in itself would cause significant 
neuronal depolarisation, potentially leading to a hyper-excitable feedback loop. Additionally, 
uptake would result in a significant increase in internal Na+ concentration, which is 
counterproductive to the neuron’s need to remove internal Na+ following an action potential and 
would represent a major metabolic strain on the already metabolically greedy neurons. 
1.4.2 Impairments in astrocytic glutamate clearance are features of disease 
Unsurprisingly, impairments in the maintenance of extracellular brain glutamate concentration is 
observed in numerous diseases. A number of accounts have linked astrocytic glutamate transporter 
dysfunction both to epilepsy and the neurodegenerative diseases, such as amyotrophic lateral 
sclerosis (ALS), multiple sclerosis, Alzheimer’s disease and Parkinson’s disease. In addition, there are 
also suggestions that dysfunction in these transporters might be features of depression and other 
emotional disorders.  
1.4.2.1 Astrocyte glutamate transporters and epilepsy 
The first demonstration that increased glutamate concentrations are a feature of epilepsy came from 
the results of an in vivo microdialysis investigation into the concentrations of GABA and glutamate 
in the hippocampi of epilepsy patients from 1989 to 1992 (During and Spencer, 1993). The 
investigators found that an increase in glutamate concentration appeared in the epileptogenic 
hippocampus approximately 1.5 minutes prior to seizure onset, but not in the contralateral 
hippocampus. At the onset of seizure glutamate levels became further elevated, with concentrations 
in glutamate also beginning to increase in the opposing hippocampus. Ten minutes post seizure the 
non-epileptic hippocampus glutamate concentrations had returned to baseline, whereas the 
epileptic side had persistently elevated glutamate levels >15 minutes post seizure (During and 
Spencer, 1993). The patients went on to receive surgical resection of the epileptic hippocampus, 
with microscopy of the removed tissue revealing moderate to severe pyramidal neuron loss 
throughout the hippocampal tissue along with reactive gliosis (During and Spencer, 1993).  
19 
 
Given the observance of elevated glutamate concentrations in epilepsy, later work investigated the 
role of the glutamate transporters in epileptic disease. A significant reduction in astrocytic EAAT2 
expression was found in patients with temporal lobe epilepsy (TLE) that went on to develop 
hippocampal sclerosis, but no change was found in EAAT2 expression in patients without neuronal 
loss (Proper et al., 2002, Mathern et al., 1999). More recently it was reported that there was a 
decrease in both EAAT1 and EAAT2 in epileptic hippocampi of patients with intractable 
treatment-resistant TLE (Sarac et al., 2009). It is not known if reduced astrocytic glutamate 
transporter function initiates some epileptic diseases or exacerbates it, or even if it is simply an 
outcome of prolonged disease, in humans. However, animal models have shown that removal of 
functional astrocytic EAAT2, and not neuronal EAAT3, is sufficient to cause severe and lethal 
epilepsy, demonstrating the possible involvement of astrocytic glutamate transporter dysfunction 
in the development of epilepsy (Tanaka et al., 1997, Binder and Steinhäuser, 2006). 
1.4.2.2 Involvement in neurodegenerative disease 
There are numerous neurodegenerative diseases, which are characterised by a progressive loss of 
neurons. The different diseases are characterised by disease progression and the specific neurons and 
brain regions that are primarily affected, for example, in motor neuron diseases there is a loss of 
motor neurons, whereas Parkinson’s disease is characterised by a loss of dopaminergic neurons in 
the substantia nigra. As mentioned in Chapter 1.3, excessive extracellular glutamate is neurotoxic 
and can lead to cell death by various mechanisms, and as such is believed to be a factor in the 
development and progression of the neurodegenerative diseases. Indeed, regardless of the role that 
insufficient glutamate clearance may play in the acute development and progression of epileptic 
activity, a frequent long-term outcome in human epileptic patients is neuronal degeneration 
(presumably from repeated elevations in glutamate concentrations), particularly in patients with 
reduced hippocampal EAAT2 levels (During and Spencer, 1993, Farrell et al., 2017, Proper et al., 
2002). Given that astrocytes are the main glutamate sink, insufficient astrocytic glutamate clearance 
to meet requirements is therefore one potential pathway to increased glutamate concentrations and 
resulting neuronal death. Therefore, much research has gone into investigating the role of astrocytes 
and their glutamate clearance in different neurodegenerative diseases, with some unequivocal links 
to disease emerging. 
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One prominent example is in ALS, a motor neuron disease characterised by progressive loss of 
motor neurons in the motor cortex, somatosensory cortex and spinal cord, with around 90% of cases 
occurring sporadically and 10% with familial linkage. From 1992 it was discovered that impaired 
glutamate uptake in motor regions was a feature of tissue samples from patients with sporadic ALS, 
and in 1995 that there was a pronounced reduction specifically in EAAT2 protein levels in these 
tissue samples (Rothstein et al., 1992, Rothstein et al., 1995). Additionally, one patient with 
sporadic ALS was found to have a mutation in the SLC1A2 gene that resulted in an EAAT2 protein 
with reduced glutamate transporter activity, suggesting EAAT2 dysfunction may cause some cases 
of disease (Trotti et al., 2001). Familial forms of ALS on the other hand were found to be associated 
with mutations in the superoxide dismutase gene (SOD1), with SOD1 mutant protein being shown 
to reduce functional EAAT2 protein levels in animal models by initiating the cleavage of EAAT2 
by Caspase-3  (Deng et al., 1993, Rosen et al., 1993, Gibb et al., 2007, Boston-Howes et al., 2006). 
Specific deletion of Slc1a2 in the spinal cord of mice was recently shown to be sufficient to lead to 
motor neuron degeneration by the fifth month of the mice’s lives (Sugiyama and Tanaka, 2018). 
Finally, in work with our collaborators we have found that in the P301S tauopathy model mouse, 
which results in motor neuron loss of the spinal cord, there is an approximate 35% decrease in Slc1a2 
expression in disease mice (Hasel et al., 2017). It is unclear if it is reduced EAAT function that leads 
to initial motor neuron death, or if it is the death of neurons that leads to the decrease in functional 
EAAT, although a combination of both seems likely to be involved in many cases. 
A significant and growing disease burden in modern society is Alzheimer’s disease and other 
dementias. In the UK there are approximately 850,000 people estimated to be living with a form of 
dementia, with nearly 210,000 new diagnoses each year, overtaking heart disease as the leading cause 
of death in the UK. Globally, approximately 50 million people are estimated to have dementia, 
costing the global economy an estimated $818 billion USD each year, with that number expected 
to reach 82 million people by 2030 at a cost of $2 trillion USD  (WHO, 2017, Matthews et al., 
2016). Dementias are a collection of neurocognitive disorders that cause varying cognitive 
dysfunction, with all featuring the presence of neurodegeneration. The most common dementia is 
Alzheimer’s disease (AD) which is characterised by the pathological presence of plaques and 
neurofibrillary tangles, along with progressive (and often severe) atrophy and neuron loss 
throughout the hippocampus and cortex.  
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As with motor neuron disease, there is interest in the role that glutamate dysregulation may play in 
the progression of neurodegeneration in dementias. From the 1990s it was observed that amyloid β, 
the main protein found in AD-associated plaques, reduced the function and expression of EAAT1 
and EAAT2 in rat hippocampal and cortical astrocytes (Harris et al., 1996, Parpura-Gill et al., 1997, 
Matos et al., 2008). Studies of human tissue samples have found the aberrant expressions of both 
the normally astrocyte specific EAAT1 transporter and the enzyme glutamine synthetase in subsets 
of cortical pyramidal neurons of AD patients, suggesting a marked dysfunction in astrocyte 
glutamate metabolism (Robinson, 2000, Scott et al., 2002). Reduced expression of both EAAT1 
and EAAT2 have further been observed in the hippocampi of patients with AD, alongside a 
significant decrease in glutamate transporter function in human AD cortices (Jacob et al., 2007, 
Masliah et al., 1996). Additionally, work with our collaborators has found that there is a significant 
reduction in both EAAT1 and EAAT2 expression in human frontotemporal dementia patients 
carrying the MAPT exon 10 +16 mutation compared to aged-matched controls (Spires-Jones & 
Hardingham lab, unpublished). Altogether, accumulated evidence suggests that impaired astrocytic 
glutamate recycling in the hippocampus and cortex is a feature of dementias and may play a role in 
the pathological progression of these burgeoning diseases.  
1.5 Glutamate transporter regulation 
Due to the links of impaired astrocytic glutamate uptake with disease, boosting the function of these 
transporters to rectify reduced or insufficient glutamate uptake may be a potential therapeutic 
strategy. In order to do this, one needs to know which signalling pathways are responsible for 
regulating astrocytic glutamate transporter expression. Unfortunately, these pathways have yet to 
be fully elucidated, although some hints have appeared. In particular, it has been long known that 
the presence of neurons is able to increase astrocytic glutamate transporter function. 
Before the different EAAT isoforms were isolated, it was observed that culturing cerebellar 
astrocytes in the presence of cortical neuronal conditioned media increased glutamate uptake 
(Drejer et al., 1983). Over a decade later, astrocytic EAAT1 and EAAT2 were first found to be 
significantly downregulated in the striatum following glutamatergic denervation, and the following 
year it was reported that EAAT1 was upregulated in cortical astrocyte cultures following activation 
of astrocytic AMPA and kainate receptors  (Levy et al., 1995, Gegelashvili et al., 1996). These 
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reports strongly implicated a role for neurons and neuronally released glutamate in regulating 
astrocytic glutamate transporters, which was confirmed in 1997 by two independent groups. 
Swanson and colleagues cultured cortical astrocytes alone or in the presence of cortical neurons, 
finding that culture with neurons both increased astrocytic EAAT1 expression and robustly 
induced EAAT2 expression – which was not detected in pure astrocyte cultures (Swanson et al., 
1997). It was further documented by Gegelashvili and colleagues that physical culture of neurons 
with cortical astrocytes increased astrocytic EAAT1 expression, as well as inducing EAAT2 
expression (Gegelashvili et al., 1997). Additionally, the group showed that feeding pure cortical 
astrocytes with neuronal conditioned media was able to induce EAAT2 expression in astrocytes, 
although they did not find EAAT1 to be affected by conditioned media. They concluded from this 
work that a neuronally released soluble factor was responsible for the regulation of EAAT2, whereas 
contact mediated interactions were predominant in the regulation of EAAT1 (Gegelashvili et al., 
1997). Interestingly, this group had earlier reported that glutamate was able to increase cortical 
astrocytic EAAT1 expression, suggesting soluble factors could play a role in regulating this 
transporter as well (Gegelashvili et al., 1996). Work since then has focused on discovering the 
signalling molecules and pathways behind this neuronal regulation. 
1.5.1 Regulation of astrocytic EAAT1 and EAAT2 by soluble factors 
1.5.1.1 Cyclic AMP signalling 
One of the first chemicals shown to induce glutamate transporter function in astrocytes was the 
cyclic AMP analogue, dibutyryl cyclic AMP (db-cAMP) (Hertz et al., 1978). Primary astrocytes 
grown alone showed little response to glutamate and appeared flat, whilst astrocytes fed with 
db-cAMP became more morphologically complex with significantly greater glutamate uptake 
(Hertz et al., 1978, Goldman and Chiu, 1984, Gegelashvili et al., 1996). As a result, many researchers 
began to treat astrocyte cultures with db-cAMP as standard practice, to make them more 
reminiscent of their in vivo counterparts. This suggests that one potential mechanism for the 
neuronal regulation of astrocytic glutamate transporters is through an induction of the astrocytic 
cAMP signalling pathway, which is shown in Figure 1.4.  
Further evidence for a role of cAMP signalling in astrocytic EAAT regulation comes from studies 
showing that application of the adenyl cyclase activator forskolin, to stimulate cAMP production, 
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to both astrocyte cultures and striatal homogenates is able to increase glutamate uptake (Pisano et 
al., 1996, Schlag et al., 1998). The mechanism behind this cAMP induced upregulation is less clear, 
with one group finding inhibition of cAMP’s downstream target of protein kinase A (PKA) to be 
sufficient to block the effects of forskolin, whilst others found an effect of PKA inhibition in pure 
astrocyte cultures but no effect on astrocyte glutamate transporter function when grown in the 
presence of neurons (Schlag et al., 1998, Pisano et al., 1996). The latter finding suggests that 
although PKA activation may upregulate EAAT1 and EAAT2 activity in astrocytes in the absence 
of neurons, in the presence of neurons this pathway is occluded by other mechanisms that are 
responsible for the observed neuronal regulation of astrocytic EAATs.  
 
Figure 1.4: The cyclic AMP signalling pathway 
Cyclic AMP is produced from ATP following the activation of the adenyl cyclase complex (AD) via Gs 
proteins. The cAMP activates protein kinase A (PKA), which phosphorylates various targets. This includes 
the serine133 residue on CREB, with phosphorylation of this residue causing CREB to translocate into the 




1.5.1.2 Glutamate signalling 
Despite early reporting that astrocytic AMPA and kainate receptor activation may upregulate 
EAAT expression, and that denervation decreases EAAT2 expression, it is still debatable whether 
neuronal glutamatergic synaptic activity has a role in astrocytic EAAT expression. Both work from 
our lab and others have found no effect of pharmacological blockade of neuronal activity on 
astrocytic EAAT expression (Schlag et al., 1998, Hasel et al., 2017). Contrary to these findings, it 
has been reported that in hippocampal astrocyte-neuron co-cultures pharmacological block of 
synaptic activity does reduce protein levels of both EAAT1 and EAAT2 (Perego et al., 2000). 
Furthermore, acute kainate injections to induce seizure activity in rats were seen to initially cause a 
significant increase in cortical EAAT2 expression, peaking after 4 hours, before ultimately 
decreasing below baseline levels (following neuronal death) (Simantov et al., 1999).  
1.5.1.3 Other pathways 
The EAAT2 transporter is able to be regulated by neuronal secreted factors, and much of the 
subsequent work into EAAT regulation has been focused on EAAT2 in particular (Gegelashvili et 
al., 1997). Epidermal growth factor application has been shown to upregulate EAAT2 expression 
through activation of NF‐κB signalling, with neuron-dependent induction of astrocytic NF-κB 
having been shown to upregulate astrocytic EAAT2 expression (Zelenaia et al., 2000, Sitcheran et 
al., 2005, Ghosh et al., 2011). Additionally, enhanced expression of Pax6 in pure astrocyte cultures 
has been recently shown to induce EAAT2 expression, while knockdown of Pax6 in astrocytes 
grown with neurons was seen to strongly repress neuron-induced EAAT2 expression (Ghosh et al., 
2016). However, the authors do not speculate upon the neuronally released factor(s) that may 
modulate EAAT2 expression through astrocytic Pax6.  
1.5.2 Contact dependent regulation of EAAT1 and EAAT2 
In contrast to neuronally released factors, relatively little work has investigated the contact-
dependent signalling pathways behind neuronal EAAT1 and/or EAAT2 regulation. It has been 
reasonably well established that unlike EAAT2, neuronal upregulation of EAAT1 expression is via 
a contact-dependent mechanism and not through a soluble factor, but here the knowledge ends 
(Gegelashvili et al., 2000). Furthermore, it has not been established if contact-dependent signalling 
also has a role in EAAT2 regulation.  
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1.5.2.1 The Notch signalling pathway 
Notch is an important contact dependent signalling pathway present in astrocytes; in fact, it is the 
interaction of Notch ligands expressed on neuronally committed precursor cells with uncommitted 
precursors that first initiates the precursors’ development into astrocyte lineage cells (Namihira et 
al., 2009). An overview of the Notch signalling pathway is shown in Figure 1.5. Briefly, when Notch 
ligands (for example Delta and Jagged1 & 2) contact the receptors (Notch1-4) the receptors 
undergo cleavage by the enzyme γ-secretase, releasing the Notch intracellular domain (NICD) of 
the receptor. The NICD then translocates into the cell nucleus, where it associates with the Notch 
effector, CBF1, and Mastermind-like (MAML) to activate transcription, with the Hes and Hey 
family of genes being well-established examples of this transcriptional pathway (Kopan and Ilagan, 
2009, Fischer and Gessler, 2007). 
 
 
Figure 1.5: The Notch signalling pathway 
Notch is a contact dependent signalling pathway. When a Notch ligand contacts a Notch receptor this 
initiates a cleavage event through the enzyme γ-secretase, releasing the Notch intracellular domain (NICD). 
The NICD then translocates into the cell nucleus, where it pulls down various proteins, such as MAML, and 
associates with the Notch effector, CBF1. This association turns on transcription, with Hes5 and Hey2 
examples of genes transcribed by this cascade. The γ-secretase inhibitor DAPT is able to prevent activation 




In drosophila only the EAAT1 subtype of high affinity glutamate transporters are found, where it 
is located on glia cells. Using this model system it was observed that Notch signalling mediated by 
neuronally expressed Delta ligands induced the expression of EAAT1 in drosophila glia cells (Stacey 
et al., 2010). If this is a conserved process, these results could suggest a role for Notch signalling not 
only in allowing astrocyte cell type differentiation, but also in inducing astrocytic EAAT expression. 
Strengthening the case for Notch, recently, using mouse astrocyte and astrocyte-endothelial co-
cultures, endothelial cells were observed to induce EAAT2 expression in astrocytes through contact 
dependent Notch signalling (Lee et al., 2017). Interestingly, a paper by Angulo-Rojo and colleagues 
suggests a link between cAMP signalling and Notch in astrocytes (Angulo-Rojo et al., 2013). They 
observed that application of db-cAMP increased the amount of NICD that translocated into the 
cell nucleus, and that either application of the γ-secretase inhibitor DAPT to block NICD cleavage, 
or application of the PKA inhibitor H89 to prevent cAMP mediated PKA signalling, was sufficient 
to prevent this cAMP induced increase (Angulo-Rojo et al., 2013). They confirmed that db-cAMP 
was able to induce Notch transcription, first by showing increased CBF1 activity via a luciferase 
assay. They then demonstrated that db-cAMP treatment increased both Hes5 gene and Hes5 
protein expression, which was also prevented by inhibition of either Notch (via DAPT application) 
or PKA (via H89) signalling (Angulo-Rojo et al., 2013). This suggests the possibility that the as yet 
undetermined neuronal signalling molecule that induces astrocytic EAAT expression through the 
cAMP pathway is in fact physiologically mediated by the contact-dependent Notch pathway in the 
CNS. 
Lending support to the hypothesis that it is neuron-dependent Notch signalling that primarily 
controls astrocytic EAAT expression, in our lab we have found that neurons are enriched for the 
Notch ligands, whilst astrocytes are enriched for the Notch receptors (see appendix A1 i). 
Furthermore, we have seen that neurons induce Notch effector activity in astrocytes (appendix A1 
ii), and that the transcription of the Notch downstream genes is induced in astrocytes by the 
presence of neurons (appendix A1 iii).  
In Chapter 3 I investigate the role of neuronal regulation of astrocytic EAAT expression and 
function, with a particular aim to answer the outstanding question of whether neuronal Notch 
signalling is responsible for controlling astrocytic EAAT function.  
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1.6 Astrocyte-to-neuron communication 
After researchers had established that astrocytes respond to neuronal activity, in particular with 
their roles in glutamate uptake and potassium buffering, the next question was whether astrocytes 
in turn signalled back to neurons. A passive effect of astrocytes on neuronal function was already 
implicated due to their control of external K+ and glutamate concentrations, which could in turn 
lead to dampening or enhancement of neuronal activity, as well as neuronal death. But the question 
remained whether astrocytes actively signalled back to neurons, which might additionally give them 
direct control of either neuronal gene expression and/or function. The first evidence that this could 
be the case came in the early 1990s, when it was observed that inducing Ca2+ events in cultured 
astrocytes could evoke Ca2+ events in neighbouring cultured neurons, via Ca2+ induced astrocytic 
glutamate release (Nedergaard, 1994, Parpura et al., 1994). Additionally, it was observed that, as 
well as enhancing survivability, cortical neurons grown on cortical astrocytes developed enhanced 
synchronous Ca2+ waves, that were mostly absent in the surviving neurons grown without 
astrocytes (Nakanishi et al., 1994). It was further shown that glia were also able to induce 
spontaneous activity in retinal ganglion cell preparations (Pfrieger and Barres, 1997). These early 
demonstrations of astrocytic effect on neuronal activity triggered an explosion of work over the past 
two decades investigating the potential signalling events from astrocytes to neurons. 
Unfortunately, despite the wealth of evidence that astrocytes exert an influence on neuronal 
activity, no studies have yet investigated whether and what non-cell-autonomous signalling 
pathways astrocytes activate in neurons and the functional consequences of this signalling. This is 
a major gap in our current understanding of the brain, and a question I in part seek to answer in 
Chapters 4 & 5 of this thesis, that is: how do astrocytes control neuronal gene expression and 
function? For the remainder of this chapter I will provide background information on aspects of 
neuronal function that astrocytes are believed to be actively involved in regulating.  
1.7 Astrocytic involvement in neuronal development 
A major area of research is focused on the involvement of astrocytes in neuronal development, 
including their effects on the differentiation of cells into different neuronal subtypes, dendrite and 
synapse formation.  
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1.7.1 Morphology and cell type development 
Astrocytes have long been observed to affect neuronal morphological development. From 1980 
Banker observed that culturing hippocampal neurons with astrocytes significantly increased the 
number of neuronal protrusions (Banker, 1980). Later it was shown that astrocytes from different 
regions had different effects on neuronal morphological development. First, dopaminergic neurons 
from the mesencephalon were either plated onto astrocytes prepared from the mesencephalon or 
striatal regions. The dopaminergic neurons grown on astrocytes from the same region developed 
multiple complex branches, whereas those grown on astrocytes from the striatum developed 
relatively few branches (Denis-Donini et al., 1984). Later the group investigated growing striatal or 
mesencephalic neurons on either striatal or mesencephalic astrocytes: again, neurons from the 
mesencephalon showed more mature development when grown on astrocytes also from the 
mesencephalon, whereas striatal neurons appeared more mature when grown on striatal astrocytes 
rather than mesencephalic (Autillo-Touati et al., 1988, Chamak et al., 1987). This work indicated 
that astrocytes not only effect neuronal morphology, but that astrocytes from different regions are 
able to exert different control over neurons.  
Multiple studies have since shown a role for astrocytes in guiding axon and dendritic growth as well 
as determining neuronal morphology throughout different brain regions, including the brainstem, 
cortex, hippocampus, retina, olfactory bulb, midbrain and striatum (Martin et al., 2012, Cheng et 
al., 2018, Ebrahimi et al., 2016, Le Roux and Esquenazi, 2002, Jacobs et al., 2016, Steinbach et al., 
2001, Bailey et al., 1999, Garcia-Abreu et al., 2000, Wagner et al., 1999, Gates and Dunnett, 2001, 
Matsutani and Yamamoto, 1998). Both physical location and orientation of astrocytes as well as 
secretion of astrocytic factors, such as fibroblast growth factor, are believed to be important for this 
control of neuronal morphology (Chotard and Salecker, 2004, Procko and Shaham, 2010, Le Roux 
and Esquenazi, 2002). 
1.7.2 Synaptogenesis 
The fundamental feature of CNS function is synaptic communication between neurons, mediating 
information transfer and storage. In order for successful neurotransmission to occur, pre- and post-
synapse formations must develop on the right neurons at the right physical location, and correctly 
localise in apposition to each other. Furthermore, each synapse must form a correct specialisation, 
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for example becoming a GABAergic or glutamatergic synapse. The process of synaptogenesis is 
therefore both complex given the variety of neurotransmitter receptors and tightly regulated, with 
the underlying mechanisms yet to be largely understood (for review see Kurshan & Shen, 2019 and 
Südhof, 2018). In general, pre-synaptic densities form at the end of axons, where they contain 
neurotransmitter vesicles and release machinery, while post-synaptic densities form (typically) on 
dendritic spines and contain neurotransmitter receptors. The two densities co-localise in apposition 
to each other, although whether it is the pre-synapse that induces the formation of the post-synaptic 
density, or the post-synapse that guides the pre-synapse towards it may vary depending on region 
and synapse. Additionally, the process of specialisation may be hardwired into certain cell types, 
whereas for others specialisation may instead occur after pre- and post-synapse co-localisation 
(Südhof, 2018, Kurshan and Shen, 2019). 
Several proteins have been shown to be important in synapse formation, chiefly among them the 
cell adhesion molecules (CAMs) which are found in the pre- and post-synapses and are believed to 
be important in synaptic formation and positioning. Many CAMs have been described, including 
neuroligins, neurexins, latrophilins, pentraxins and brain angiogenesis inhibitors (BAIs) (Südhof, 
2017, Südhof, 2018). The importance of these proteins has been demonstrated with hippocampal 
neurons grown with HEK or COS cells engineered to express different CAMs. Neuroligin-1 and -2 
expression in HEK cells were shown to induce pre-synapse formation in axons, as was synCAM 
(with co-expression of synCAM and glutamate receptors in HEK cells sufficient to form functional 
post-synaptic responses), whilst neurexin expressing COS cells caused both GABA and 
glutamatergic post-synapse formation on neuronal dendrites (Graf et al., 2004, Biederer et al., 2002, 
Scheiffele et al., 2000). Aside from neuronally expressed CAMs, several other players have been 
implicated in synapse formation, including a variety of astrocyte associated proteins.  
Suspicions that astrocytes may be involved in neuronal synaptogenesis were first roused by work 
from the Barres group during the development of purified retinal ganglion cell (RGC) cultures. 
They initially observed that cultured RGCs showed little spontaneous activity on their own (after 
20 days in culture only 63% of RGCs displayed spontaneous activity), whereas growing these cells 
in the presence of glia from the superior colliculus increased the number of RGCs displaying 
spontaneous activity to 100% (Pfrieger and Barres, 1997). Interestingly, the authors mention that 
co-culturing RGCs with purified neurons from the superior colliculus had a similar effect to glia in 
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inducing spontaneous synaptic activity, which would suggest the effect is not specific to glia, but 
rather a general effect of cells from that brain region on RGCs. However, they did not explore this 
idea further and instead showed that culturing purified RGCs in the presence of glia conditioned 
media was sufficient to replicate the effect of direct co-culture on spontaneous events (Pfrieger and 
Barres, 1997). Next, they demonstrated that this increase in spontaneous events was not necessarily 
due to an increase in excitability in co-cultured RGCs but instead due to an increase in synapse 
number, as there was a 12-fold increase in frequency (and amplitude) of miniature EPSCs (mEPSC) 
in co-cultured RGCs. I note here that they did not investigate whether there was an increase in 
excitability in co-cultured RGCs in addition to the observed increase in quantal release probability, 
as increased excitability could also cause an increase in spontaneous activity. Using electron 
microscopy (EM) they found that mono-cultured RGCs developed structurally normal synapses, 
although there were twice as many synapses in the presence of glia, which was further corroborated 
by the presence of positive pre-synaptic puncta staining in purified RGCs. From this the authors 
conclude that glia must secrete factors that transform structurally present but silent synapses in 
RGCs into functionally active synapses (Pfrieger and Barres, 1997).  
Several years later the original authors largely repeated their original findings: increased spontaneous 
activity in RGCs cultured either in the presence of glia from the superior colliculus or glial 
conditioned media, whilst still observing structural synapses in the absence of glia (Ullian et al., 
2001). They confirmed it was a protein in the glial conditioned media, as treatment with proteinase 
prevented the effect (Nägler et al., 2001). Additionally, they found that although there were similar 
amounts of pre- and post-synaptic associated protein, there was an increase in “puncta” like 
formations of these proteins in co-cultured RGCs, with approximately a 5-fold increase in 
co-localised pre- and post-synaptic puncta in RGCs grown in the presence of astrocytes. They 
explored the effect of astrocytes on synaptic stability by first growing RGCs in the presence of 
astrocyte conditioned media (ACM) for 5 days before exchanging the ACM for unconditioned 
media for a further 6 days. Removal of ACM reduced both the pre-synaptic quantal content of 
evoked activity as well as co-localised synaptic puncta to approximately a third of the values recorded 
in the presence of ACM (Ullian et al., 2001). They then investigated the developmental time point 
that synaptic puncta appear in the superior colliculus of rats (where RGCs extend their axons to), 
finding that puncta appeared during the first post-natal week, which corresponded to the time when 
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astrocytes appeared to undergo rapid proliferation as assessed by S100β staining (Ullian et al., 2001). 
They hypothesised that astrocytes are required for the formation of stable synapses, which is why 
synapses don’t appear until after astrocyte proliferation. Disappointingly, the authors did not 
investigate the effect of co-culture of RGCs with neurons from the superior colliculus on synapse 
co-localisation and stability, noting that they observed these neurons to have a similar effect as glia 
on the spontaneous activity of RGCs in their earlier work.  
Nevertheless, following on from this work a series of astrocyte factors have now been implicated in 
synaptogenesis, an overview of which is given in Figure 1.6. In this introduction I will specifically 
focus on work related to astrocyte involvement in excitatory, that is glutamatergic, synapse 
formation, although it should be noted that astrocytes may also have a role in GABAergic synapse 
formation.   
 
 
Figure 1.6 Astrocytic proteins associated with excitatory synaptogenesis 
A list of astrocyte secreted factors (bar neuroligin-2) that are proposed to be involved in excitatory 
synaptogenesis. Abbreviations: receptor protein tyrosine phosphatases (RPTP), superior colliculus (SC), 
retinal ganglion cells (RGCs). Sources: (Allen et al., 2012, Blanco-Suarez et al., 2018, Farhy-Tselnicker et 
al., 2017, Kucukdereli et al., 2011, Eroglu et al., 2009, Stogsdill et al., 2017, Risher et al., 2018, 





Thrombospondins (TSPs) are a group of oligomeric, multidomain, extracellular Ca2+ binding 
glycoproteins, that interact with many components, including the extracellular matrix (ECM), cell 
surfaces, cytokines and growth factors, to regulate a multitude of activities throughout the body 
(Adams and Lawler, 2011). There are five members of the family in vertebrates, TSP1-5, which fall 
into two subgroups according to their structural assembly: group A (TSP-1 and -2) that  form 
trimers, and group B (TSP3-5) that assemble as pentamers (Adams and Lawler, 2011). In the brain 
TSP1-4 gene expression has been observed across microglia, oligodendrocytes, neurons and 
astrocytes, although their cell-type expression pattern differs between mice and humans (Zhang et 
al., 2014).  
In 2001, TSP-1 and -2 were first proposed as astrocytic secreted factors necessary for the promotion 
of excitatory synapse formation in RGCs. (Christopherson et al., 2005). The authors demonstrated 
that either a cortical astrocyte feeder layer or ACM was able to increase the number of co-localised 
synaptic puncta in purified rat RGCs, however only the feeder layer was able to increase mEPSC 
events in these retinal cells (Christopherson et al., 2005). They went on to show a potential role for 
both TSP-1 and -2 in the increase of puncta co-localisation, with application of TSP-1 to RGCs 
increasing puncta, and depletion of TSP-2 from ACM reducing the number of co-localised puncta, 
although there was an increase in non-co-localised puncta in TSP-2 depleted ACM 
(Christopherson et al., 2005). As with ACM treatment, neither TSP-1 or -2 were able to increase 
the spontaneous activity of RGCs, unlike direct co-culture with astrocytes. However, ACM, TSP-1 
and TSP-2 were all demonstrated to increase the pre-synaptic activity of RGCs, whilst having no 
effect on mEPSC frequency or amplitude, or response to glutamate application, compared to 
controls (Christopherson et al., 2005).  
With regards to TSP expression, they observed widespread immunoreactivity to TSP-1/2 
throughout the superior colliculus and cortex in the P8 rat brain, which had all but disappeared by 
P21. They showed that some synaptotagmin (a pre-synaptic vesicular membrane docking protein) 
immunoreactivity appeared co-localised with TSP-1/2 immunoreactivity at P8 – but given the fact 
essentially all P8 tissue showed immunoreactivity to TSP-1/2, any protein tested would be expected 
to show apparent co-localisation with TSP-1/2. As TSP-1/2 was absent by P21, they conclude 
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TSP-1/2 is only transiently needed to stabilise structural but silent synapses. As their earlier work 
found that removal of astrocytes resulted in reversal of puncta co-localisation this would mean that 
some other astrocytic factor is required for the ongoing puncta stability at later time points (Ullian 
et al., 2001, Christopherson et al., 2005). Using specific TSP-1 and TSP-2 antibodies they detected 
both TSP-1 and TSP-2 protein in P5 rat cortical tissue, that was largely gone in adult brain samples. 
Using RT-qPCR they detected mRNA of both TSP-1 and TSP-2 in purified cortical astrocytes – 
but they either did not investigate or disclose whether they detected TSP-1 or -2 protein in purified 
astrocytes.  
To investigate the in vivo influence of TSP-1 and -2 they investigated the number of pre-synaptic 
puncta in cortical tissue from TSP-1 and TSP-2 knockout mice. There was no difference in cortical 
pre-synaptic puncta number between wild-type mice and TSP-1 or TSP-2 knockout animals. They 
then created a TSP-1/TSP-2 double knock out mouse. In this model they observed a 31% reduction 
in co-localised puncta in the cortex of P21 animals (Christopherson et al., 2005). They reported no 
difference in dendritic area between wild-type and double knock-out animals but did not directly 
compare whole cell morphology between animals. Perhaps the biggest limitation of this study is the 
lack of tissue let alone cell-type specificity: they employed a global double TSP-1/2 knockout model 
– given the abundance and multifaceted roles of TSPs throughout the body and brain, one might 
expect some differences in global knockouts (Adams and Lawler, 2011, Risher and Eroglu, 2012). 
To date, no astrocyte conditional TSP-1 or -2 knock-out has been generated, which would greatly 
strengthen the case for astrocyte TSP-1/2 involvement in synaptogenesis.   
Several years later the same group determined that the synapse promoting effect of TSPs was 
mediated by their interaction with the neuronal α2δ-1 subunit (also known as the gabapentin 
receptor), a subunit of L-type voltage-gated Ca2+ channels. Alpha-2δ-1 is found throughout the 
brain, with particularly strong expression in the cortex, hippocampus and hypothalamus, and has a 
role in Ca2+ channel regulation (Cole et al., 2005). The authors first determined that the effect of 
TSPs on inducing excitatory synaptic puncta in RGCs was mediated by the EGF-like repeat domain 
of TSP complexes (Eroglu et al., 2009). They then investigated the presence of proteins that 
expressed domains that the EGF domains of TSPs are known to interact with, which included the 
α2δ group, finding that RGCs expressed the α2δ-1 subunit. They further observed that in the rat 
cortex α2δ-1 subunits appeared in puncta formations in apposition to both pre- and post-synaptic 
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puncta, and using immunoprecipitation confirmed that the EGF domains of TSPs were associated 
with α2δ-1. Following overexpression of α2δ-1 in RGCs they found that the TSP induced increases 
in synaptic puncta were enhanced. Furthermore, knockdown of α2δ-1 in RGCs prevented both 
astrocyte and TSP mediated increases in synaptic puncta, whilst treatment with the α2δ-1 
antagonist gabapentin prevented the effects of ACM and TSP on RGC puncta number (Eroglu et 
al., 2009).  
Turning to an in vivo model they first overexpressed α2δ-1 in mouse cortical cells and measured the 
number of co-localised synapses at P21. They found a nearly 2-fold increase in co-localised vGlut2 
and PSD-95, but no difference in co-localised vGlut1 and PSD-95. Conversely, treatment of pups 
with gabapentin for 6 days resulted in a significant decrease in co-localised vGlut2/PSD-95 puncta 
in P7 mice cortices (Eroglu et al., 2009). Interestingly, several years later using an α2δ-1 knockout 
mouse model they observed the opposite: a reduction in vGlut1/PSD-95 puncta in cortical layer 
II/III cells, but no change in vGlut2/PSD-95 co-localisation (Risher et al., 2018). Correspondingly, 
they observed a significant reduction (-58%) in mEPSC frequency of these neurons, as well as a 
slight reduction in amplitude, as would be expected from reduced synapse numbers. In contrast to 
the previously claimed lack of morphological difference of cortical neurons in TSP-1/TSP-2 double 
knockout mice, this time they investigated morphology and found a significant difference between 
cells in the α2δ-1 knockout model and wild-type controls, with knockout animals showing a 
reduced dendritic length and significantly less branching (Risher et al., 2018). This discrepancy 
could be due to the other roles α2δ-1 plays besides its role as a TSP receptor. Using serial section EM 
they investigated the effect of α2δ-1 on spine morphology, finding that in mutant animals there was 
a significant reduction in the number of spines. As α2δ-1 is expressed throughout the body, they 
generated a conditional α2δ-1 model which sparsely removed α2δ-1 from cortical neurons. As with 
global knockouts, there was a reduction in both synapses and spine numbers in this conditional 
model (Risher et al., 2018).  
Separately, a group investigating the protective mechanisms of gabapentin following cortical insult 
likewise used an α2δ-1 knockout model. In the insult model they employed, there was an increase in 
TSP and excitatory synaptogenesis as well as cell death following injury in wild-type mice, which 
was prevented by either gabapentin treatment or by α2δ-1 knockout (Lau et al., 2017). Whilst α2δ-1 
knockout prevented an increase in synapses following injury, there was no difference in co-localised 
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vGlut1/PSD-95 staining in cortical cells between wild-type control, wild-type plus gabapentin 
treatment or α2δ-1 knockout animals that had not undergone cortical insult (Lau et al., 2017). 
Correspondingly, they found no difference in mEPSC frequency between these conditions, along 
with observing no difference in phenotype, behaviour or epileptogenic potential between wild-type 
and α2δ-1 knockout animals (Lau et al., 2017). These findings conflict with the other report, 
suggesting that astrocytic TSP activation of α2δ-1 is not needed for normal neuronal synapse 
development, and instead the pro-synaptic effects of TSP/α2δ-1 signalling only occur following a 
pathological insult.  
Overall, these results demonstrate that TSP signalling through α2δ-1 can promote excitatory 
synaptogenesis. However, several questions still remain, firstly whether it is astrocyte secreted TSPs 
that mediate this response in vivo, and secondly whether this signalling pathway is required for 
normal excitatory development, or if it only comes into play in vivo under pathological conditions.  
1.7.2.2 Hevin/SPARCL1 and Sparc 
Hevin, also known as SPARC-like 1 (SPARCL1), is a secreted matricellular protein (as are 
thrombospondins), found in both astrocytes and neurons throughout the brain (Mongrédien et al., 
2019). Given the observed effect of TSPs on synaptogenesis, the Barres/Eroglu group investigated 
whether other astrocyte secreted proteins of the same family may also have an effect on 
synaptogenesis (Kucukdereli et al., 2011). They found that hevin and sparc were both enriched in 
astrocytes, but unlike TSPs, they were enriched throughout adult life. As standard, to begin they 
grew purified RGC cultures, which were either left alone or treated with ACM, hevin, or TSP, 
finding that like ACM or TSP treatment, hevin significantly increased the number of co-localised 
puncta in RGCs (Kucukdereli et al., 2011). Again, as with TSP, hevin increased the number of 
structural but silent synapses in RGCs, as measured with EM and functionally by lack of change in 
mEPSC frequency. Depletion of hevin from ACM reduced the number of synapses by 30%, with 
hevin depletion of TSP-1/2 knockout ACM completely preventing any effect of ACM on synapse 
number. Of note, in their earlier study depletion of ACM TSP-2 alone was sufficient to block the 
entire effect of ACM on RGC synapse number, yet in this later study ACM lacking both TSP-1 
and TSP-2 only partially reduces the effect of ACM (Christopherson et al., 2005, Kucukdereli et 
al., 2011).   
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Conversely, application of sparc to RGCs did not have any effect on synapse number, but when 
applied in combination with hevin reduced the effect of hevin application, suggesting sparc may 
work in opposition to hevin. Indeed, when the authors depleted sparc from ACM they saw an 
increase in synapse number, agreeing with this hypothesis (Kucukdereli et al., 2011). Sparc was not 
found to co-immunoprecipitate with hevin, suggesting the two proteins may competitively interact 
with hevin’s synapse inducing neuronal target. To investigate the role of these proteins in vivo the 
authors investigated the expression of hevin and sparc in the superior colliculus (SC) of mice, where 
RGC axons terminate. Both hevin and sparc were widely expressed in the SC by P14, and both 
appeared to be predominantly astrocytic, and found in association with each other and with 
glutamatergic synapses (Kucukdereli et al., 2011). In hevin knockout mice they observed a 30% 
reduction in excitatory synapse number in the SC, whereas in sparc knockouts they found a 70% 
increase in synapse numbers, further suggesting these two proteins have oppositional functions to 
each other (Kucukdereli et al., 2011). 
In a later paper the group explored the role of hevin in the cortex (Risher et al., 2014). As with the 
SC, they found extensive hevin staining that peaked in the cortex between P14-25. In the synaptic 
zone of the primary visual cortex in hevin knockout animals they found a reduction in 
thalamocortical vGlut2/PSD-95 co-localised puncta that was not due to a decrease in thalamic 
projections, and unexpectedly, an increase in intracortical vGlut1/PSD-95 co-localised puncta 
(Risher et al., 2014). Overall, they saw no difference in mEPSC frequency of pyramidal cortical 
cells, with the suggestion that the increase in vGlut1/PSD-95 is a compensation for the lack of 
vGlut2/PSD-95 thalamocortical synapses in hevin knockouts. They then investigated the effects of 
hevin on spine morphology, finding that hevin knockouts had an increase in immature filapodial 
protrusions and a significant reduction in mature mushroom spines in the cortex of adult mice. 
Moreover, they noted an increased occurrence of projections synapsing onto the dendritic shaft, 
rather than onto spines, as well as an increase in spines with multiple excitatory contacts, normally 
a feature restricted to immature synapses (Risher et al., 2014). Looking further into spines with 
multiple contacts they observed that the majority of these cases involved contacts from both 
intracortical and thalamocortical inputs in hevin knockout mice, with intracortical inputs 
eventually overcoming thalamocortical inputs, suggesting that hevin is required for stabilising 
thalamocortical synaptic inputs (Risher et al., 2014). 
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Having discovered a potential role for astrocyte secreted hevin in thalamocortical synapse 
stabilisation (noting the use of global hevin knockout mice, rather than astrocyte conditional 
knockouts) in their next paper they propose a mechanism for this hevin mediated control (Singh et 
al., 2016). Due to their observations that hevin appeared to modulate both pre-synapses as well as 
post-synaptic NMDA GluN2B subunits they hypothesised that hevin may play a role in linking 
pre- and post-synapses together. To test this hypothesis they first cultured RGCs in the presence of 
HEK293 cells expressing either membrane anchored hevin or membrane anchored control proteins 
(mCherry or alkaline phosphatase), and found increased puncta localisation of the pre-synaptic 
marker synapsin-1 around HEK cells expressing hevin (Singh et al., 2016). However, cleavage of 
hevin between its N- and C- domains prevented pre-synaptic clustering. To investigate the effects 
on the post-synapse, they co-cultured RGCS in the presence of magnetic beads coated in either full 
length, N-terminal domain or C-terminal domain hevin, finding either full length or the C-terminal 
domain was able to induce clustering of the post-synaptic marker homer-1. Unlike culturing RGCs 
in the presence of full length hevin, application of either hevin’s C-terminal, N-terminal, or a 
combination of both was unable to increase synaptic puncta co-localisation of RGCs (Singh et al., 
2016). This demonstrates that although specific terminals are involved in the localisation of pre- or 
post-synaptic puncta, the full length of unbroken hevin is required for co-localisation of synapses, 
suggesting hevin acts as a bridge.  
As mentioned in Chapter 1.7.2, the neuroligin and neurexin CAMs are able to organise 
co-localisation of pre- and post-synapses, with post-synaptically expressed neuroligins attracting 
post-synapses, and pre-synaptically expressed neurexins attracting post-synapses. Given this, the 
group hypothesised that hevin may act in conjunction with a subset of these CAMs to facilitate this 
synaptic organisation. They found that hevin was associated with neuroligins 1-3 (NL1-3), and that 
its effect on enhancing puncta co-localisation in RGCs was dependent on the expression of NL1-3 
in RGCs (Singh et al., 2016). Furthermore, NL1 was co-immunoprecipitated with the C-terminal 
domain of hevin, suggesting that the observed interaction of the C-terminal domain with the post-
synapse is via interaction with NL. They next looked into the pre-synaptic neurexins and found that 
hevin was only significantly co-immunoprecipitated with the neurexin isoform NRX1α, and that 
this association did not occur with the C-terminal domain of hevin. Under normal conditions 
NRX1α is able to directly bind to various neuroligin isoforms including NL1 and NL2, but is 
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unable to interact with NL1 variants containing a B insertion (NL1B) (Chih et al., 2006, Boucard 
et al., 2005). Unlike NRX1α, the authors demonstrated that hevin was able to bind to the NL1B 
variant, which could indicate hevin’s physiological role as a mediator of NRX1α and NL1B binding 
(Singh et al., 2016). In vivo, both NRX1α and NL1 knockout mice were found to have a significant 
decrease in vGlut2/PSD-95 co-localisation and a corresponding increase in vGlut1/PSD-95 
co-localisation in the primary visual cortex, as they had likewise observed in hevin knockout mice 
(Singh et al., 2016, Risher et al., 2014). However, these knockout models also prevent the binding 
of NL1 and NRX1α to all the direct binding partners that they have on neurons, which would be 
expected to have pronounced effects on synapse formation, independent of any interactions with 
astrocytic proteins. On the other hand, knocking out NRX1α from specifically thalamic neurons, 
or NL1 specifically from cortical neurons impaired hevin’s ability to increase co-localisation of 
vGlut2/PSD-95 puncta. Although this work does not show that hevin is specifically required for 
NRX1α and NL1B binding, it does suggest a role for hevin in facilitating NRX1α and NL 
interactions in thalamocortical synaptogenesis. 
They further investigated the requirements of astrocytic hevin for ocular dominance plasticity in 
mice, hypothesising that reduced synaptic NMDA receptor subunit expression in hevin knockouts 
would impair plasticity. Indeed, they found an impairment in this form of plasticity in hevin 
knockout animals, which was rescued by viral re-expression of hevin in astrocytes. Slightly 
misleadingly they claim astrocytic hevin is therefore needed for ocular dominance plasticity: they 
did not show the effects of neuronal, or non-astrocytic, hevin re-expression, and a more convincing 
demonstration would have been via generation of a conditional astrocytic hevin knockout model. 
Evidence strongly shows a role for hevin in synaptic regulation, but the extent of this role in 
neuronal synaptic development, and whether hevin secretion is a specific to astrocytes, is yet to be 
determined.  
1.7.2.3 Glypicans 
While both thrombospondins and hevin promote structurally sound but post-synaptically silent 
excitatory synapses, the heparan sulphate proteoglycans glypican-4 and -6 (GP-4 & -6), are 
hypothesised to transform silent synapses into active synapses. This was first demonstrated in 
RGCs, with Allen and colleagues showing that co-culturing RGCs with a feeder layer of astrocytes 
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increased mEPSC frequency, as well as increasing the surface expression and puncta formation of 
three AMPA receptor subunits, GluA1, GluA2 and GluA4, without altering these proteins’ total 
tissue expression (Allen et al., 2012). Despite the group’s repeated earlier observations that only 
direct co-culture is sufficient to induce an increase in mEPSC frequency with ACM treatment 
having no effect on mEPSC frequency in RGCs (see Pfrieger & Barres, 1997 and Christopherson 
et al., 2005), this time they saw that ACM treatment not only increased mEPSC frequency in 
RGCs, but that the effect was stronger than co-culture with astrocytes (Allen et al., 2012). They 
analysed the ACM to determine what proteins were present, and by fractionation narrowed the list 
of candidate proteins down to 25, which they expressed individually in COS7 cells, eventually 
finding that GP-4 was able to increase mEPSC frequency in RGCs in the presence of TSP. A 
western blot for GP-4 on media derived from RGCs or astrocytes showed that astrocytes not RGCs 
secrete GP-4. Application of purified GP-4 to mono-cultured RGCs in the absence of TSP was 
found to be sufficient to increase both mEPSC frequency and amplitude, with GP-4 treatment 
found to specifically upregulate the surface expression of the GluA1 AMPA receptor subunit 
(Allen et al., 2012). Additionally, GP-4 treatment of RGCs increased co-localised synaptic puncta 
by nearly 3-fold, which was nearly as much as astrocyte co-culture.  
Along with GP-4, the related glypican family member GP-6 was also amongst the 25 candidate 
proteins they had isolated, and so they investigated whether GP-6 had a similar effect. Like GP-4, 
GP-6 was able to induce structural synapses in RGCs and increase surface expression of GluA1 
subunits. Depletion of both GP-4 and GP-6 from ACM prevented the ACM increases in mEPSC 
amplitude and GluA1 surface clustering, indicating that GP-4 and GP-6 are involved in 
strengthening the post-synapse. However, depletion of GP-4 and GP-6 did not prevent their 
observed increase in mEPSC frequency, and there was still a significant increase in co-localised 
synaptic puncta in this GP depleted ACM. These results seem somewhat incongruous: GP-4 is able 
to increase frequency of mEPSC events and synaptic puncta, yet the depletion of both GP-4 and 
GP-6 from ACM has no effect on mEPSC frequency or synaptic puncta. Mechanistically, the 
authors showed that GP first clusters GluA1 on the RGC process surface, with formation of the 
post-synaptic machinery following sometime after this clustering. Furthermore, removal of GluA1 
by siRNA prevented GP-4 mediated increases in synapse number, whereas ACM treatment of 
GluA1 lacking RGCs still induced synapse formation, suggesting that the TSP and GP synapse 
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formation pathways are different (which only raises further questions as to why GP depleted ACM 
had no effect on total synapse number) (Allen et al., 2012). 
Turning to an in vivo model, they found that GP-4 and GP-6 were 3 to 6 times more enriched in 
astrocytes than neurons, respectively, in the cortex, and 1.5 to 2 times more enriched in the 
hippocampus at P7. However, it is worth noting that by P12 in the hippocampus GP-4 expression 
was largely seen in neurons and reduced in astrocytes, and by P24 entirely restricted to pyramidal 
neurons (Allen et al., 2012). Expressional change of GP-4 with age in the cortex, or GP-6 in cortex 
or hippocampus, was not shown or described. In a GP-4 knockout mouse they found mEPSC 
amplitudes of hippocampal CA1 neurons to be reduced by 22% in P12 pups, although this 
difference had largely gone by P24. Structurally, there was no decrease in co-localised synaptic 
puncta in GP-4 knockout mice at P12, but there was a significant reduction in co-localised puncta 
containing GluA1 (Allen et al., 2012).   
Recently, the group reported on the signalling pathway through which GP-4 recruits GluA1 
AMPA receptor subunits (Farhy-Tselnicker et al., 2017). As GP-4 led to an increase in surface 
clustering of GluA1 subunits, they theorised that this might be in part due to an increase in AMPA 
receptor stability. Glypicans are known to interact with both the neuronally expressed type 2a 
receptor protein tyrosine phosphatases (RPTPs) and leucine-rich repeat transmembrane proteins 
(LRRTMs), with several studies showing the binding of GPs, and in particular GP-4, to LRRTMs 
to be important in excitatory synapse regulation (Coles et al., 2011, de Wit et al., 2013, Siddiqui et 
al., 2013). Secondly, several factors are involved in regulating AMPA receptor strength and stability, 
including the extracellular acting neuronal pentraxins NP1 and NP2 (also known as NARP) 
(Bassani et al., 2013). As such, Allen and colleagues investigated the relation between GP-4 and 
neuronal pentraxins, and RPTPs/LRRTMs.  
To begin, they undertook gene expression profiling of purified cultured RGCs which had been 
treated with either GP-4 or TSP for 12 hours, finding no overlap in gene expression changes 
between these two conditions (Farhy-Tselnicker et al., 2017). Amongst the 49 genes whose 
expression changed in the presence of GP-4 was NP1, a known regulator of AMPA receptors, with 
GP-4 treatment of RGCs additionally shown to increase extracellular NP1 concentrations by nearly 
2-fold (Farhy-Tselnicker et al., 2017). Treating RGCs with either ACM or GP-4 resulted in an 
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increase in NP1 accumulation on neuronal surfaces, whereas TSP-1 had no effect on NP1, and this 
accumulation still occurred even in the presence of an mRNA synthesis inhibitor. Confirming NP1 
interaction with GluA1 is necessary for GP-4 increases in synapse number, when GP-4 was applied 
while inhibiting NP1’s ability to interact with GluA1 there was no longer an induction of 
co-localised synaptic puncta (Farhy-Tselnicker et al., 2017). Similarly, knockdown of NP1 with 
siRNA prevented GP-4 mediated increases in both surface GluA1 clusters and synaptic puncta. 
Next they determined what protein GP-4 interacted with to cause this increase in NP1 secretion, 
finding that the axonally expressed RPTPδ and RPTPσ subtypes were responsible for GP-4’s 
synaptogenic and GluA1 clustering effect (Farhy-Tselnicker et al., 2017). 
To determine the importance of this interaction in vivo, they investigated the localisation of GP-4 
in the superior colliculus and visual cortex in P6 mice, which is an interesting choice as their previous 
paper focused on the hippocampus due to GP-4’s prominent expression in that region. They claim 
GP-4 is localised to astrocytes in the cortex and not neurons, although in the image they provide I 
noted apparently equally strong GP-4 co-expression with neuronal Tubb3 (Farhy-Tselnicker et al., 
2017). In GP-4 knockout mice they observed a significant increase in NP1/vGlut2 co-localised 
puncta, suggestive of a failure to release NP1 from pre-synaptic terminals. To investigate if it is 
astrocyte GP-4 that is responsible for inducing NP1 release they generated a GP-4/aldh1l1cre line 
to remove GP-4 from astrocytes. Unfortunately staining in the cortex showed a large proportion of 
neurons to be also expressing aldh1l1cre, so they focused their investigation on the superior 
colliculus, which showed a somewhat lower neuronal expression of aldhl1lcre, although still quite 
significant (Farhy-Tselnicker et al., 2017). Regardless, they observed a significant increase in NP1 
pre-synaptic puncta in the conditional knockout line compared to controls in the superior 
colliculus (Farhy-Tselnicker et al., 2017). Knocking out either GP-4 or RPTPδ resulted in a 
significant reduction in co-localised synaptic puncta in the superior colliculus, as well as a significant 
reduction in post-synaptic GluA1 clustering (Farhy-Tselnicker et al., 2017).   
Overall, it appears GP-4 can act on the pre-synaptic RPTP receptors to increase NP1 release, which 
increases GluA1 clustering. More work needs to be done to answer the question of the relative 
astrocytic importance in this mechanism in the wider CNS, and what the functional outcomes may 
be.   
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1.7.2.4 Cholesterol, Neuroligins & Chordin-like 1  
Several other astrocyte proteins have been implicated in excitatory synaptogenesis, including 
cholesterol, neuroligins and chordin like-1. Early on in the hunt for astrocyte derived factors that 
were mediating an increase in activity of RGCs cholesterol was proposed as a candidate (Mauch et 
al., 2001). Pfrieger and colleagues found an induction of apolipoprotein E (apoE) spots in RGCs 
treated with ACM, and although apoE application did not increase synaptic activity, application of 
cholesterol, which can be carried by apoE-containing lipoproteins, was able to increase spontaneous 
activity in RGCs (Mauch et al., 2001). Additionally, they found depletion of cholesterol from 
ACM was able to prevent the ACM induced increase in spontaneous activity in RGCs, and that 
application of cholesterol increased the number of co-localised synaptic puncta. From this they 
concluded that astrocyte derived cholesterol, carried by apoE complexes, was the astrocyte derived 
factor increasing spontaneous activity and synapse numbers in RGCs (Mauch et al., 2001). No 
further reports have documented evidence of astrocyte derived cholesterol as being important for 
synaptogenesis, nor investigated whether it may play a role beyond RGCs, or if it has a role in vivo. 
Interestingly, apoE/apoE receptor signalling is important for correct brain organisation and 
synaptic plasticity, with apoE being a primarily astrocyte produced factor (Holtzman et al., 2012, 
Lane-Donovan and Herz, 2017). 
More recently, astrocytic neuroligins were demonstrated to promote excitatory synapse formation 
in neurons. This work is promising, as neuroligins are CAMs with known roles in synapse 
formation when expressed in neurons. After finding that neuroligins 1-3 (NL1-3) expressed on 
astrocytes are important for astrocytic morphological elaboration, Eroglu and colleagues noted that 
in the visual cortex of mice that had had NL2 sparsely knocked down, there were approximately 
half the number of co-localised excitatory synapses in the region of NL2-free astrocytes compared 
to the regions of neighbouring wild-type astrocytes (Stogsdill et al., 2017). Functionally, in a 
conditional astrocyte NL2 knockout mouse line, mEPSC amplitude and frequency in layer V visual 
cortical neurons were significantly less compared to heterozygous littermates (Stogsdill et al., 2017). 
It should be noted the authors employed a GLAST-CreERT2 line to remove astrocytic NL2 but 
did not report on the cell-type expression of this transgene in the region of interest. This is 
significant, as GLAST-CreERT2 lines have been shown to lack specificity for astrocytes; indeed, in 
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the hippocampus a higher proportion of neurons express the GLAST-CreERT2 than astrocytes 
(Srinivasan et al., 2016).  
Lastly, astrocyte secreted chordin-like 1 (Chdl1) has been proposed as necessary for the 
transformation of excitatory synapses into mature GluA2 AMPA receptor subunit containing 
forms (Blanco-Suarez et al., 2018). AMPA receptors lacking GluA2 are Ca2+ permeable, and their 
expression is associated with synapse immaturity, whereas most AMPA receptors in the mature 
cortex contain the GluA2 subunit, rendering them Ca2+ impermeable (Brill and Huguenard, 2008). 
After proposing that GP-4 and GP-6 are able to induce GluA1 clustering, Allen and colleagues 
hypothesised that another astrocyte secreted factor subsequently induced the recruitment of the 
GluA2 subunit. As with previous studies, the group began by preparing purified RGC cultures, 
showing that RGCs treated with ACM had higher GluA2 clustering (Blanco-Suarez et al., 2018). 
They then ran a biochemical screen for candidate proteins in ACM, with the candidate Chrdl1 
being shown to induce GluA2 clusters on RGCs. They also found that treating RGCs with a 
physiological level of Chdl1 was able to increase co-localised synapse numbers to the same extent as 
co-culture with astrocytes, as well as being sufficient to increase mEPSC frequency (Blanco-Suarez 
et al., 2018). This is an interesting finding, given that depletion of other factors, such as TSP, GP-4, 
GP-6, or cholesterol from ACM were able to prevent increases in synapse number in RGCs: their 
findings here suggest the Chrdl1 present in those previous studies should have at least partially 
masked those results. It is also a further confliction with previous work as to whether ACM is 
sufficient to increase mEPSCs, or whether direct astrocyte co-culture is required for this induction. 
Regardless, the group generated a Chrdl1 knockout animal, finding a significant reduction in 
GluA2 positive excitatory synapses in the cortex, along with a significant reduction in excitatory 
thalamocortical synapses, but no change in excitatory intracortical synapses (Blanco-Suarez et al., 
2018). Unlike RGCs, in these cortical cells they observed no difference in mEPSC frequency in 
Chrdl1 knockout animals, although there was a slight increase in mEPSC decay time, which they 
attribute to a decrease in GluA2 subunit expression (Blanco-Suarez et al., 2018).  
1.7.2.5 Retinal Ganglion Cells  
Common to most of the studies investigating astrocyte involvement in excitatory synaptogenesis is 
the use of RGCs as a model. This was initially brought about as purified neurons typically do not 
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survive very well in culture without astrocytes present, making it very hard to elucidate the impact 
of astrocytes on their development. However, in the 1980s Barres developed a protocol for the 
isolation and growth of RGCs in culture (Barres et al., 1988, Barres and Chun, 1993). These cells 
were capable of surviving without astrocytes when they were grown in a defined medium, opening 
the door to investigate the effects of glia on synaptogenesis in retinal cells. Although these cells are 
not necessarily representative of neural cells from other areas of the brain, they have since become 
the model from which generalisations of astrocyte-neuron interactions are derived. Here I will 
briefly summarise what these cells are, and the limitations of using this system as a model for these 
investigations. 
 
Figure 1.7 Retinal cell network 
Retinal ganglion cells (RGCs) receive input from amacrine (A) and bipolar cells (B), which receive light input 
from rod (R) and cone (C) photoreceptors. RGCs project axons through the optic nerve into the CNS, where 
they form synapses in visual centres of the brain. Surrounding the neural cells within the retina are numerous 
Müller glia cells (M), which span the retinal layers. ONL = outer nuclear layer, OPL = outer plexiform layer, 
INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, H = horizontal cell. 





Retinal ganglion cells are a heterogeneous family of cells located in the retina that are solely 
responsible for transmitting the visual information received by the eye into the brain (Figure 1.7). 
They receive input from retinal amacrine and bipolar cells, which they send into the CNS through 
axons that project into the lateral geniculate nucleus within the thalamus or the superior colliculus 
within the midbrain (Masland, 2012, Cruz-Martín et al., 2014, Reinhard et al., 2019). Currently 
there are estimated to be around 40 distinct types of RGCs, which receive and transmit different 
visual information, including the newly described intrinsically photosensitive RGCs, which express 
melanopsin, allowing them to directly respond to light input (Bae et al., 2018, Baden et al., 2016, 
Rheaume et al., 2018, Schmidt and Kofuji, 2011). Surrounding these RGCs are Müller glia, the 
predominant, if not sole, macroglia within the retina, where they fulfil the role of astrocytes 
(Bringmann et al., 2006). Both Müller glia and RGCs (along with other retinal cells) are produced 
from retinal progenitor cells, and not the neural radial glia progenitor cells of the brain from which 
astrocytes and other CNS neurons are derived (Cepko, 2014).  
This presents some obvious limitations when using purified RGCs as a model for synaptogenesis in 
general. Firstly, RGCs are a highly organised heterogeneous group of cells that are only just 
beginning to be characterised, for example the subset of RGCs that respond directly to light could 
result in environmental light having an unknown impact on recorded activity. Secondly, despite 
surviving in culture alone, they are not a resilient group of cells: their survival is dependent upon 
feeding with an extensive list of hormones and factors, importantly requiring frequent 
supplementation with insulin, brain derived neurotrophic factor (BDNF), ciliary neurotrophic 
factor (CNTF), and forskolin (Meyer-Franke et al., 1995). Thirdly, they are not derived from the 
same precursors as neurons of the CNS – they are a distinct lineage surrounded by other cells from 
this same lineage such as Müller glia, and hence it is hard to extrapolate findings on their 
development to the development of neurons and astrocytes that are derived from a separate pool. 
For example, synapse development between retinal cells is highly dependent on light input, which 
is not true for the brain at large. Finally, and perhaps most importantly, within the retina the 
dendrites of each RGC form selective synapses with specific bipolar or amacrine cells, and transmit 
this received information through terminals that synapse onto highly specific neurons within the 
CNS – they do not form synapses with each other (Gollisch and Meister, 2010). This renders the 
use of purified RGCs as a model for synaptogenesis questionable, as synapse formation would not 
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normally occur between these cells. This problem is highlighted by the early finding that culturing 
RGCs with neurons from the RGC projection area, the superior colliculus, was sufficient to induce 
synaptogenesis in the absence of glia (Pfrieger and Barres, 1997). Therefore, the lack of synapse 
formation seen between isolated RGCs in culture does not necessarily represent a deficiency in these 
cells’ intrinsic synaptogenic capabilities. It may instead be physiologically normal, as they have no 
target cells present, and the forced astrocytic induction of synapse formation between RGCs may 
in fact be the abnormal situation. 
Given these problems it is desirable to develop a system for studying the effects of astrocytes on 
neurons that uses cells from other areas of the brain, such as the cortex, to understand the true 
relationship between astrocytes and their regional neuronal partners. Despite the historical finding 
that neurons do not typically survive well without astrocytes, a better understanding of factors 
needed for neuronal survival has meant that today primary CNS neurons are capable of surviving 
without glia, given the right media and culture conditions. For example, in our lab we are able to 
consistently produce healthy viable primary cultures of pure cortical neurons free of glia, by 
combination of an optimised culture preparation procedure, and supplementing basic feeding 
media with a combination of rat serum, B-27 and glutamine. Perhaps a key feature of our system is 
the density of the neurons, as we plate cells at a high, more physiologically accurate, concentration 
of ~500,000 cells per cm2. Even halving this density results in a decrease in neuronal health and 
survival of our cells, and yet it is typical to read papers that plate at much lower densities still, from 
20,000-100,000 cells per cm2. As we are able to produce robust cortical neuronal cultures that do 
not require astrocytes, this presents an excellent opportunity to address whether or not these 
findings in RGCs are generalisable to cortical neurons, and to further elucidate the influence of 
astrocytes on neuronal functional development in a neuronal population beyond RGCs. 
1.8 Astrocyte involvement in neuronal activity  
Astrocytes play an active role in modulating neuronal activity by releasing various molecules which 
neurons are able to sense and/or uptake. A common feature of the work in RGCs presented in 
Chapter 1.7 was the increase in spontaneous activity driven by astrocytes. Although part of this may 
be due to an increase in synapse formation in RGCs, there are other ways in which astrocytes can 
modulate neuronal activity. For example, astrocytes may play a passive role in supporting neuronal 
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activity by providing neurons with neurotransmitter and metabolic precursors, which becomes 
particularly important under conditions of high activity. Beyond passive modulation, astrocytes are 
now suspected to have important roles in regulating neuronal plasticity, for example they are able 
to release neuro-modulatory molecules, such as D-serine and glutamate, which can potentiate 
neuronal receptor activation. Here I will briefly discuss some of the ways in which astrocytes are 
proposed to control neuronal plasticity.  
1.8.1 Synaptic plasticity 
Synaptic plasticity refers to changes in neuronal responses that results in an increase or decrease of 
synaptic activity that persists over time. There are several types of plasticity, including long-term 
potentiation (LTP) and long-term depression (LTD) which are thought to mediate learning and 
memory, as well as homeostatic plasticity that seeks to oppose pathological changes in activity in 
order to maintain stable neuronal activity (Martin et al., 2000, Tien and Kerschensteiner, 2018). All 
forms of plasticity are integral features of cognitive function, and recently astrocytes have been 
shown to play an active part in these neuronal phenomena.  
1.8.1.1 Long-term potentiation 
Long-term potentiation refers to a long term increase in synaptic strength, induced following 
repetitive high frequency stimulation or pre-synaptic activity coincident with post-synaptic 
depolarisation, and is typically dependent on NMDA receptor activation (Martin et al., 2000, Bliss 
and Collingridge, 1993). Several studies have now reported a requirement of astrocyte secreted 
D-serine, an NMDA receptor co-agonist, for the induction of LTP. Early after the turn of the 
millennia a potential dependence on astrocytes for NMDA receptor dependent LTP was discovered 
in hippocampal culture preparations (Yang et al., 2003). The authors prepared hippocampal 
cultures grown either on a bed of astrocytes or without astrocytes but instead fed with ACM to 
ensure synaptogenesis. They were able to induce LTP only in co-cultured hippocampal neurons, 
not those just fed with ACM, and further showed that the induction of this LTP was dependent 
on the NMDA receptor co-agonist D-serine (Yang et al., 2003). In acute hippocampal slices they 
additionally showed that either degrading endogenous D-serine or inhibiting the NMDA receptor 
co-agonist binding site, caused a significant reduction in induced LTP. They found that application 
of 0.2 mM glutamate to glial, but not neuronal, terminal preparations resulted in an increase in 
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D-serine concentrations (Yang et al., 2003). This work demonstrated that this form of LTP is not 
mediated by a passively released astrocytic factor, but instead that astrocytes sense neuronal activity 
and actively respond. 
Several years later the importance of astrocytic released D-serine for LTP was further described 
(Henneberger et al., 2010). The authors recorded field potentials in the hippocampal stratum 
radiatum, inducing LTP by Schaffer collateral stimulation, in the vicinity of a patch-clamped 
astrocyte. Under normal conditions they were able to induce LTP in the vicinity of recorded 
astrocytes, which was unaffected by addition of exogenous D-serine and blocked by antagonism of 
the NMDA receptor. However, when they clamped the astrocyte’s internal Ca2+ concentrations 
they were unable to induce LTP in the astrocyte’s vicinity, but applying exogenous D-serine was 
able to rescue LTP (Henneberger et al., 2010). To confirm the inhibition of LTP in the area of Ca2+ 
clamped astrocytes was due to inhibition of astrocytic D-serine release they included a serine 
racemase inhibitor to the internal patch solution to prevent astrocytic D-serine production and ran 
a high frequency stimulation protocol in the presence of an NMDA receptor antagonist, AP-V, to 
exhaust astrocytic D-serine stores before washing out the AP-V. When they ran the LTP induction 
protocol, now with no astrocytic D-serine stores, they were unable to induce LTP (Henneberger et 
al., 2010). These findings suggest that neuronal transmitter release induces Ca2+ signalling in 
astrocytes, which causes the release of the NMDA receptor co-agonist D-serine, which is required 
for the successful induction of NMDA receptor dependent LTP.  
Later on in 2012 the involvement of astrocytes in LTP was first demonstrated in vivo in the 
cholinergic system (Navarrete et al., 2012). The authors induced LTP of CA3-CA1 hippocampal 
synapses in anaesthetised rats by tail-pinch sensory stimulation, noting that this stimulation also 
induced Ca2+ elevations in astrocytes. LTP was prevented by administration of either muscarinic 
receptor (mAChR) or metabotropic glutamate receptor (mGluR) antagonists, although astrocytic 
Ca2+ responses persisted in the presence of mGluR antagonism (Navarrete et al., 2012). The authors 
used inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice (IP3R2-/-), which primarily 
mediates intracellular astrocytic Ca2+ signalling, to investigate whether astrocytic Ca2+ elevations 
were necessary for this form of LTP (Navarrete et al., 2012). Application of acetylcholine to these 
slices induced Ca2+ elevations in neurons from knockouts and wild-types, but only induced Ca2+ 
elevations in wild-type astrocytes. There was a significant reduction in LTP induced by sensory 
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stimulation in these knockout animals, suggesting activity mediated release of astrocytic glutamate 
through Ca2+ signalling is required for cholinergic LTP in vivo (Navarrete et al., 2012) . 
More recently, astrocyte stimulation was shown to be sufficient to increase memory in in vivo 
behaving mice (Adamsky et al., 2018). The authors expressed the Gq-coupled designer receptor 
hM3Dq in hippocampal CA1 astrocytes, allowing them to induce Ca2+ elevations in these CA1 
astrocytes by applying the drug CNO. To begin, they found that activation of these designer 
receptors in CA1 astrocytes caused a significant increase in both frequency and amplitude of 
mEPSC events in CA1 neurons in slice. When they induced LTP via Schaffer collateral stimulation 
they found that the activation of astrocytic Gq receptors to increase astrocytic Ca2+ resulted in a 
50% enhancement of LTP (Adamsky et al., 2018). This enhancement was masked by treatment with 
D-serine and blocked by chelation of astrocytic Ca2+. Behaviourally, they found that mice 
expressing the designer Gq receptor in hippocampal astrocytes that had been treated with CNO 
had enhanced performance in contextual memory tasks, with a 40% increase in recall in a contextual 
freezing foot-shock task compared to controls (Adamsky et al., 2018).  
1.8.1.2 Long-term depression 
Unlike LTP, long-term depression is marked by a persistent decrease in synaptic strength, often 
following extended low-frequency stimulation, and like LTP is thought to be involved in learning 
and memory (Collingridge et al., 2010). LTD is not as well described as LTP, but astrocytic 
involvement in LTD is now an emerging area of research, with several reports beginning to 
implicate these cells mechanistically.  
A form of LTD termed spike-timing dependent LTD (t-LTD) occurs when pre-synaptic activity 
follows post-synaptic spiking within a few milliseconds, and is believed to be important for sensory 
mapping in the developing cortex (Min and Nevian, 2012, Dan and Poo, 2006). This form of 
plasticity requires activation of both pre-synaptic NMDA receptors as well as cannabinoid 
receptors (CB1R) (Min and Nevian, 2012). In 2012 Min and Nevian showed that astrocytic Ca2+ 
signalling was induced by activation of astrocytic CB1R, and that this activation was present and 
required for the induction of t-LTD in the rat barrel cortex (Min and Nevian, 2012). They then 
demonstrated that astrocytic CB1R-induced Ca2+ signalling caused the release of astrocytic 
glutamate, and that this glutamate was required for the induction of t-LTD in the barrel cortex. 
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Furthermore, they found that stimulating an astrocyte whilst concurrently stimulating pre-synaptic 
afferents was sufficient to induce t-LTD (Min and Nevian, 2012). 
More recently, astrocytes were shown to be involved in hippocampal NMDA receptor dependent 
LTD induced by low-frequency stimulation. The authors first found that low-frequency 
stimulation was able to induce astrocytic Ca2+ responses in hippocampal slices, causing astrocyte 
release of glutamate, which then activated neuronal NMDA receptors (Navarrete et al., 2019). 
When they quenched internal astrocytic Ca2+, or recorded from slices of IP2R2-/- mice, they observed 
strong impairments of low-frequency stimulation induced NMDA receptor dependent LTD 
compared to controls. To investigate the role of astrocytic released glutamate in LTD, they created 
mice lines lacking astrocytic expression of VAMP2 and VAMP3 to prevent astrocytic exocytic 
glutamate release, with hippocampal cultures from these mice showing a marked reduction in LTD 
compared to control (Navarrete et al., 2019). The authors then used mice expressing 
channel-rhodopsin 2 in astrocytes, finding that optogenetic stimulation of astrocytes increased 
astrocytic Ca2+ and induced astrocytic glutamate release, and that this was able to induce NMDA 
receptor dependent LTD (Navarrete et al., 2019). As previous studies had implicated a role for p38 
mitogen-activated protein kinases (MAPK) the group then investigated the role of astrocytic versus 
neuronal p38 MAPK activity in LTD (Navarrete et al., 2019). They found that astrocytic p38α 
MAPK, but not neuronal, was specifically required for the induction of LTD, and that astrocytes 
lacking p38α MAPK no longer released glutamate following low-frequency stimulation (Navarrete 
et al., 2019). Behaviourally, they found that mice lacking astrocytic p38α MAPK had a significant 
enhancement in long-term memory as assessed by a contextual fear task compared to both controls 
and mice lacking neuronal p38α MAPK (Navarrete et al., 2019).  
These works clearly implicate a central role for activity induced release of astrocytic glutamate in the 
development of various forms of LTD.  
1.8.1.3 Activity-regulated homeostatic plasticity 
Homeostatic plasticity of neuronal activity is the attempt to maintain synaptic activity around an 
optimal set-point: in response to too much activity, changes will occur to dampen the neurons’ 
activity levels down, whilst too little activity induces changes to neuronal properties to try and 
increase activity levels back up. There are two main aspects to this plasticity, the modulation of a 
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cell’s intrinsic properties to increase or decrease excitability, and the modulation of synaptic strength 
which can be measured by changes in mEPSC frequency and amplitude (Lazarevic et al., 2013, 
Turrigiano et al., 1998, Echegoyen et al., 2007, Desai et al., 1999). Homeostatic plasticity is believed 
to involve the regulation of numerous channels and the mechanisms behind its different facets are 
only just beginning to be elucidated (Lazarevic et al., 2013, Lee et al., 2015).  
Here too in this fundamental process astrocytes may play vital roles. In 2006 Stellwagen and 
Malenka discovered that astrocytic TNF-α was required for the homeostatic increase in mEPSC 
amplitude following 48 hours of activity deprivation in hippocampal pyramidal cells (Stellwagen 
and Malenka, 2006). Separately, it was shown that hippocampal astrocytes in situ respond to 
long-term inhibition of neuronal activity with increased Ca2+ signals mediated by group I mGluRs, 
whilst long-term increases in neuronal firing led to a decrease in astrocytic mGluR mediated 
spontaneous Ca2+ events (Xie et al., 2012). This demonstrated that astrocytes are able to sense and 
respond to long-term dysregulation of neuronal activity, a necessary requirement for mediating 
homeostatic responses. To date no other work has explored the involvement of astrocytes in either 
homeostatic regulation of excitability or whether they are required for reducing synaptic strength 
down in hyperactive scenarios, although their involvement in homeostatic processes has been 
hypothesised (Thalhammer and Cingolani, 2014, Sims et al., 2015).  
1.8.2 Neuronal KIR channels 
The potassium inward rectifiers (KIR) are a family of K+ channels which are typically open under 
resting membrane potentials allowing the flux of K+ ions. Upon membrane depolarisations their 
pores become increasingly blocked, preventing the efflux of K+ ions, and giving them their 
characteristic inward rectification. Each KIR channel is comprised of four KIR subunits resulting in 
a heteromeric channel (Bichet et al., 2003). The subunits fall into 7 subfamilies (KIR1-7), with 
channels typically formed by different subunits within the same family, although that is not always 
the case (Bichet et al., 2003). The different KIR channels fall into four functional groups, 
constitutively active (KIR2.X), G-protein gated (KIR3.X), ATP-sensitive (KIR6.X) and transport 
channels (KIR1.1, 4.X, 5.X & 7.X) (Hibino et al., 2010). The subunits are found throughout the 
brain, and within the cortex the KIR2.X and KIR3.X subunits are predominantly expressed 
(Shcherbatyy et al., 2015). KIR channels play many physiological roles, including the control of 
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neuronal excitability through alterations in membrane properties, with KIR channels leading to 
decreased membrane resistance and hyperpolarised membrane potentials (Hibino et al., 2010). 
Thus, higher KIR channel expression decreases excitability whilst lower expression leads to an 
increase in excitability. A clear example of this is seen in astrocytes: their abundant expression of 
KIR4.1 is what sets their exceedingly low membrane resistance and hyperpolarised membrane 
potentials (Butt and Kalsi, 2006, Neusch et al., 2006).    
Given KIR’s involvement in setting neuronal excitability it is possible that the regulation of their 
expression may be one mechanism underlying the homeostatic plasticity of neuronal excitability. In 
support of this, KIR expression was found to be increased in epileptic tissue, and chronic 
electroconvulsive shock was found to significantly upregulate both KIR3.1 and KIR3.2 subunits 
(Young et al., 2009, Stegen et al., 2009, Pei et al., 1999, Stegen et al., 2011). This could suggest that 
in response to pathologically high activity levels these channels undergo homeostatic upregulation 
in an attempt to mitigate elevated activity levels. Despite the protective role KIR channel 
upregulation may play in response to pathologically high excitability, too much KIR can conversely 
be a bad thing. Several patients with severe developmental delays effecting language, social and 
motor skills (with one patient still unable to walk at the age of 17) were found to have a gain-of-
function mutation in KIR6.2 that meant the channel was always open (Gloyn et al., 2004). There 
were no other abnormalities in neurological structure or reductions in cortical or cerebellar size, and 
no abnormality in muscle biopsies, in these patients that could otherwise explain the severe 
neurological phenotype.  
Given the functional importance of KIR in controlling neuronal activity, and the severe effects when 
this goes wrong, it is important to understand how these channels are regulated. One intriguing 
possibility is that astrocytes might control neuronal KIR expression. Firstly, astrocytes are known to 
increase neuronal activity, and KIR expression is important for setting cell excitability. As such, one-
way astrocytes might increase neuronal activity could be by decreasing neuronal KIR expression. 
Interestingly, cholesterol has been shown to regulate KIR function, decreasing KIR2.1 and KIR3.1 
activity, with hypercholesterolemia causing a significant downregulation of KIR3.1 expression in 
aortic smooth muscle cells (Ya-Jun et al., 2016, Rosenhouse-Dantsker, 2019). As mentioned earlier, 
astrocyte-secreted cholesterol was proposed as a mediator of synaptogenesis due its effect on 
increasing spontaneous neuronal activity: maybe this increase in activity was due to an increase in 
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excitability borne from KIR downregulation (Mauch et al., 2001). Secondly, astrocytes have a 
suspected role in regulating activity-dependent homeostasis, whilst KIR channels are suspected to be 
subject to activity-regulated homeostasis. Another possibility then, is that astrocytes may somehow 
control the expression of neuronal KIR in an activity-dependent manner.   
In Chapters 4 & 5 I investigate whether astrocytes control neuronal KIR expression, and whether 
this leads to functional alterations in neuronal activity. 
1.9 Thesis summary 
In this thesis I aim to elucidate some of the key interactions between neurons and astrocytes and the 
outcomes of this interaction on CNS function. My thesis is broken down into two broad sections, 
first looking at the influence of neurons on astrocytes, and second, looking at the effect of astrocytes 
on neurons.  
In the first results chapter (Chapter 3) I seek to answer whether neurons control astrocytic EAAT 
function, and to find the signalling pathway mediating this control. To do this I used our labs 
published mixed species astrocyte/astrocyte-neuron RNA-sequencing dataset to investigate 
neuronal control over astrocytic glutamate transporters. I confirm that neurons increase astrocytic 
glutamate transporter expression and function, as previous studies have likewise shown. I then use 
information gained from work in our lab to find the signalling pathway from neurons to astrocytes 
that controls the regulation of these astrocytic transporters. I demonstrate that neuronal contact-
dependent Notch signalling controls astrocytic EAAT expression and function. I further show that 
this Notch signalling is constantly required in order to maintain astrocytic EAAT expression, which 
may have important consequences for neurodegenerative disease.  
In the second part of my thesis I seek to answer how cortical astrocytes control cortical neuronal 
gene expression and function, which is split across two chapters (Chapter 4 and Chapter 5). In the 
beginning of Chapter 4 I used our labs cortical culture setup to address the open question of how 
astrocytes control cortical neuronal gene expression. To date, there are no reports on any neuronal 
genes being regulated by astrocytes, primarily due to the historical problems of being unable to 
maintain neurons in the absence of astrocytes. Our lab used a robust system for growing purified 
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cortical neurons in the absence of glia, on which an RNA-sequencing screen of cortical rat neurons 
grown alone or in the presence of cortical mouse astrocytes was run to address this gap in our 
knowledge. This dataset, presented for the first time in this thesis, reveals that the cortical neuronal 
transcriptome is extensively under the control of non-cell-autonomous signalling from astrocytes. I 
focus on a functionally important group of genes that were uncovered by this screen as being 
downregulated in neurons by astrocytes: the KIR family of channels.  
I first ask how astrocytic regulation of KIR controls neuronal membrane properties and excitability, 
finding that reduced KIR expression in cortical neurons due to astrocytes results in an expected 
alteration in membrane properties, leading to an increase in excitability. I then show that the 
expression of these KIR channels is under activity-dependent homeostatic regulation by the second 
week of culture, but only in the presence of astrocytes. Next, I seek to uncover the signalling 
pathway behind the reduction of cortical neuronal KIR, finding that it is an astrocyte secreted factor 
that reduces KIR expression. Lastly in Chapter 4, I present the results of my proteomic screen of 
ACM, providing a list of candidate molecules for the astrocyte-regulation of KIR expression which 
will be the focus of experiments going forward. 
In Chapter 5 I ask what the possible role of astrocytes, and astrocyte control of neuronal KIR, is on 
excitatory synaptic development and activity in cortical neurons. I find that cortical neurons grown 
in the presence of astrocytes have significantly higher spontaneous activity than those grown 
without, and that KIR overexpression in co-cultured neurons blocks spontaneous activity. This 
suggested that astrocytic enhancement of cortical neuron excitability due to the downregulation of 
neuronal KIR led to an increase in neuronal activity. I then investigate whether this enhanced activity 
might, in part, drive the previously reported astrocyte mediated excitatory synaptogenesis. 
Unexpectedly, I discover that cortical neurons grown in the absence of astrocytes form functionally 
active synapses to the same extent as their counterparts grown with astrocytes under basal 
conditions – suggesting that not only does KIR expression not control cortical developmental 
synaptogenesis, but neither do astrocytes! However, following 48 hours of activity deprivation, 
which is known to cause a homeostatic increase in synaptic strength, only cortical neurons grown 
in the presence of astrocytes were observed to have a significant increase in mEPSC frequency. 
Moreover, following TTX washout of activity-deprived neurons grown in the absence of astrocytes 
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there was very little induced spontaneous network events, whereas TTX removal from neurons 
grown with astrocytes induced robust spontaneous bursts of network activity.  
Based on my findings I suggest that astrocytes play a fundamental role in controlling activity-
dependent homeostatic plasticity, both at the level of excitability and synaptic strength, with this 
dual control leading to a dramatic regulation of neuronal activity.  
1.9.1 Aims 
In my thesis I seek to address the following four primary aims: 
1. To establish that neurons induce a functional increase in cortical astrocytes’ capacity to transport 
glutamate, and to determine whether this non-cell-autonomous induction is mediated by the 
contact-dependent Notch signalling pathway. 
2. To establish whether and to what extent there is a non-cell-autonomous signalling pathway from 
astrocytes to cortical neurons. 
3. To determine whether non-cell-autonomous signalling from cortical astrocytes to neurons leads 
to functional changes in neurons, in particular whether this signalling leads to an increase in 
neuronal activity. 
4. To investigate whether any observed changes induced in neurons via astrocyte-signalling is 












Chapter 2  
 




Chapter 2 – Materials and Methods 
2.1 Cell culture: cortical tissue 
Primary cell cultures of cortical neurons and cortical astrocytes were generated from tissue collected 
from embryonic day 17.5 CD1 mice and embryonic day 20.5 Sprague-Dawley rats.  Embryos were 
euthanized by decapitation, their brains removed, and cortices dissected out into dissociation media 
(DM+K: 81.8 mM Na2SO4, 30 mM K2SO4, 5.84 mM MgCl2, 252 μM CaCl2, 1 mM HEPES, 0.1% 
Phenol Red, 20 mM glucose and 1 mM kyurenic acid). Cortices were placed in round bottom 
culture tubes (Corning) and digested in DM+K containing 20 units/mL of L-cysteine-activated 
papain enzyme (Worthington Biochemical Corporation) for 40 minutes at 37°C, shaking every 10 
minutes, with fresh papain/DM+K solution added halfway through.   
Following digestion cortices were washed twice with DM+K, and twice with 1% NBA media, 
containing Neurobasal-A (Gibco), Anti-Anti (anti-bacterial/antimycotic, Invitrogen), B27 
supplement (Life Technologies), glutamine (1 mM, Sigma) and 1% rat serum (Envigo). Cortices 
were then placed in a fresh 2 mL of 1% NBA and triturated gently using a 5 mL serological pipette 
on a low speed pipette gun (approximately 50 times). A further 2 mL of 1% NBA was then added 
to the tube, and after letting the tissue settle for a minute, the top 2 mL of suspension was collected 
and placed in a fresh tube. The remaining suspension was again triturated. If no tissue chunks 
remained it was added to the collected suspension, if not then a further 2 mL of 1% NBA was added, 
and the process repeated until all cells were completely dissociated. The dissociated suspension was 
then topped up to 10 mL with 1% NBA, and added to Opti-MEM (Gibco) solution supplemented 
with glucose (20 mM, Sigma) and Anti-Anti, at a concentration of 1 rat cortex/14 mL solution, and 
1 mouse cortex/7 mL solution (giving an approximate concentration of 1,000,000 cells/mL).   
For neuronal cultures, 0.5 mL cell suspension (500,000 cells/well) was plated down onto glass 
coverslips (VWR) that had been placed into the wells of 24-well plates (Greiner), and pre-coated 
with poly-d-lysine (5 μg/mL, Sigma) and Laminin (13 μg/mL, Roche). For co-culture experiments, 
the coverslips had been pre-seeded with astrocytes 72 hours prior. The plates were then incubated 
at 37°C with 5% CO2 for two hours, before aspirating the Opti-MEM solution, and feeding with 
1 mL 1% NBA containing 4.8 μM cytosine arabinoside (AraC) (unless otherwise stated) for cells in 
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Chapter 4 and 5. Cells used in Chapter 3 were instead fed with 0% NBA (NBA media without the 
addition of rat serum added). On day in vitro (DIV) 4 the wells were topped up with an additional 
1 mL of fresh feeding media. 
For astrocyte cultures, 10 mL of cell suspension (~130,000 cells per cm2) was pipetted into a 75 cm2 
cell culture flask (Greiner) pre-coated with poly-d-lysine (5 μg/mL, Sigma). The plates were 
incubated at 37 °C with 5% CO2 for two hours, before aspirating the Opti-MEM solution, and 
feeding with 20 mL of DMEM solution (Dulbecco's Modified Eagle Medium with high glucose, L-
glutamine, sodium pyruvate and phenol-red, Gibco) that was supplemented with Anti-Anti and 
10% fetal bovine serum (Gibco). On DIV4, 10 mL of DMEM was removed and a fresh 10 mL 
added.  
To generate pure astrocytic cultures the flasks were passaged on DIV7 and DIV11. Briefly, cells 
were washed with phosphate buffered solution (PBS, Gibco), and then incubated in 5 mL of 0.05% 
trypsin-EDTA (Gibco) at 37 °C for 5 minutes. The flasks were then gently rocked to ensure all cells 
were detached from the flask, collected into a 15 mL falcon tube with 5 mL of DMEM, and 
centrifuged at 800 RPM for 4 minutes. The supernatant was aspirated, and the cells were dissociated 
and collected into fresh DMEM at a concentration of 1x 75 cm2 flask of cells into 50 mL media. 
This suspension was then divided between three new poly-d-lysine coated 75 cm2 flasks (15 mL per 
plate). On DIV11 the process was repeated, but instead plating the astrocyte suspension onto coated 
coverslip-containing 24-well plates at a concentration of 1 mL/well (at a cell density of ~100,000 
astrocytes per coverslip). Nota bene, as astrocytes are proliferative cells, the final density of 
astrocytes per coverslip at the time of recording will be greater than the density at plate down. 
On (neuronal) DIV7 a 50% media exchange was done to feed the cells. For cells that were to be 
grown to DIV15, on DIV9, 11 and 13/14, 50% media exchanges were carried out using 0% NBA 
media supplemented with 10 mM glucose. Cells grown to DIV21+ followed the same feeding 
schedule, except on DIV13/14 a 50% media exchange was done with transfection media (TMITS) 
containing (in mM): 114 NaCl, 5.3 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, 1 glycine, 30 glucose, 0.5 
sodium pyruvate, 0.2% NaHCO3, 0.001% phenol red, 10% Minimum Essential Media (-glutamine, 
Gibco), 1% Anti-Anti and 1% insulin-transferrin-selenium (100x, Invitrogen). Fifty percent media 
exchanges with TMITS were repeated on DIV17 and DIV21.  
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2.2 Cell culture: retinal ganglion cells 
Preparation of retinal ganglion cells (RGC) was done following the Cold Spring Harbor Laboratory 
protocol (Winzeler and Wang, 2013), with minor adjustments. 
Postnatal day 5-6 rat pups were euthanized by decapitation before the eyeballs were enucleated into 
chilled DM+K media and kept on ice. Retinas were dissected from the eye in chilled DM+K, by 
first making an incision into the front of the eye, removing the lens and vitreous matter and then 
carefully tearing the sclera away from the retina.  Retinas were kept in ice cold DM+K until all 
dissections were finished, before being transferred to a round bottomed culture tube containing 
DM+K with 20 units/mL of L-cysteine-activated papain enzyme and deoxyribonuclease I (DNAse; 
0.07%, Worthington) and incubated for 30 minutes at 37 °C. The enzyme was removed and 
replaced with 2 mL of low ovomucoid solution (low-ovo), consisting of a 1.5% BSA (Sigma), 1.5% 
trypsin inhibitor (Worthington) and 0.07% DNAse D-PBS (Gibco) solution. A rabbit anti-rat 
macrophage antibody (80 μL, Cedarlane) was then added to the remaining 6 mL of low-ovo 
solution and mixed thoroughly. The low-ovo solution was aspirated from the retinas and a fresh 1 
mL of the remaining low-ovo/anti-rat macrophage solution was added. The retinas were then gently 
triturated four times with a 1 mL pipette before adding a further 1 mL of low-ovo solution, with 
the top 1 mL then collected into a fresh falcon tube after the cells had settled. This was repeated 
until all of the 6 mL of low-ovo solution was used. 
The 6 mL of dissociated retinal cells was left to incubate at room temperature for 10 minutes to 
allow binding of the anti-rat macrophage antibody before being centrifuged for 12 min at 
1,000 RPM. The supernatant was removed, and the cells were re-suspended in 6 mL of a high-
ovomucoid D-PBS solution (high-ovo) containing 3% BSA and 3% trypsin inhibitor, before being 
returned to the centrifuge for a further 12 minutes. The high-ovo solution was removed and 
replaced with panning buffer made from D-PBS containing 0.01% BSA and insulin (5 μg/mL, 
Sigma). The panning buffer cell suspension was then passed through a 20-micron filter 
(pluriSelect). The filtered cells were poured onto a 15 cm negative panning dish pre-coated with 
goat anti-rabbit IgG (H + L) (Jackson Immunoresearch) and left at room temperature for 
15 minutes, before transferring the solution of non-adherent cells onto a second pre-coated negative 
panning plate for a further 45 minutes, shaking every 15 minutes. The macrophage depleted retina 
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cell solution was then transferred onto 10 cm positive panning plate, pre-coated with goat anti-
mouse IgG (H + L) (Jackson Immunoresearch) and an anti-Thy1.1 antibody (clone OX-7, Sigma) 
and left for another 45 minutes, shaking every 15 minutes.  
The positive plate was aspirated and gently washed several times with D-PBS so only adherent cells 
remained. The plate was rinsed with calcium-free EBBS (Sigma) before incubating in 0.05% trypsin-
EDTA for approximately 4 minutes at 37 °C until adherent cells shook off. The solution was 
collected into a falcon tube with D-PBS containing 30% fetal bovine serum (Gibco) and centrifuged 
at 1,000 RPM for 12 minutes. The supernatant was aspirated, and the retinal ganglion cells were 
resuspended in 1 mL 1% NBA and counted. They were then plated at a density of 50,000-100,000 
cells per coverslip in RGC growth media consisting of 1% NBA with added forskolin (4.2 μL, 
Tocris), BDNF (50 ng/mL) and CNTF (10 ng/mL), onto coverslips in 24 well plates pre-coated 
with poly-d-lysine and laminin, or else onto coverslips pre-seeded with a bed of mouse astrocytes. 
Cells were fed with fresh RGC growth media every four days. 
2.3 Transfections and plasmids 
Neurons and astrocytes were transfected in TMITS media (as described in Chapter 2.1) using 
Lipofectamine 2000 (2.33 μL/well, 1 μg/mL, Life Technologies), with a total plasmid 
concentration of 0.60 – 0.65 μg/mL. The Lipofectamine 2000/plasmid mix was incubated at room 
temperature for 20 minutes, before adding TMITS to give a total volume of 300 μL/well. Media 
from the wells to be transfected was removed (and saved aside if from neurons) before adding 
300 μL of plasmid solution to each well. For astrocyte transfections, cells were transfected 48 hours 
after their plate down onto coverslips (before neuronal co-culture) and incubated with the plasmid 
mixture for 45 minutes at 37 °C, before being aspirated and fed with 1 mL DMEM media. For 
neuronal transfections, cells were transfected with green fluorescent protein (GFP) on DIV4 and 
left in the plasmid mixture for 2 hours at 37 °C before aspiration. They were then fed with saved 
media and topped up with an additional 1 mL of fresh 1% NBA (+AraC) media. The following 
plasmids were used in this thesis: CBF1_VP16 (RBP-J) was a gift from Tasuku Honjo (Kato et al., 
1997), KIR2.1 was a gift from Matthew Nolan. 
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2.4 Electrophysiological recordings 
2.4.1 Solutions 
Standard electrophysiological recordings were performed in an external solution of artificial 
cerebrospinal fluid (aCSF) containing (in mM, all Sigma): 150 NaCl, 2.8 KCl, 10 Na-HEPES, 
2 CaCl2, 1 MgCl2 & 10 glucose, and pH adjusted to 7.3 with NaOH. For RGC recordings, the 
aCSF contained (in mM): 150 NaCl, 2.8 KCl, 10 Na-HEPES, 2.5 CaCl2, 2 MgCl2 & 10 glucose, 
pH adjusted to 7.3 with NaOH. 
Internal recording solutions for astrocytes consisted of (in mM, all Sigma): 130 KCl, 4 glucose, 
10 Na-HEPES, 0.1 EGTA, 0.025 CaCl2, 20 sucrose, pH set to 7.2 with KOH, and osmolarity set 
to ~290 mOsm by addition of sucrose. For neuronal current-clamp and intrinsic property 
recordings a K-gluconate internal solution was used consisting of (in mM): 130 K-gluconate, 
4 glucose, 10 Na-HEPES, 0.1 EGTA, 0.025 CaCl2, 20 sucrose, pH adjusted to 7.3 with KOH. For 
neuronal and RGC voltage-clamp recordings of spontaneous activity and mEPSCs, a Cs-gluconate 
internal solution with 8 mM Cl- was used, consisting of (in mM): 140 Cs-gluconate, 3 CsCl, 
0.2 EGTA, 10 HEPES, 5 QX-314 chloride, 2 Mg-ATP, 2 Na-ATP, 0.3 Na2GTP, 
10 phosphocreatine, pH adjusted to ~7.4 with CsOH. 
2.4.2 General recording set-up 
All recordings were performed at room temperature (20-23 °C), using an Axopatch 200B amplifier 
(Molecular Devices), low pass filtered at either 5 kHz (for all astrocyte and neuronal intrinsic 
property/current-clamp recordings) or 2 kHz (for neuronal and RGC mEPSC recordings), and 
digitized at 5 kHz (spontaneous neuronal voltage-clamp recordings), 10 kHz (astrocyte and mEPSC 
recordings) or 50 kHz (intrinsic property current-clamp recordings) through a National 
Instruments BNC-2090 analogue-digital interface (National Instruments). All astrocyte, RGC and 
neuronal mEPSC and spontaneous activity experiments were recorded using WinEDR software 
(V3.7.5), and all neuronal intrinsic property/current-clamp experiments were recorded using 
WinWCP (V5.2.7; both Strathclyde Electrophysiology Software). 
Perfusion of aCSF was achieved using a gravity fed set-up, at a rate of ~2 mL/min, with the inflow 
positioned ~2 mm away from the cell and the outflow located ~10 mm on the opposing side to 
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achieve efficient flow across the recorded cell. The perfusion system had six aCSF holding chambers, 
which were individually controlled using a six-channel valve controller (Warner Instrument 
Corporation) to rapidly apply drugs or change recording aCSF solutions. 
Recording electrodes for whole-cell patch-clamp were pulled on a Model P-87 Flaming / Brown 
Micropipette Puller (Sutter Instruments), using thick-walled borosilicate glass of dimensions: 
AlisonA1.5 mm OD x 0.86 mm ID (Harvard Apparatus). Electrodes for astrocytic recordings had 
tip resistances of ~7-8 MΩ, and electrodes for neuronal recordings had resistances of ~4 MΩ.  
Membrane potentials given in the results have not been corrected for the liquid junction potential 
(LJP) of the internal pipette solutions used. The LJP is approximately -4.6 mV for recordings using 
the KCl based internal solution (astrocyte recordings), and ~-16 mV for the gluconate-based 
solutions used (neuronal and RGC recordings). As such the true membrane potentials are more 
hyperpolarised than represented in the figures, for example the true neuronal RMP average in 
Figure 4.3 will be approximately -63 to -67 mV.   
2.4.3 Astrocyte recordings 
Astrocytes were whole-cell voltage-clamped at -80 mV. Upon break-in, the amplifier was switched 
to current-clamp with I = 0 to take the resting membrane potential (RMP), before being returned 
to voltage-clamp, whereupon a current-voltage protocol (from -110 mV to 0 mV in 10 mV steps) 
was run to check cell identity and to determine the membrane resistance (RM). The cell was then 
recorded in voltage-clamp at -80 mV whilst the perfusion of aCSF was run. EAAT currents were 
induced by rapidly applying aCSF containing L-Asp (200 μM, Sigma) for approximately 5 s, and 
then returning to aCSF. L-Asp application was repeated 3 times, and on the final application the 
L-Asp perfusion was instead switched to a solution of aCSF containing both L-Asp (200 μM) as 
well as the EAAT antagonist TFB-TBOA (20 μM, Tocris), to confirm current identity. For 
recording transfected astrocytes, cells positively expressing CBF1_VP16-GFP or Globin-GFP were 
visually identified by excitation with 467 nm light from a Colibri 7 LED system (Zeiss). Cells with 




2.4.4 Neuronal recordings: intrinsic properties and excitability 
Neurons were whole-cell voltage-clamped at -60 mV, and their RMP taken immediately upon 
break-in. From voltage-clamp at -60 mV a current-voltage relationship protocol was run 
(-80 to -50 mV, 5 mV steps) before current-clamping the neurons at -60 mV. A current injection 
stimulus protocol was run to determine the rheobase and to generate the frequency-input 
relationship. Current was injected for 0.5 s pulses, from -50 pA to +140 pA in 10 pA steps, with 
5 seconds recovery at current-clamp I = -60 mV between each injection. The protocol was repeated 
to take an average result, with the access resistance checked between each recording.  
For drug application experiments the above procedure was followed, before the RMP and 
current-voltage relationships were re-taken. Standard aCSF perfusion was then switched to the drug 
containing perfusion, and after 5 minutes of drug application the RMP and current-voltage 
relationships were repeated. The cell was then returned to current-clamp I = -60 mV and the current 
injection protocol repeated a further two times. The drugs used in this experiment were tertiapin Q 
(15 nM, abcam), ML 133 hydrochloride (4 μM, Tocris) and BaCl2 (5 μM, Sigma). Cells whose access 
resistance changed >30% during recording were discarded. 
2.4.5 Neuronal recordings: spontaneous activity and mEPSC 
The RMP was taken immediately after break-in and neurons were then voltage-clamped at -60 mV. 
The spontaneous activity was first recorded with standard aCSF perfusing, with a test pulse injected 
every 2 minutes to monitor the access resistance. Recording times varied from 2-10 minutes 
depending on the activity level of the cell. For mEPSC recordings the standard aCSF was then 
switched for aCSF containing 300 nM tetrodotoxin (TTX) and 50 μM picrotoxin (PTX, Tocris), 
and mEPSCs were recorded for a further 2-10 minutes, checking the access every 2 minutes. If the 
access resistance was >30 MΩ or changed >20% during recording the cell was discarded. 
2.5 Western blotting 
Samples were collected in RIPA buffer and stored at -20 °C. On the day of use, the samples were 
defrosted on ice and a colorimetric BCA assay (Pierce) was run to determine the protein 
concentration of the samples (measured with a FLUOstar Omega microplate reader). Aliquots of 
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the samples were then taken and diluted in dH2O to a concentration of 32.5 μg/65 μL. Reducing 
agent (10 μL, NuPAGE) and sample buffer (25 μL, NuPAGE) were added to 65 μL of the diluted 
sample (final protein concentration 10 μg/20 μL). The samples were then vortexed, spun down and 
boiled for 10 minutes.   
Samples were vortexed again before being loaded into a 4-12% Bis-Tris Protein Gel (NuPage), at a 
volume of 20 μL per well, with ladder loaded into the outside lanes (10 μL, SeeBlue). Electrophoresis 
was run using MOPS buffer at 120 V. Once the gel had run, proteins were transferred onto a 
methanol activated PVDF membrane (Millipore) using transfer buffer (96 mM glycine, 12 mM Tris 
and 20% Methanol) at 80 V for 1 hour. Following transfer, the membrane was blocked in TBS-T 
solution (20 mM Tris, 137 mM NaCl and 0.1% Tween-20, pH 7.6) containing 5% milk for 1 hour 
at room temperature. The membrane was then cut in half along the ~35 kDa level, and each half 
incubated in its respective primary antibody overnight at 4 °C. Primary antibodies used were: Anti-
Calmodulin (1 μg/mL; Merck 05-173) and Anti-GIRK1 (1:5,000; ab129182).  
The following day the membranes were washed 3 times in TBS-T, and then incubated for 2 hours 
at room temperature in 10 mL of TBS-T +5% milk block with the appropriate HRP-linked 
secondary antibodies. Secondaries used were anti-rabbit IgG HRP-linked antibody (1:1000, Cell 
Signalling Technologies 7074) and polyclonal goat anti-mouse HRP (1:500, Dako P0447). 
Following secondary application, the membrane was washed 3 times in TBS-T, exposed to 
enhanced chemiluminescent reagents (LumiGlo) for 1 minute, and developed manually on 
Carestream BIOMAX light film. Blots were digitally scanned and densitometric analysis was 
performed using ImageJ. 
2.6 Conditioned media experiments 
To generate astrocytic conditioned media (ACM) for application to neuronal cultures, on astrocyte 
DIV11 the flasks were split and plated down in 1% NBA instead of DMEM. On neuronal DIV0 a 
proportion of this astrocytic media was pipetted from the astrocytes’ wells, collected in a falcon 
tube, and dosed with AraC. After aspirating Opti-MEM from the neuronal samples, this treated 
ACM was used to feed the neurons instead of standard 1 % NBA. Astrocyte plates were topped up 
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with fresh 1% NBA and maintained alongside neurons. For neuronal DIV4 feeding, media was 
again collected from the astrocyte plate, treated with AraC, and fed to the neurons.  
To generate ACM for mass spectrometry analysis, on astrocyte DIV7, 1x 75 cm2 flask was split and 
plated into 1x 225 cm2 flask, and on DIV11 this flask was split again (in DMEM) into 2x 225 cm2 
flasks. After 48 hours the DMEM was removed, the flasks washed 3x with D-PBS and 1x with their 
respective collection medias, and then 20 mL of their collection media was added. The two different 
sample collection medias used were Neurobasal-A minus phenol red (Gibco) with added glutamine 
(1 mM) and Anti-Anti (1%), and phenol-red free DMEM (Gibco) with added Anti-Anti (1%). 
Three days later the sample was collected from each flask into chilled 50 mL falcon tubes containing 
protease inhibitor (cOmplete). All following steps were carried out on ice. Samples were centrifuged 
at 2,000 g for 20 minutes at 4 °C, and then the supernatant was passed through a sterile 0.22 μm 
filter (Fisher) into a chilled falcon. Fifteen mL of the sample was then added to the reservoir chamber 
of a pre-chilled 3K centrifugal tube (Amicon), before being centrifuged at 4,000 g for 30 minutes 
at 4 °C. The filtrate was discarded, and the reservoir topped up to 15 mL with chilled dH20 before 
returning to the centrifuge for a further 45 minutes. The concentrated samples were recovered into 
chilled Eppendorf tubes, a BCA assay run to determine protein concentration, before being stored 
at -80 °C.  
To generate neuronal conditioned media, 20 mL of rat suspension was plated into a 75 cm2 flask 
and fed with 1% NBA + AraC on DIV0 and DIV4. On DIV5 the flask was washed 3x with D-PBS, 
once with the sample conditioning media (phenol red-free NBA), and then 10 mL of the 
conditioning media was applied. On DIV7 the media was collected and concentrated as per the 
ACM protocol.  
2.7 Immunohistochemistry and confocal imaging 
On DIV14 samples were fixed in 1% formaldehyde for 20 minutes, washed 3 times with PBS, 
permeabilised with 0.5% NP40 (Life Technologies) for 5 minutes and then blocked in 1% BSA 
(Sigma) for 15 minutes. Antibodies were applied in 1% block solution, with 300 μL of solution 
applied to each well. The following antibodies were included in the solution: Synapsin 1 polyclonal 
rabbit antibody (1:1,000, SySy 106 103), Homer 1 monoclonal mouse antibody (1:200, 
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SySy 160 011) and fluorescein isothiocyanate (FITC)-conjugated GFP (1:500, abcam, ab6662). 
The plate was wrapped in foil and left to rotate at 4 °C overnight. The following morning the 
primary antibody solution was collected and saved, the wells washed three times with PBS, and then 
300 μL of 1% block solution containing secondary antibodies was applied to each well. The 
secondaries used were: anti-mouse Cy3 (1:500, Jackson ImmunoReseach, 115-165-044) and 
anti-rabbit Alexa Flour 647 (1:1,000, abcam, ab150083). The plates were left rotating in secondary 
antibodies for two hours at room temperature. The coverslips were then washed five times in PBS 
and mounted on glass microscopy slides using Vectashield mounting media (with DAPI). The slides 
were covered and sealed from light and left at room temperature for two hours for the mounting 
medium to set, then stored at 4 °C in a slide box.  
The samples were later imaged for synaptic markers on a Nikon A1R FLIM confocal microscope. 
GFP positive cells were selected under 10x magnification, before switching to an oil-submerged 60x 
lens to record processes of interest. For each recorded cell, 3 dendrites were selected and imaged at 
approximately 100 μm out from the cell body, which was typically on a secondary or tertiary branch. 
Around five cells were imaged per coverslip, across three independent culture batches. Images were 
analysed offline in Fiji (ImageJ), counting co-localised pre- and post- synaptic markers that occurred 
along the GFP positive dendrite region imaged. Co-localised puncta appeared as purple-yellow 
marks, where the pre-synaptic (blue) post-synaptic (red) and dendrite (green) markers overlapped. 
The number of synapses counted for each dendrite was divided by the length of the region and 
multiplied to give the number of synapses per 10 μm length. The average number of synaptic 
puncta/10 μm across the three dendrites per cell was taken to get the cell average.   
2.8 RNA-sequencing 
The samples that generated the RNA-sequencing data set of neuronal gene expression changes due 
to astrocytes were prepared and sent for sequencing by Dr Jing Qiu, University of Edinburgh. 
Briefly, pure rat neuronal cultures, or cultures of rat neurons on mouse astrocytes, were prepared as 
described in Chapter 2.1. Rat neuron and rat neuron-mouse astrocyte samples were collected on 
DIV8, with rat neuron cultures also collected at DIV14. The RNA was extracted from the samples, 
and converted into complementary strand DNA (cDNA), and sequenced by Edinburgh Genomics 
at a read depth of 50 million per species. The bioinformatic analysis on the returned sequencing was 
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conducted by Dr Owen Dando, University of Edinburgh. The reads were sorted by species, into rat 
or mouse, using the method as described in Hasel et al., 2017 and Qiu et al., 2018, with rat reads 
signifying neuronal expression, and mouse astrocytic.  
The samples used to generate the sequencing data set of neuronal gene expression regulated by 
astrocyte conditioned media was prepared for RNA-sequencing by Dr Philip Hasel, New York 
University (formerly, University of Edinburgh). The prepared samples were sequenced by the 
Edinburgh Genomics Core Facility, and the bioinformatic analysis of the results was conducted by 
Dr Owen Dando and Dr Xin He, University of Edinburgh.   
2.9 Mass spectrometry  
ACM and NCM samples sent for secretomic profiling were sent to the MRC Institute of Genetics 
and Molecular Medicine (IGMM) Mass Spectrometry core facility at the University of Edinburgh, 
for untargeted proteomic analysis.  
Briefly, at the core facility samples were adjusted to 6M guanidine HCl/tris (pH 8.5).  
Reduction/alkylation was acheived by addition to 5 mM TCEP and 10 mM CAA, before heating 
samples to 95 °C for 5 minutes.  After cooling to room temperature, LysC (0.2 μg) was added and 
samples were diluted to 3M guanidine and incubated overnight at 37 °C.  Trypsin (0.3 μg) was then 
added and samples diluted to 1M guanidine before a final incubation of 4 hours at 37 °C. Resulting 
peptides were cleaned on C18 Stage Tips.  Peptides were separated for 40 minutes on a gradient 
4-30 % acetonitrile (0.5% acetic acid throughout) using a Thermo Ultimate 3000-series RSLC Nano 
coupled with an IonOpticks Aurora C18 nano packed emitter in a Proxeon nano source fitted with 
Sonation column oven at 50 °C.   
Ionised peptides were analysed on a Thermo Fusion Lumos in data-dependent mode and 
identified/quantified using MaxQuant version 1.6.7.0 with release 2019_07 of Uniprot Mouse and 
Human proteomes.  Statistical analysis was performed using Wasim Aftab’s implementation of 
Kammers et al., (2015) Linear Models for Microarray Data (LIMMA) pipeline for two group 
comparison in a proteomic experiment (Aftab, 2018).  
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Six concentrated ACM samples (3x replicates of NBA based ACM, 3x replicates of DMEM based 
ACM) and three samples of concentrated NCM (NBA based) were screened. There was little 
difference between NBA and DMEM conditions for ACM, so the results for the 6 samples were 
averaged together to give the relative amount of each detected protein in ACM, and the 3 neuronal 
samples were averaged to give the NCM protein levels.  
2.10 Data analysis and statistics 
Electrophysiology analysis was run using Stimfit (v0.15.4) software. In-built analysis functions were 
used to extract the data from IV relationships and FI protocols, which was then exported to Excel 
for further analysis.  
For spontaneous activity and mEPSC analysis, a custom noise filtering script was written and 
implemented in Stimfit. Basically, a Fast Fourier Transform is run over the recording to detect 
constant sources of noise. The noise waves are then subtracted from the recording, to improve the 
clarity of the trace. For spontaneous activity, large events that have over 200 pC charge passing 
through them are first detected, removed and recorded as events, providing details such as the charge 
and amplitude of each event. A mini analysis script is then run to detect remaining small 
spontaneous events, extracting them and recording details including their amplitude, time constant 
and charge. The total charge, from both large and small events, for the recording is than calculated, 
as well as the average amplitude from all events. For mEPSC recordings, the noise protocol and mini 
analysis script is run. The results are then exported to Excel for further analysis.  
All results are given as mean ± standard error of mean (SEM), unless otherwise stated. Basic 
statistical analysis, such as paired and unpaired Student’s t-tests, were run in Excel. For most analysis 
a linear mixed effects (LME) analysis of variance (ANOVA) model was run using R statistical 
software. This analysis was set up to take variation between the different cultures into consideration. 
Each data point was coded for the culture batch it was taken from, and the variation in results due 
to week by week culture variation was then incorporated as a random variable into the statistical 
analysis. This is particularly important for this work, as many of the variables being measured, such 
as activity and synapse number, are dependent on culture density and health, with culture to culture 
variations having large effects on results between weeks (often larger than the effect measured 
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between tested conditions). Whereas a standard ANOVA is unable to take the random variation 
between these culture “clusters” into account, a mixed effect model can, making it the more 
powerful and appropriate model for the datasets presented in this thesis.  
2.11 Ethics 
Animal breeding, maintenance and procedures were performed in accordance with UK Animals 
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Chapter 3 – Neuron to astrocyte signalling: Neurons control 
functional expression of astrocytic glutamate transporters EAAT1 
and EAAT2 
3.1 Introduction 
Several instances of neuronal control of astrocytic form and function have been previously 
described. This includes the dramatic morphological changes that cultured astrocytes undergo in 
the presence of neurons (Hatten, 1985). Functionally there has also been an observed increase in 
glutamate transport in astrocytes grown in the presence of a neuronal feeder layer (Swanson et al., 
1997, Gegelashvili et al., 1997, Drejer et al., 1983).   
Although these early studies hint at the communication between these two major CNS cell types, a 
thorough exploration into the full extent of neuronal control of astrocyte function had yet to be 
undertaken. To explore this non-cell-autonomous signalling from neurons to astrocytes our 
laboratory used a mixed species culture approach to elucidate the impact of neurons on astrocytic 
gene expression (Hasel et al., 2017). We found that neurons both up and downregulated 1,000’s of 
astrocytic genes (see Figure 1.1). 
Prominently among these upregulated astrocytic genes were genes associated with neurotransmitter 
uptake and metabolism. In line with previous studies showing an increase of astrocytic glutamate 
transport in the presence of neurons we found that both astrocytic glutamate transporter genes, 
Slc1a2 (EAAT2) and Slc1a3 (EAAT1), were significantly upregulated by neurons. Other genes 
associated with the glutamate and GABA pathways, such as glutamine synthetase (Glul), glutamate 
dehydrogenase (Gad1) as well as the GABA transporters GAT1 & 3 (Slc6a1 & Slc6a11), were also 
upregulated in the presence of neurons (Hasel et al., 2017). 
Given the functional importance of astrocytic glutamate uptake in CNS health and disease, I first 
sought to investigate whether this change in gene expression was associated with a functional 
increase in glutamate uptake. Secondly, I sought to establish the signalling pathway from neurons 
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that induced this increase in astrocytic EAAT expression, and thirdly whether this signalling was 
required throughout development to maintain functional glutamate clearance.  
I show that under our mixed species co-culture approach rat neurons can induce the dramatic 
morphological changes in mouse astrocytes that has been previously observed in same-species 
systems. I then demonstrate that in the presence of neurons, astrocytes display an enhanced 
glutamate uptake capability, and that this increase in uptake is in part mediated by neuron-
dependent Notch signalling. I additionally show that neuronal Notch signalling is required 
throughout development to maintain astrocytic glutamate transporter function.  
NB: throughout this chapter I refer to mouse astrocytes cultured alone as mono-culture (MC) 
astrocytes, and mouse astrocytes that have had rat neurons seeded on-top as co-culture (CC) 
astrocytes.  
Much of the data in this chapter is published in Hasel et al., 2017.   
3.2 Neurons alter astrocyte morphology 
From the first days of pure astrocyte cultures it was observed that astrocytes grown alone appear as 
flat “fried-egg” or “pancake” shaped cells (Hatten, 1985). This is in stark contrast to their in vivo 
morphology, where they display a highly branched and complex star-like structure, from which they 
derive their name. However, growing these in vitro astrocytes in the presence of neurons transforms 
the astrocytes, pushing them towards the complex stellar structures that are observed in the brain. 
We previously confirmed that our rat neurons retained the ability to induce these same 
morphological changes to our mouse astrocytes (Hasel et al., 2017).  
Examples of the in vitro MC and CC astrocytes that are used for the experiments throughout this 




Figure 3.1: Neurons alter astrocyte morphology, increasing astrocytic complexity 
Mouse astrocytes in the absence and presence of rat neurons. i) MC astrocytes display a flat “pancake” 
morphology compared to ii) CC astrocytes grown in the presence of rat neurons which display a more 
complex branched morphology that is associated with astrocytes in vivo. Scale: 20 μm. Astrocytes are 
stained for GFAP (green channel), and neurons with Neurochrom™ (red channel). Image taken from Hasel 
et al., 2017. 
3.3 Neurons do not alter the basic membrane properties of astrocytes 
Given the dramatic effect of neurons on astrocytic gene expression, I first investigated whether this 
resulted in a change to the astrocytes’ basic membrane properties.  
It is believed that astrocytes’ membrane properties are set by KIR4.1, which is one of the highest 
expressed genes and proteins in astrocytes (Butt and Kalsi, 2006, Neusch et al., 2006). This channel 
acts as a leak channel, allowing the ready passage of K+ through the cell’s membrane (Hibino et al., 
2010). Classically, in vivo astrocytes display hyperpolarised resting membrane potentials (RMP) 
close to the K+ reversal potential of -80 mV, a slightly inward rectifying current-voltage (IV) curve, 
as well as low membrane resistance (RM), in line with their properties being set by KIR4.1, in addition 
to the absence of depolarisation induced currents. 
In our RNA-seq data we observed no significant change in expression of the gene for KIR4.1 
(Kcnj10) in the presence of neurons, although it was one of the most highly expressed astrocytic 
genes. Given this, if KIR4.1 was primarily responsible for setting the astrocytic membrane properties 
I predicted to see little difference between MC and CC astrocyte membrane properties. 
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To investigate the effect of neurons on astrocyte membrane properties I used whole-cell patch-
clamp. I saw little difference in the IV relationship between MC and CC astrocytes (Fig. 3.2 i) and 
no difference between conditions in either the RMP or RM (Fig. 3.1 ii & iii). As such, despite their 
large influence on astrocyte morphology and gene expression, neurons do not control the basic 
membrane properties of astrocytes.  
 
 
Figure 3.2: Neurons do not significantly alter the intrinsic properties of astrocytes  
i) IV relationship of MC and CC astrocytes recorded at DIV8-10 (from neuronal plate down). ii) There was no 
significant difference between the RMP of MC and CC astrocytes (p = 0.58 unpaired Student’s t-test, n = 7, 
7 for MC and CC, respectively). iii) Likewise, there was no difference in the RM (p = 0.28 unpaired Student’s 
t-test, n = 7, 7 for MC and CC, respectively).  
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3.4 Neurons increase EAAT currents in astrocytes, which is prevented by 
inhibition of the Notch signalling pathway 
To investigate whether there was an increase in astrocytic glutamate transporter function in CC 
astrocytes accompanying the increase at the mRNA level I used whole-cell voltage-clamp 
recordings. As the astrocytic glutamate transporters are electrogenic, with a net 2+ movement of 
charge per transport cycle, their activity can be measured as an inward movement of charge upon 
transporter activation (Zerangue and Kavanaugh, 1996).  
To activate the transporters, I applied the EAAT substrate L-Aspartate (L-Asp) in the presence of 
the NMDA receptor antagonist AP-5 to minimise any channel activation. At the end of each 
recording I applied the high affinity EAAT antagonist TFB-TBOA (20 μM) to confirm L-Asp 
induced current identity.  
L-Asp application to DIV8 MC astrocytes resulted in a small inward current (mean = 3.6 ± 1.0 pA, 
n = 16; Fig. 3.3 i). This current was significantly greater when L-Asp was applied to DIV8 CC 
astrocytes (mean = 25.1 ± 3.4 pA, n = 19; Fig. 3.3 ii & iv), showing that the increase in mRNA 
expression was associated with an increase in functional uptake. 
Next, I wanted to find the signalling pathway behind this increase in EAAT expression. Work in 
the lab had shown that a prominent signalling pathway from neurons to astrocytes was the contact 
dependent Notch signalling pathway (Hasel et al., 2017; see Fig. 1.5). Additionally, we observed 
that inhibiting Notch signalling repressed not only the known downstream Notch genes Hes5 and 
Hey2, but also Slc1a2 (appendix A1 iii).  
Although several pathways have been previously proposed for inducing astrocytic EAAT 
expression, I investigated whether the increase in Notch signalling observed in CC astrocytes also 
had a role in regulating functional EAAT activity in astrocytes. I inhibited Notch signalling in 
astrocytes by growing CC astrocytes in the presence of the γ-secretase inhibitor DAPT and then 
recorded their L-Asp induced currents. The induced EAAT currents in DIV8 CC astrocytes where 
Notch had been inhibited were significantly smaller compared to control CC astrocytes (mean = 





Figure 3.3: Neurons increase astrocytic EAAT currents, which is prevented by inhibition of Notch 
signalling 
Astrocytic EAAT currents in DIV8-10 cultures (from neuronal plate-down) were induced by application of the 
EAAT substrate L-Asp (200 μM). i) Example trace of an L-Asp induced current in MC astrocytes, ii) CC 
astrocytes, and iii) CC astrocytes treated with the Notch signalling pathway inhibitor DAPT (10 μM) for 1 
week. iv) Currents in CC astrocytes were significantly larger than currents in MC astrocytes (p < 0.0001, 
LME ANOVA, df = 42). Inhibition of Notch in CC astrocytes resulted in a significant decrease in EAAT 
currents (p < 0.0001, LME ANOVA, df = 42). All cells were voltage-clamped at -80 mV and recorded in the 








3.5 Activating Notch signalling in mono-culture astrocytes is sufficient to 
boost EAAT function 
To confirm whether Notch signalling is involved in the increase in EAAT function in CC astrocytes 
I transfected MC astrocytes with the constitutively active form (CBF1_VP16) of the Notch 
effector, CBF1. Using a CBF1-luciferase reporter our lab had shown that expression of this plasmid 
in MC astrocytes was an effective way to boost Notch signalling activity in the absence of neurons 
(appendix A1 iv). 
 
 
Figure 3.4: Activating Notch signalling in MC astrocytes is sufficient to boost EAAT activity 
Mono-culture astrocytes were transfected with either the control plasmid globin-GFP or the constitutively 
active Notch effector CBF1_VP16-GFP 48 hrs after plate-down and recorded at DIV10. i) Example 
responses in control MC astrocytes and ii) MC astrocytes with active Notch signalling to L-Asp (200 μM). iii) 
MC astrocytes with activated Notch transcription displayed significantly larger responses to L-Asp (p = 
0.003, Student’s t-test, n = 8 & 10 cells for globin & CBF1_VP16, respectively, from 3 independent cultures). 
All cells were voltage-clamped at -80 mV and recorded in the presence of 100 μM AP-5. 
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I found that MC astrocytes expressing this active Notch effector had significantly larger responses 
to the EAAT substrate L-Asp than MC astrocytes expressing a globin control plasmid (15.8 ± 2.8 
pA & 4.2 ± 1.2 pA, respectively; Figure 3.4). This demonstrates that activating the Notch 
transcription pathway in astrocytes is sufficient to boost EAAT function and provides an 
explanation for at least one signalling pathway from neurons to astrocytes that controls astrocytic 
EAAT expression and function.   
3.6 Neuronal Notch signalling is needed throughout life to maintain EAAT 
expression 
Up to now I’ve shown that signalling from neurons is required to induce astrocytic EAAT 
expression and function. This is an important function of astrocytes, with deterioration in 
astrocytic EAAT expression and function observed in neurodegenerative disease and aging (Masliah 
et al., 1996, Jacob et al., 2007, Trotti et al., 2001). One obvious question then is, is this signalling 
from neurons required throughout life to maintain EAAT expression, or is their expression set after 
their initial induction? If signalling is constantly required, then could faulty neuronal signalling be 
a potential cause of impaired astrocytic glutamate clearance? 
To answer these questions, I grew MC and CC astrocytes out to a more mature timepoint, 
DIV22-25. I then blocked Notch signalling in some CC astrocytes from DIV0 with DAPT 
treatment, or, after recording currents at DIV13 to check the establishment of EAAT function, I 
applied DAPT treatment from DIV14. This allowed me to see whether blocking Notch signalling 
after EAAT currents were established a) did nothing, b) prevented any further changes to EAAT 
function, or c) reduced expression back down to MC levels. 
By DIV13 CC astrocytic currents were shown to be well established and robust (mean = 209.3 ± 
53.5 pA, n= 9 cells, 3 cultures; Figure 3.5 I & vi). In line with the results of Chapter 3.4, at DIV22 
induced EAAT currents were significantly greater in CC astrocytes compared to MC astrocytes, 
albeit to a larger extent than seen at DIV8 (mean = 150.9 ± 34.0 vs 12.0 ± 7.0 pA, n = 9 & 6 cells, 
for CC & MC, respectively; Figure 3.5 ii, iii & vi). Similarly, treatment of CC astrocytes with 
DAPT from DIV0 to prevent Notch activity resulted in a significant reduction in EAAT function 




Figure 3.5: Notch signalling is needed to maintain astrocytic EAAT function 
Example traces of EAAT mediated currents in response to 200 μM L-Asp in i) DIV13 CC astrocyte, ii) DIV24 
CC astrocyte, iii) DIV24 MC astrocyte, iv) DIV24 astrocyte treated with DAPT from DIV0, and v) DIV24 
astrocyte treated with DAPT from DIV14. Cells were voltage-clamped at -80 mV and all recordings were 
done in the presence of 100 μM AP-5. vi) At DIV22-25 there was a significantly larger EAAT mediated 
response in control CC astrocytes compared to MC astrocytes (p = 0.009, LME ANOVE, df = 29), as well 
as CC astrocytes treated with DAPT from either DIV0 or DIV14 (p = 0.028 & 0.027, for DIV0 and DIV14 
respectively, LME ANOVA, df = 29).  There was no difference in EAAT response in CC astrocytes treated 
with DAPT from DIV0, or from DIV14 after currents had been established. Recordings were taken from cells 
across at least 3 independent culture batches. 
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When CC astrocytes were only treated with DAPT from DIV14, after the establishment of EAAT 
function, their induced EAAT activity was significantly less than control CC astrocytes (mean = 
43.9 ± 14.9 pA, n = 8 cells; Fig. 3.5 v & vi). Moreover, the responses of the CC astrocytes with 
Notch inhibited after EAAT function had been established was indistinguishable from the 
responses of CC astrocytes that had Notch inhibited from DIV0 (41.1 ± 13.8 versus 43.9 ± 14.9 
pA, p = 0.95, LME ANOVA, df = 29). Of note, the responses of both DAPT treated CC astrocytes 
appeared slightly greater than MC astrocytes to L-Asp, suggesting either incomplete Notch 
inhibition or the involvement of some other pathway in EAAT induction in astrocytes.   
I’ve shown here that not only is Notch signalling from neurons required for the induction of EAAT 
transporter function, but it is also required throughout the astrocytes life in order to maintain 
EAAT functional activity.  
3.7 Discussion 
3.7.1 Summary of findings 
I have shown in this chapter that cortical neurons control some important functional aspects of 
cortical astrocytes. Neurons do not alter the gene expression of the highly expressed KIR4.1 channel, 
and correspondingly have little impact on the basic membrane properties of astrocytes. However, 
neurons significantly upregulate the expression of Slc1a2 and Slc1a3, and I showed that this 
upregulation corresponded to a significant increase in the function of the astrocytic glutamate 
transporters, EAAT1 and EAAT2. I then demonstrated that neurons control this functional 
astrocytic EAAT expression via the contact-dependent Notch signalling pathway. Importantly, the 
work I presented in this chapter suggests that neuronal Notch signalling is continuously required 
in order to maintain astrocytic EAAT expression and function.  
3.7.2 Neurons control astrocytic EAAT1 and EAAT2 through Notch signalling 
Consistent with previous studies I have shown in this chapter that neurons increase the activity of 
astrocytic glutamate transporters. This finding was predicted from the results of RNA-sequencing 
work conducted by our lab, which saw a dramatic increase in the gene expression for these 
transporters, Slc1a2 and Slc1a3 (see Figure 1.1). The results of this sequencing additionally showed 
that the expression for Kcnj10 (KIR4.1) in astrocytes was relatively unaffected by the addition of 
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neurons. As KIR4.1 is believed to play a significant role in determining astrocytic membrane 
properties I predicted that neurons should have little effect on astrocytic properties, which I found 
to be the case. Given these two findings, I wondered if the results of this sequencing might also 
provide a clue as to the signalling pathway by which neurons control the astrocytic glutamate 
transporters. Although several factors have been found to modulate the expression of astrocytic 
EAATs, the evidence is still inconclusive as to the physiological signalling pathway(s) that 
regulate(s) their expression. Given the fundamentally important role these transporters play in the 
nervous system, with their combined deletion being lethal and impairments in their function 
associated with disease, finding the pathway by which they are regulated remains of high imperative. 
Within the group of astrocytic genes that were upregulated by neurons were Hes5 and Hey2, known 
downstream products of the Notch signalling pathway. Investigating this further, I found 
astrocytes to highly express Notch receptors, whereas neurons expressed Notch ligands. These 
observations were suggestive of an astrocytic Notch signalling pathway being present in these cells 
that was activated by neurons, a finding confirmed by Dr Philip Hasel (appendix A1 ii). Therefore, 
I decided to investigate whether the Notch signalling pathway might be controlling the astrocytic 
glutamate transporters. I found that inhibiting Notch by preventing the cleavage of the NICD with 
the γ-secretase inhibitor DAPT strongly reduced the EAAT transporter function in the presence of 
neurons. This suggested that neuronal activation of Notch in astrocytes was responsible for 
inducing astrocytic EAAT function. If this pathway was responsible alone for astrocytic EAAT 
induction, then simply activating Notch in astrocytes should boost EAAT function independent 
of neuronal presence. To investigate this, I transfected astrocytes with the constitutively active form 
of the Notch effector – which results in increased Notch activity in transfected astrocytes (appendix 
A1 iv). Indeed, I found that simply turning on Notch in MC astrocytes, without neurons present, 
was sufficient to boost astrocytic EAAT function. This result also nicely confirmed the results of 
my earlier DAPT experiment, ruling out the possibility that the reduction in EAAT function was 
due to non-specific effects of γ-secretase treatment, rather than Notch inhibition per se. Overall, 
these results show that neurons increase astrocytic functional EAAT expression via the contact-
dependent Notch signalling pathway.  
My findings here suggest that the observations that neuronal Notch ligands induce the glial 
glutamate transporter EAAT1 in drosophila is a conserved signalling pathway in mammals (Stacey 
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et al., 2010). There is also the possibility that this induction of astrocytic EAAT transporters is not 
specific to neurons, as endothelial cells have also been shown to induce mouse astrocytic EAAT2 in 
culture (Lee et al., 2017). As well as astrocytes’ close association with neurons, they also send their 
processes to blood vessels, so physiologically this presents the possibility that these endothelial cells 
also have a role in inducing astrocytic EAAT transporters in the brain. In relation to past work on 
astrocytic EAAT regulation, my results in this chapter give rise to a further interesting possibility. 
As discussed in Chapter 1.5, earlier studies had found that cAMP signalling was able to induce 
EAAT function in astrocytes in a similar manner to neuronal co-culture. However, how this cAMP 
induction related to the physiological neuronal signalling cascade that induced astrocytic EAAT 
had not been discovered. In light of a 2015 paper suggesting that cAMP increases NICD 
translocation and Notch pathway activity, it is certainly possible that the previously observed effects 
of cAMP on astrocytic EAAT induction may be due to enhancement of Notch activity (Angulo-
Rojo et al., 2013). In future work it would be interesting to confirm whether the effects of cAMP 
on astrocytic EAAT function are in fact mediated by Notch signalling, which would solve the 
mystery of cAMP’s physiological relationship to neuron induced astrocytic EAAT expression. 
3.7.3 Notch signalling is needed to maintain astrocytic EAAT function  
Importantly, my work has shown that Notch signalling is continually required to maintain 
astrocytic EAAT expression. Not only does Notch increase astrocytic EAAT function, its removal 
completely reverses this induction. The potential significance of this finding is in relation to the fact 
that astrocytic EAAT dysfunction and reductions in EAAT expression have been repeatedly 
associated with neurodegenerative diseases of all varieties (Van Den Bosch et al., 2006, Pál, 2018, 
Hoshi et al., 2018, Masliah et al., 1996, Li et al., 1997, Jacob et al., 2007). The link between impaired 
astrocytic glutamate clearance and neuronal loss due to excitotoxic insult has always been clear, and 
it seems obvious that such dysfunctions may in part contribute to the progression of 
neurodegeneration. My observation that removing Notch reduces astrocytic EAAT function 
presents the possibility that some neurodegenerative diseases may be the result of a snowball effect 
involving glutamate clearance, hence the typical appearance later in life followed by rapid decline. 
For example, something may trigger a reduction in neuron numbers or neuronal branching leading 
to a decrease in contact with astrocytes, reduced astrocytic Notch signalling and finally reduced 
EAAT expression. This reduced expression of EAATs may then lead to greater exposure of neurons 
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to extracellular glutamate, triggering apoptosis, resulting in greater loss of neurons and greater loss 
of contact with astrocytes, further reducing astrocytic EAAT expression. Similarly, small 
dysfunctions in the Notch signalling pathway, or small reductions in astrocytic EAAT function, 
may be what initially leads to neuronal death through prolonged elevated extracellular glutamate 
concentrations. This neuronal death then causes further reductions in Notch signalling and 
astrocytic EAAT function, exacerbating cell loss.  
Support for this hypothesis comes from observations that impairments in γ-secretase function have 
long been associated with Alzheimer’s disease. As well as γ-secretase’s role in cleaving the NICD, it 
is also involved in cleavage of the amyloid precursor protein (APP); increased cleavage of APP into 
toxic Aβ fragments leads to the production of amyloid plaques, a characteristic feature of AD 
(Jurisch-Yaksi et al., 2013). As it turns out, mutations that cause familial early onset AD have 
predominantly been found to be in a component of the γ-secretase complex, namely presenilin-1 
and -2 (Hutton and Hardy, 1997, Sassi et al., 2014). These mutations alter the activity of γ-secretase 
and cause an increase in production of toxic Aβ fragments. Therefore, an early human AD drug 
trial was with a broad spectrum γ-secretase inhibitor, with the belief that preventing toxic Aβ and 
amyloid production would improve disease (De Strooper, 2014). However, the opposite occurred: 
inhibiting γ-secretase worsened AD progression, with this worsening attributed to the incidental 
inhibition of Notch signalling (De Strooper, 2014, Henley et al., 2014). Significantly, presenilin 
mutations that give rise to early onset AD and increased pathogenic Aβ production are concurrently 
found to have a significantly reduced ability the cleave the NICD, suggesting that although mutant 
presenilin might enhance production of toxic Aβ it also results in loss of Notch activation 
(Moehlmann et al., 2002, Brai et al., 2016, Song et al., 1999, Chen et al., 2002). Further linking 
Notch-EAAT impairments to neurodegenerative diseases, a recent paper found significant 
reductions in NICD in hippocampal tissue of human ALS patients compared to controls (Gómez-
Pinedo et al., 2019). This work complements our lab’s findings of both reduced Notch pathway 
genes (Hes5 and Hey2) and importantly reduced Slc1a2 expression, in a mouse model of motor 
neuron disease, suggestive of reduced Notch signalling (Hasel et al., 2017). Therefore, as Notch 
signalling induces astrocyte EAAT functional expression, the reduced astrocytic Slc1a2 and Slc1a3 
expression that is seen in AD and motor neuron disease may be due to reduced Notch activity, for 
example due to mutant γ-secretase activity. This reduction may then lead to the increased 
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excitability and glutamate dysregulation seen in patients, which may exacerbate neurodegeneration 
(Amatniek et al., 2006).  
Several studies have now investigated the role of impaired Notch signalling in forebrain neurons in 
neurodegeneration, producing conflicting results. Early studies found that conditional knockout 
of either the nicastrin or presenilin components of γ-secretase specifically in forebrain excitatory 
neurons caused impairments in learning and memory followed by neurodegeneration (Tabuchi et 
al., 2009, Saura et al., 2004). However, two independent groups in 2012 who produced conditional 
knockouts of Notch receptors and the Notch effector CBF1 (RBPj) specifically in excitatory 
forebrain neurons found that inhibition of Notch signalling in these neurons had no impact on 
memory and did not lead to neurodegeneration (Zheng et al., 2012, Sato et al., 2012). On the surface 
these results suggest that the toxic effect of mutant γ-secretase is not due to reduced Notch 
signalling, but these findings do not rule out the possibility that impairments in astrocytic Notch 
signalling may be involved in the pathological development of disease. Interestingly, heterozygous 
Notch1+/- and RBPj+/- mice were found to have deficits in spatial memory and learning 
(homozygous knockouts being embryonic lethal), suggesting that reduced Notch signalling in cells 
other than forebrain neurons does lead to cognitive impairment (Costa et al., 2003). Given my 
results here demonstrating the requirement of Notch signalling for astrocytic EAAT function it 
would be interesting for future work to re-explore the involvement of Notch signalling in 
neurodegeneration, but this time investigating the role of impaired astrocytic Notch signalling, 
rather than neuronal. 
Interestingly, as well as the reported reductions of astrocytic EAAT expression in neurodegenerative 
disease, it appears that there may be a natural decline in the expression of these transporters with age 
in humans. From a dataset produced by Barres and colleagues in 2016, where they reported the gene 
expression in astrocytes purified from healthy human CNS tissue (subjects ranging from 8 to 63 
years old), the mean expression of the astrocytic glutamate transporters SLC1A2 and SLC1A3 was 
approximately 35% lower in the 6 samples from subjects >40 years old compared to the 6 samples 
from subjects <40 years old (see appendix A10; Zhang et al., 2016). Furthermore, the expression of 
Notch pathway related genes, including HES5 and the γ-secretase components – in particular 
nicastrin, was approximately 30% lower in astrocytes from these older human samples (Zhang et al., 
2016). These results suggest that during the course of human aging there is a reduction in Notch 
85 
 
signalling in astrocytes, resulting in a decrease in glutamate transporter expression. This further 
supports a link to impaired Notch signalling/astrocyte glutamate clearance and dementia, as the vast 
majority of cases of non-familial AD and dementia appear later in human life. Thus, exacerbation 
of these age-related reductions, for example due to lifestyle factors, may lead to the onset of dementia 
in sporadic cases.    
It is an open question whether the decline in astrocytic Notch or glutamate clearance precedes 
neurodegeneration, or whether reductions in neurons and neurodegeneration lead to the reduction 
in Notch signalling and transporter expression. Either way, it would be intriguing to see whether 
boosting Notch signalling and EAAT expression in healthy older-aged humans (without familial 
AD) could prevent or reduce the later incidence of dementia. 
3.7.4 Conclusions 
Neurons are responsible for controlling the expression of the physiologically important glutamate 
transporters in astrocytes. They induce astrocytic EAAT1 and EAAT2 expression and function 
through the contact dependent Notch signalling pathway, with removal of this signalling causing a 
significant reduction in astrocytic EAAT function. Further work is required to assess whether the 
previously observed effects of cAMP on astrocytic EAAT function are due to an interaction with 
the Notch signalling pathway. Importantly, future investigations should focus on the potential 
involvement of reduced Notch signalling in astrocytes, and the downstream effects on astrocytic 
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Chapter 4 – Astrocytes alter neuronal gene expression and 
physiological properties 
4.1 Introduction 
Historically astrocytes had clear functions ascribed to them, prominently their roles in glutamate 
clearance and K+ buffering. Recently, the suggested roles of astrocytes in neuronal function have 
been greatly expanded, with astrocytes now believed to play important roles in directing neuronal 
development and more directly influencing neuronal function. One prominent theory suggests that 
astrocytes are required for excitatory synapse formation. This idea was first brought forward from 
early work on retinal ganglion cell (RGC) cultures, where it was observed that culturing RGCs in 
the presence of astrocytes lead to an increase in excitatory synapse formation (Pfrieger and Barres, 
1997, Ullian et al., 2001).  Since then a number of astrocyte secreted proteins have been proposed 
as excitatory synapse promoters, including thrombospondins, glypicans and SPARCL1, largely 
based on work with purified RGCs (Allen et al., 2012, Eroglu et al., 2009, Christopherson et al., 
2005, Singh et al., 2016, Kucukdereli et al., 2011). The evidence for astrocyte dependent excitatory 
synapse formation in other brain regions, such as the cortex, is less clear. As well as their potential 
involvement in synapse development, astrocytes are believed to actively participate in neuronal 
activity by secreting neuro-modulatory chemicals, such as glutamate, in what has been termed the 
tri-partite synapse (Perea et al., 2009, Araque et al., 1999). Along these lines, there is evidence to 
suggest that astrocyte released factors are required for both LTP and LTD (Henneberger et al., 
2010, Adamsky et al., 2018, Min and Nevian, 2012, Navarrete et al., 2019). However, despite the 
increased interest in how astrocytes communicate with neurons, and how this may alter neuronal 
function, no work has yet investigated how astrocytes control neuronal gene expression and the full 
extent of astrocytic-neuronal interactions.  
Given the recent interest in astrocytes’ roles in neuronal function and the lack of accompanying 
knowledge, I first sought to investigate how astrocytes may alter cortical neuronal gene expression. 
I employed a robust culture system that allows for healthy cortical neuronal growth and survival in 
the absence of astrocytes, in order to address the historical bias and limitations of using RGCs as a 
model for astrocyte-neuron interactions. I used a similar mixed-species approach with these cells as 
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in the previous chapter, this time culturing rat cortical neurons alone, or on a bed of mouse cortical 
astrocytes, combined with RNA-sequencing results from this system.  
Under this set-up I found that cortical astrocytes influenced many cortical neuronal genes, but not 
always the genes expected. I used the lab’s RNA-seq data to hypothesise how astrocytes might affect 
neuronal properties: of interest I found that astrocytes downregulated the expression of neuronal 
K+ inward-rectifier channels (KIR). As these channels are important for setting membrane 
properties, I hypothesised that this would lead to functional differences in neurons cultured with 
astrocytes leading to enhanced excitability. Indeed, I found that neurons cultured with astrocytes 
do have differences in their properties that led to an increase in their excitability, and that 
manipulating KIRs is able to replicate these effects. Furthermore, these K+ channels go on to be 
regulated in an activity-dependent way, but only in the presence of astrocytes. To investigate the 
mechanism behind this control of KIR expression, I then used astrocyte conditioned media to show 
that an astrocyte secreted factor was responsible for these changes. Using unbiased proteomics, I 
then explored what factors in ACM may be responsible for the regulation of KIR channels. 
NB: Throughout Chapter 4 I refer to rat neurons cultured alone as mono-culture (MC), and rat 
neurons cultured on mouse astrocytes as co-culture (CC). This is different to Chapter 3.  
4.2 AraC treatment prevents astrocyte growth and proliferation 
To generate astrocyte-free cortical neuronal mono-cultures the chemotherapy drug cytosine 
arabinoside (AraC) was used. AraC is able to incorporate itself into DNA during cell proliferation, 
and once in the cellular DNA induces cell death. As astrocytes proliferate, the addition of AraC to 
culture media is taken up by any currently proliferating astrocytes. At the point of plate down all 
astrocytes enter a phase of proliferation, and as such treatment with AraC effectively removes all 
astrocytes from the culture.  
To generate a co-culture, rat cell suspension is plated on top of a bed of established mouse astrocytes. 
These astrocytes have had time to settle, and many are no longer undergoing proliferation, so 
treatment with AraC does not kill these established astrocytes off.  
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The effectiveness of this strategy is shown in Figure 4.1, with panels i & iii depicting rat suspension 
plated onto blank coverslips (mono-culture), and ii & iv depicting the same culture plated onto 
established mouse astrocytes (co-culture). Both conditions had been treated with AraC on DIV0 
and DIV4, and at the time of collection (DIV15) it can be observed that the mono-culture is still 
free of astrocytes.  
 
Figure 4.1: Rat neurons cultured in the absence and presence of mouse astrocytes, treated with 
AraC 
Treatment with the cytotoxic agent AraC (4.8 μM) on rat DIV0 and DIV4 successfully prevents astrocyte 
proliferation. Panels i & iii show DIV15 rat cortical cells that were seeded onto coverslips. AraC treatment 
kills astrocytes in the rat suspension undergoing proliferation, preventing their survival, creating a neuron 
mono-culture. Panels ii & iv show DIV15 rat suspensions that were instead seeded onto an established bed 
of mouse astrocytes. AraC does not kill established mouse astrocytes no longer proliferating, creating a 
mixed species co-culture.  
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4.3 Investigating the effect of astrocytes on the neuronal transcriptome using 
mixed-species RNA-sequencing 
To investigate how cortical astrocytes effect cortical neuronal gene expression, the lab employed a 
mixed species RNA-sequencing approach (as described in Hasel et al., 2017). Rat neurons were 
grown alone or on a bed of mouse astrocytes, samples collected and prepared, and then sent for 
sequencing. The resultant reads from the RNA-sequencing were sorted on species, using the 
difference in genome between mice and rats. The change in gene expression in rat reads with the 
addition of mouse astrocytes was then analysed, which represents the change in neuronal gene 
expression due to astrocytes.  
 
Figure 4.2: Change in neuronal gene expression due to astrocytes  
Results from the mixed species RNA-seq of DIV8 rat neurons cultured alone or on top of mouse astrocytes. 
There was a total of 1,960 neuronal (rat) genes that were significantly up or downregulated >1.5 fold in the 
presence of astrocytes (out of a total of 13,178 rat genes). As a whole, the expression of the KIR family of 
genes were downregulated by co-culture, with the most prominently expressed members in neurons, Kcnj3 
(KIR3.1) and Kcnj4 (KIR2.3), showing the greatest degrees of downregulation. Data courtesy of Dr J. Qiu 




The results of this analysis were sorted into genes with >1.5-fold change in expression with a 
significance of P_adjusted ≤ 0.05 in the presence of astrocytes, and those with either ≤1.5-fold 
change or P_adjusted > 0.05, as shown in Figure 4.2. Overall, 14.9% of cortical neuronal genes were 
significantly up- or downregulated by >1.5-fold by astrocytes.  
Some of the most significantly upregulated genes were those for tubulins (appendix A2). Synaptic 
associated proteins, on the other hand, were largely unaffected by the presence of astrocytes 
(appendix A3). However, the KIR family of genes as a whole were significantly downregulated in the 
presence of astrocytes (appendix A4). In particular the genes for KIR3.1 and KIR2.3, which were the 
most expressed KIRs in neurons, were the most downregulated by astrocytes. This down regulation 
was not due to a hastening of maturation: gene expression of KIRs was seen to increase from DIV8 
to DIV15 in cortical neurons (appendix A4). Therefore, astrocytes impede KIR expression in cortical 
neurons.  
4.4 Neuronal membrane properties are altered in co-cultured neurons, 
consistent with a decrease in KIR expression 
Due to the change in cortical neuronal KIR expression, I sought to establish if this led to physical 
changes in neuronal properties. First, I looked at the membrane and action potential properties of 
MC neurons compared to CC neurons. I found that the resting membrane potential (RMP) was 
significantly depolarised in CC cells compared to MC cells (Fig 4.3 i: mean = -52.1 ± 1.0 mV vs -47.9 
± 1.1 mV, n = 44 & 24, for MC and CC cells, respectively). I further found that the membrane 
resistance (RM) was significantly higher in CC cells, consistent with a decrease in KIR expression 
(Fig 4.3 ii: mean = 523.3 ± 37.1 vs 702.7 ± 60.6 MΩ, n = 44 & 24, for MC and CC respectively). I 
also saw that the amplitude of the first action potential to be induced was significantly higher in CC 
neurons (Fig 4.3 iii: mean = 69.1 ± 2.3 vs 81.8 ± 2.7 mV, for MC and CC respectively), although 
the mechanism behind this is not further explored in this work.  
To check for any effects of AraC treatment on the CC cells, I had a third condition of CC cells 
grown without the addition of AraC. In these samples there is a mix of mouse and rat astrocytes 
along with the rat neurons. I found no difference between CC cells grown with or without AraC 




Figure 4.3: The presence of astrocytes alters the membrane properties of cortical neurons at DIV8 
The membrane properties of rat cortical neurons were recorded at DIV8. Neurons were either grown in rat 
mono-culture (+AraC, n = 44 cells), rat neuron + mouse astrocyte co-culture (+AraC, n = 24 cells), or co-
culture without AraC (-AraC, n = 22; rat neuron & rat astrocyte on mouse astrocyte) to control for any effects 
of AraC treatment. i) Both co-culture conditions caused a significant depolarisation in RMP compared to 
mono-culture (p = 0.008 and p = 0.02 for CC +AraC and CC -AraC, respectively, LME ANOVA, df = 79). ii) 
The membrane resistance in cortical neurons grown with astrocytes was also significantly increased 
(p = 0.02 and  p = 0.003 for CC +AraC and CC -AraC, respectively), as well as the height of the first action 
potential (p < 0.001 and  p  = 0.002 for CC +AraC and CC -AraC, respectively). Cells were recorded from 9 
independent culture batches. 
 
4.5 Neuronal excitability is increased by the presence of astrocytes 
Having observed my hypothesised changes in cortical neuronal membrane properties in the 
presence of astrocytes, I next investigated whether there was an effect of astrocytes on the 
excitability of these cells. To do this I examined the frequency-current (FI) relationship in MC and 
CC cells. This relationship is the measure of the number of action potentials elicited due to a given 
input current (with cells current-clamped at a specified holding potential, in this case -60 mV). The 
minimum current that is required to be injected to induce an action potential is known as the 
rheobase. An increase in a cell’s excitability is then marked by a leftward shift in the FI relationship 




There was a leftward shift in the FI relationship between MC neurons and both CC neurons +AraC 
and CC neurons -AraC treatment, with significantly more action potentials fired in both CC 
conditions compared to MC for current injections ranging from 20 pA to 80 pA (Fig 4.4 ii). This 
was accompanied by a significant decrease in the rheobase for CC conditions (Fig 4.4 iii: mean 
current to fire an AP = 67.7 ± 4.1, 37.9 ± 4.9 and 32.3 ± 2.8 pA, n = 44, 24, 22, for MC, CC +AraC 
and CC -AraC, respectively). Overall, there is an increase in the excitability of cortical neurons 
grown in the presence of astrocytes, which is consistent with the observed changes in their 
membrane properties. 
 
Figure 4.4: Neuronal excitability is increased in the presence of astrocytes 
i) Example traces of the frequency-input protocol run on MC and CC cortical neurons, showing the rheobase 
input step. Neurons were current-clamped at -60 mV, and a series of current injections were applied in 
successive 10 pA increments (starting from -50 pA injections). Less current was required to be injected into 
CC neurons to elicit an AP. Of note, the after-hyperpolarisation current appears to be greater in MC neurons 
than CC neurons. ii) The FI curve is leftward shifted in the presence of astrocytes. This corresponds with a 
significant decrease in the current (Iinject) required to elicit an action potential (the rheobase), as seen in iii (p 
< 0.001 for both CC +AraC and CC -AraC compared to MC, LME ANOVA, df = 79). There was no difference 
between the two CC conditions for any Iinject point in the FI relationship nor in the rheobase, showing AraC 
treatment itself is not affecting the observed results. Cells were obtained from 9 independent culture batches. 
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4.5.1 Effects of astrocytes on neurons are not specific to species  
One question arising from the experimental set-up using mixed species (mouse astrocytes and rat 
neurons) is whether the effect of astrocytes on neurons is due to an effect of different species on 
gene expression, rather than different cell type. The results of the labs’ RNA-sequencing on mouse 
neuron/mouse neuron plus mouse glia preparations shown in appendix Figure A6 suggest that this 
is not the case, as Kcnj expression is likewise reduced in glia containing samples. However, to address 
this concern, I created a same species set-up, using mouse cortical neurons grown on mouse 
astrocytes. As mouse primary neurons typically develop slightly faster than rat neurons, I 
additionally created samples of MC and CC mouse neurons that had been incubated in TTX for 
48 hours prior to recording to control for any homeostatic masking of differences in properties due 
to activity that may occur. At DIV8 there was a significant depolarisation in RMP between in CC 
+TTX treated cells compared to MC +TTX, as well as a slight but insignificant increase in RM 
(Fig A9 i-ii). In terms of excitability, activity-deprived CC neurons had a significantly lower 
rheobase than TTX-treated MC mouse neurons (Fig A9 iii). These results, combined with same-
species RNA-sequencing, suggest the effects of astrocytes on neuronal properties are not due to an 
interaction of different species, as mouse neurons also benefit from an increase in excitability when 
grown with mouse astrocytes. 
4.6 Blocking KIR in mono-culture mimics the effects of astrocytes on intrinsic 
neuronal properties 
The observed changes in membrane properties and excitability are consistent with a decrease in KIR 
expression in cortical neurons. I next decided to test whether directly altering KIR activity in cortical 
neurons was able to change the membrane properties and excitability of cells, to confirm a link with 
KIR expression to the observed changes in intrinsic properties.  
To do this, I grew MC neurons, recorded their properties, acutely applied inhibitors of KIR 
channels, and then re-recorded their properties in the presence of reduced KIR activity. The RMP 
and RM were recorded immediately prior to drug application, and again after 5 minutes of drug 
wash-on. To begin with I used a combination of the KIR3.1 antagonist tertiapin-Q (TQ) and the 
KIR2.3 antagonist ML133. Initially I trialled concentrations that would fully block KIR3.1 and 2.3, 
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which induced a strong change in RMP, RM and rheobase, but resulted in the cells entering a 
depolarising block and being unable to fire more than one AP regardless of input current. I then 
reduced the concentrations of both drugs down to the reported IC50 levels for both KIR3.1 and 2.3, 
reasoning that this would result in a partial block of their activity, akin to the partial downregulation 
(but not complete abolishment) of expression seen in CC.    
Application of TQ and ML133 at these lower concentrations resulted in a slight but insignificant 
depolarisation in the RMP (Fig 4.5 ii: mean = -52.5 ± 2.8 and 49.6 ± 2.6 mV, n = 9, before and after 
drug application, respectively), along with a significant increase in the RM (Fig 4.5 iii: mean = 385.8 
± 45.7 and 516.9 ± 61.5 MΩ, n = 9, before and after drug application, respectively). Along with 
these changes in membrane properties following KIR3.1 and KIR2.3 inhibition was an associated 
increase in excitability, with a leftward shift in the FI relationship and a significant decrease in the 
rheobase (Fig 4.5 iii-iv: mean = 68.8 ± 6.0 and 51.1 ± 6.3 pA, n = 9, before and after drug 
application, respectively). 
Next, I looked at the effects of applying the non-specific KIR inhibitor Ba2+ to MC neurons. In an 
attempt to get a partial block of KIR channels at -60 mV, I applied Ba2+ at a concentration of 5 μM. 
There was no effect of applying Ba2+ at this concentration on the RMP of MC cortical neurons, 
however there was a significant increase in their RM (Fig 4.6 i & ii: mean RM = 451.4 ± 57.1 and 
498.8 ± 67.1 MΩ, n = 13, before and after Ba2+ application, respectively). As with the specific KIR 
blockers, the non-specific blocker Ba2+ likewise induced a leftward shift in the FI relationship and a 
significant decrease in the rheobase (Fig 4.6 iii & iv: mean rheobase = 72.3 ± 6.8 and 54.6 ± 7.3 pA, 
n = 13, before and after Ba2+ application, respectively). 
These results demonstrate that reducing KIR activity in MC cortical neurons causes an alteration in 
their membrane properties and an increase in excitability. The same effect is seen by co-culture with 







Figure 4.5: Specific KIR3.1 and KIR2.3 antagonism of MC neurons increases excitability 
The membrane properties and FI relationship (i) were recorded in DIV8 MC rat neurons, with the membrane 
potential current-clamped at -60 mV for FI recordings, before the neuronally expressed KIR channels (KIR3.1 
and 2.3) were blocked by acute application of their specific antagonists tertiapin Q (TQ, 15 nM) and ML133 
(4 μM). The same properties were then re-recorded in the presence of the drugs. ii) Following drug 
application there was a slight but insignificant depolarisation in the RMP (p = 0.1, n = 9, paired Student’s t-
test), although a significant increase in RM was observed (iii; p < 0.001, n = 9, paired Student’s t-test). iv) 
and v) There was a leftward shift in the FI curve after the application of the antagonists, as well as a significant 
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Figure 4.6: Non-specific KIR block with low-dose Ba2+ increases excitability of MC neurons 
The membrane properties and excitability of MC rat neurons at DIV8 were recorded before the non-specific 
K+ channel blocker Ba2+ was applied at a low concentration (5 μM) to target the KIR family of channels. After 
Ba2+ wash-on the MC neuron properties were again recorded. i) Application of low dose Ba2+ had no effect 
on the RMP of neurons, but ii) it did significantly increase the RM (p = 0.008, n = 13, paired Student’s t-test).  
iii-iv) Ba2+ application caused a leftward shift in the FI relationship, as well as a significant decrease in the 






4.7 Homeostatic mechanisms mask effects at DIV15, but are recovered by 
inhibition of activity 
Given that KIR expression was observed to increase in MC neurons with development, I 
hypothesised that the differences between MC and CC properties at a later developmental time 
point would be enhanced. To investigate this, I maintained MC and CC cortical neurons for two 
weeks, recording their intrinsic properties and excitability at DIV15, a week later than before. 
Unexpectedly, at DIV15 there was no change in RM with CC (Fig 4.7 i: mean = 360.1 ± 28.1 and 
410.2 ± 44.1 MΩ, n = 24, 25, for MC and CC neurons, respectively, from 5 independent cultures), 
and only a slight but insignificant depolarisation in RMP (Fig 4.7 ii: mean = -50.1 ± 1.9 and -45.8 
± 1.9 mV, for MC and CC, respectively; p = 0.06, LME ANOVA). There was also no significant 
shift in the FI relationship, nor a reduction in rheobase, between MC and CC neurons (Fig 4.7 iii 
& iv). 
Neuronal properties, including both excitability and miniature EPSCs (mEPSCs), are known to 
undergo activity dependent homeostatic plasticity, with activity deprivation for 24-48 hours leading 
to an increase in these activity markers (Echegoyen et al., 2007, Lazarevic et al., 2013, Rich and 
Wenner, 2007). Therefore, one explanation for the lack of observed difference between MC and 
CC neurons may be due to an activity dependent regulation in KIR expression. If CC neurons are 
more active, their functional KIR expression may be increased in a homeostatic mechanism to reduce 
their excitability. Conversely, the functional expression of KIR channels in MC may be decreased to 
increase their excitability; however, if this were the case then this could argue against astrocytic 
regulation of KIR expression.  
To investigate if homeostatic mechanisms were masking a difference in KIR expression between MC 
and CC cortical neurons I incubated both MC and CC neurons in the presence of 300 nM TTX 
for 48 hours (from DIV13) and then recorded their intrinsic properties following TTX washout. 
After activity deprivation a significant difference in RM emerged in neurons grown in the presence 
of astrocytes (Fig 4.7 i: mean = 363.6 ± 27.0 and 594.8 ± 76.5, n = 22 & 23, for MC +TTX and CC 
+TTX, respectively, from 4 independent cultures). There was also a significant increase in RM 
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between control CC neurons and CC +TTX treated cells, but no difference between control MC 
and MC +TTX.  
 
Figure 4.7: At DIV15 the intrinsic properties of CC neurons, but not MC neurons, are activity 
regulated, masking the effect of astrocytes 
The membrane properties and excitability of rat cortical neurons were investigated a week later in 
development (DIV15). Under normal culture conditions there was no difference in any of the properties 
between MC and CC neurons at this later timepoint (i-iv). However, 48 hours treatment with the NaV-channel 
blocker TTX (300 nM) to block neuronal activity saw a re-emergence of the differences seen at DIV8: i) a 
significant increase in RM specifically in CC +TTX (p = 0.003, p < 0.001, & p = 0.015 compared to MC, MC 
+TTX and CC, respectively, LME ANOVA, df = 82) iii) There was a leftward shift in the FI curve in CC treated 
with TTX (* = significance between CC control and CC +TTX, * = significance between MC +TTX and 
CC +TTX) and iv) a significant reduction in the rheobase only in the CC +TTX condition (p < 0.001, LME 
ANOVA, df = 82). There was no effect of TTX treatment on MC neurons for any property. Cells were recorded 




When I measured the excitability, I found a significant leftward shift in the FI relationship of TTX 
treated CC cells, both from TTX treated MC cells, and from control CC cells (Fig 4.7 iii), along 
with a significant decrease in the rheobase (Fig 4.7 iv: mean = 89.1 ± 6.4, 95.9 ± 11.4, 84.8 ± 9.1 and 
38.3 ± 3.8 pA, for MC control, MC +TTX, CC control and CC +TTX, respectively). 
Additionally, a quantitative reverse transcription PCR (RT-qPCR) to investigate the relative 
expression of Kcnj3 (KIR3.1) between these four conditions at DIV15 was run by Dr P. Hasel 
(appendix A5 i). At the level of gene expression there was still a reduction in Kcnj3 expression in 
control CC neurons compared to MC at DIV15. However, following activity deprivation the 
expression of Kcnj3 was further reduced in CC neurons, whilst TTX treatment had no effect on 
Kcnj3 expression in MC cells. These results were later confirmed by RNA-seq of DIV15 MC and 
CC rat neurons ± TTX treatment for the KIR family of genes as a whole (appendix A5 ii). 
Of note, previous lab RNA-sequencing on the effects of activity on mouse neuronal gene expression 
showed less Kcnj3 and Kcnj4 expression in mixed mouse cells compared to purified neuronal cells, 
and this expression was further downregulated following TTX treatment, whilst being upregulated 
following 24 hours of enhanced activity by bicuculline treatment in mixed cell preparations 
(appendix A6). Although not able to distinguish between neuronal and non-neuronal KIR 
expression in the mixed preparation, these findings further suggest that KIR3.1 and KIR2.3 undergo 
homeostatic regulation in the presence of astrocytes.  
I’ve shown in this section that although there is significantly less KIR3.1 expression in CC neurons, 
by DIV15 there is no significant difference in functional measures. However, activity deprivation 
for 48 hours unmasks the effects of astrocytes on neurons, with TTX treated CC neurons 
displaying significantly greater excitability. This shows that in the presence of astrocytes KIR 
expression is activity-regulated, allowing for homeostatic plasticity. It is interesting to note that this 




4.9 Protein levels of KIR3.1 are decreased in CC neurons 
Up until now I have shown a change in KIR gene expression and a change in the functional 
properties of neurons. I next wanted to confirm whether there was an associated decrease in KIR 
protein levels in CC neurons. I ran western blots of samples of MC, MC +TTX, CC & CC +TTX 
treated rat cortical neurons, collected on DIV8 and at DIV15, and tested for KIR3.1 expression. The 
control protein was required to be both neuronally specific (i.e. not expressed in astrocytes), and 
relatively unregulated by activity. To this end calmodulin was selected, due to its predominant 
expression in neurons, and the little effect of activity on its expression.  
An example blot is shown in Figure 4.8 i, where the KIR3.1 protein band in CC conditions at both 
DIV8 and DIV15 is clearly less than in MC. A summary of the expression levels of KIR3.1 relative 
to DIV8 MC neurons, normalised to calmodulin, is shown in Figure 4.8 ii. The relative expressions 
of KIR3.1 in both CC control and CC +TTX conditions at DIV8 and DIV15 were significantly 
lower compared to their MC counterparts. Unexpectedly, there was no significant difference in the 
relative protein levels of KIR3.1 between control and activity-deprived CC neurons at either DIV8 
or DIV15.  
The decrease in gene expression of KIR3.1, and associated change in functional properties, in 
neurons due to co-culture with astrocytes is supported by a corresponding decrease in protein levels 
of KIR. However, the activity regulation seen in CC neurons at the gene expression and functional 







Figure 4.8: Neuronal KIR3.1 protein levels decrease with astrocyte co-culture 
Protein levels of KIR3.1 in cortical rat neurons relative to MC at DIV8, normalised to calmodulin. i) Example 
western blot stained for KIR3.1 and calmodulin. The bands for KIR3.1 are clearly stronger in all MC conditions 
compared to their counterpart CC conditions. ii)  At DIV8 protein levels in CC control and CC +TTX are both 
significantly lower than MC control and MC +TTX (p < 0.001 for both, LME ANOVA, df = 77), but there is no 
difference between CC control and CC +TTX treatment. At DIV15 again there is a significantly less KIR3.1 
protein in CC relative to MC (p = 0.005), and CC +TTX relative to MC +TTX (p < 0.001), although there is 
no difference between CC control and CC +TTX treatment on protein levels of KIR3.1 treatment. Sample 




4.10 An astrocyte secreted molecule is responsible for the change intrinsic 
properties 
Having shown that astrocytes decrease KIR expression in neurons, and that this leads to an associated 
increase in excitability, I next sought to find the pathway behind this astrocyte-induced reduction 
in KIR. This would then allow me to confirm that interacting with this pathway both changes KIR 
expression and alters neuronal intrinsic properties.  
To rule in or out an astrocyte secreted factor in inducing KIR expression changes, I investigated the 
effects of astrocyte conditioned media (ACM) on neurons. Under this set-up, mouse astrocytes are 
grown in parallel to rat MC neurons, with astrocytes being kept in standard neuronal feeding media 
(1% NBA). On each day MC neurons were fed (starting with DIV0), half the cells were fed with 
normal media, and the other half were fed with media that had been collected from the mouse 
astrocytes (astrocyte conditioned media, ACM). 
 
Figure 4.9: Change in mono-cultured cortical neuronal gene expression after three days of 
astrocyte conditioned media treatment 
RNA-seq results of the effects of feeding MC neurons with ACM. MC rat neurons were either fed with 
standard 1% NBA +AraC or with ACM collected from astrocytes and supplemented with AraC. Although the 
effect of ACM treatment is not as strong as compared to direct co-culture, there were a total of 1,710 genes 
significantly up or downregulated >1.2-fold (compared to 1,960 >1.5 fold with co-culture). This included the 
genes for the KIR3.1 and 2.3 channels (Kcnj3 and Kcnj4), suggesting an astrocyte secreted factor is 
responsible for the regulation of their expression. Data courtesy of Dr P. Hasel (experimental design and 
sample preparation) and Drs O. Dando and X. He (bioinformatic processing and analysis).  
104 
 
To begin with, samples from control and ACM treated MC rat neurons were collected, prepared, 
and sent off for RNA-sequencing (RNA-sequencing sample preparation done by Dr. P. Hasel). 
The results of this sequencing are shown in Figure 4.9. ACM treatment of cortical neurons induced 
significant changes (with >1.2 fold change) in expression in ~13.5% of genes. This is compared to 
14.9% of genes that were seen to change by direct co-culture by >1.5 fold. 
Although the effects of ACM were slightly milder than co-culture, the expression of Kcnj3 (KIR3.1) 
and Kcnj4 (KIR2.3) were both significantly downregulated in MC neurons by ACM treatment 
(appendix A7). This indicates that it is an astrocyte secreted molecule that is triggering the decrease 
in neuronal KIR expression.  
If the decrease in KIR is leading to the alteration in membrane properties and the increase in 
excitability seen in CC neurons, then ACM treatment of MC neurons should also lead to an 
increase in excitability, given that it reduces KIR expression. To test this, I recorded from standard 
MC rat neurons, or MC neurons that had been fed with ACM.  
 
 
Figure 4.10: Resting membrane potential and membrane resistance of MC rat neurons are affected 
by ACM treatment 
ACM treatment of MC rat neurons has the same effect on membrane properties as direct co-culture with 
mouse astrocytes. i) RMP was significantly depolarised by ACM treatment (p = 0.003, LME ANOVA, df = 44). 
ii) Membrane resistance of MC neurons was significantly increased by ACM treatment (p = 0.009, LME 







Figure 4.11: Neuronal excitability in DIV8 cells is increased by ACM treatment  
Treatment of MC rat neurons with ACM increased excitability at DIV8. i) Example FI traces for MC rat neurons 
grown in regular media or in the presence of ACM at DIV8. ii)The FI curve is shifted to the left in MC neurons 
treated with ACM, requiring less input current to fire action potentials. iii) The rheobase of ACM treated MC 
neurons was significantly lower, corresponding to their increased excitability (p = 0.004, LME ANOVA, 






As with direct co-culture, ACM treatment of MC neurons caused a significant depolarisation in 
the RMP (Fig 4.10 i: mean = -49.3 ± 1.9 and -41.3 ± 1.7 mV, n = 25 and 24, for control and ACM, 
respectively, from 4 independent cultures), along with a significant increase in the RM (Fig 4.10 ii: 
mean = 482.1 ± 46.4 vs 689.2 ± 64.5 MΩ). Unlike direct co-culture, there was no effect of ACM on 
the action potential amplitude (Fig 4.10 iii). 
Having established that ACM is able to induce the same changes in membrane properties associated 
with a decrease in KIR induced by astrocytes, I then looked to the excitability. I found that ACM 
treatment likewise induced a leftward shift in the FI relationship, along with a significant decrease 
in the rheobase (Fig 4.11 i & ii: mean = 74.8 ± 8.1 and 47.1 ± 5.0 pA, n = 25 and 24, for control 
and ACM, respectively, from 4 independent cultures). 
I’ve shown in this section that an astrocyte secreted molecule induces the decrease in cortical 
neuronal KIR expression. I’ve further shown that ACM treatment of MC neurons is likewise able to 
alter neuronal properties and increase their excitability. This is consistent with an astrocyte-induced 
reduction in neuronal KIR expression causing alterations in membrane properties, leading to an 
increase in excitability.  
4.11 Secretomics of ACM reveals list of astrocyte released proteins 
To narrow down a list of candidate molecules secreted from astrocytes, I prepared and sent off 
ACM samples for mass spectrometry analysis. Alongside, I also sent off neuronal conditioned media 
samples (NCM). Mass spec analysis detected 1,478 different types of proteins in the ACM. Of 
these, 801 were expressed >2 fold compared to proteins detected in NCM. Of the remaining 
proteins detected in ACM, 560 were enriched by >2 fold higher in NCM samples. Only 117 of the 
proteins detected had <2-fold difference in enrichment between ACM and NCM. As can be seen 
in Figure 4.12 (i), a large proportion of proteins detected in ACM are specific to ACM and are not 
secreted by neurons. The top 25 proteins enriched in ACM are given in Figure 4.12 (ii). Amongst 
these proteins are the previously mentioned synapse promoting SPARCL1 (Hevin) and its 
opposing/anti-synapse promoting counterpart, sparc. Also of note is an abundance of apoE in 
ACM, given that astrocytic cholesterol carried by apoE was hypothesised to increase neuronal 




Figure 4.12: Enrichment of proteins detected in astrocyte conditioned media compared to their 
enrichment in neuronal conditioned media 
i) Typically, proteins tended to be strongly enriched in either ACM or NCM; only a small subset of 117 proteins 
in ACM were expressed within 2-fold expression difference of neurons (black circles), whereas 801 proteins 
were enriched >2-fold in ACM compared to NCM (red circles). ii) A list of the top 25 most abundant proteins 




This analysis has provided a shortlist of potential signalling proteins that may be responsible for the 
downregulation of cortical neuronal KIR. My future work will use this list as a guide as I begin a drug 
screen to determine the pathway responsible.  
4.12 Discussion 
4.12.1 Summary of findings 
In this chapter I have shown that cortical astrocytes control the expression of a wide array of cortical 
neuronal genes. Included amongst these were the KIR family of genes, which were significantly 
downregulated by astrocytes. There was a corresponding significant decrease in the protein levels of 
KIR3.1 in neurons grown with astrocytes, along with alterations in membrane properties and 
ultimately an increase in neuronal excitability after one week of culture. Intriguingly, I found that 
by the second week of culture the differences in function had largely disappeared between mono- 
and co-cultured neurons. I showed that this was due to an activity-dependent decrease in excitability 
specifically in neurons grown with astrocytes, with 48 hours of activity deprivation leading to a re-
emergence of the phenotype seen at the earlier time point. Corresponding to this activity-dependent 
regulation of excitability, there was a decrease in KIR expression in co-cultured neurons following 
activity deprivation. Interestingly, the properties of cortical neurons, as well as KIR gene expression, 
grown in the absence of astrocytes were largely unaffected by activity deprivation. I then showed 
that the signal from astrocytes regulating KIR expression, membrane properties and excitability was 
a secreted factor. I ran an un-biased mass spec screen for proteins in ACM and NCM, generating a 
shortlist of candidate proteins enriched in ACM.   
4.12.2 Cortical neurons can survive in the absence of astrocytes 
In this chapter I have shown that a culture of pure primary cortical rat neurons can be grown and 
maintained successfully in the absence of glial cells. Applying the drug AraC on the day of plate 
down and again on DIV4 is sufficient to kill off all rat astrocytes present in the seeded cell 
suspension, leaving a highly purified culture of cortical rat neurons. Importantly, with just these 
two doses of AraC, by DIV15 neuronal mono-cultures are still found to be free of astrocytes. On 
the other hand, astrocytes are found throughout the neurons that were seeded onto established 
mouse astrocytes, showing that the mouse astrocytes are spared from the effects of AraC on the rat 
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cells, and remain present in co-culture. Furthermore, at this relatively mature culture timepoint, 
after the appearance of spines, the cortical neurons were found to be healthy and surviving well. 
This finding is perhaps surprising, given the importance of astrocytic glutamate clearance for 
neuronal survival. This could indicate that these neuronal mono-cultures are less active than their 
in vivo counterparts, and their spontaneous release of glutamate is low enough that their few 
expressed EAATs are sufficient to effectively remove it. 
The success of this culture preparation allows me to be able to directly investigate the effects of 
astrocytes on cortical neurons, rather than using physiologically questionable RGCs as an 
approximation for these CNS cells. No previous work has directly assessed the impact of astrocytes 
on cortical neuronal gene expression, but this culture preparation combined with our lab’s mixed-
species sorting technique, opens up the possibility to address this gap in knowledge (Hasel et al., 
2017).   
4.12.3 Astrocytes control cortical neuronal gene expression, including the KIR channels 
This chapter presents the first report of neuronal gene expression being controlled by astrocytes. I 
find that nearly 15%, of cortical neuronal genes are significantly up or downregulated by >1.5-fold 
by cortical astrocytes. Given the extensive involvement of astrocytes in neuronal development and 
synaptic activity that has been proposed over the past two decades, this degree of astrocytic control 
was not unexpected. But now for the first time we can appreciate the full extent of the effect of 
astrocytes on the cortical neuronal transcriptome. Using this information as a guide allows for 
unbiased hypotheses to be made about how astrocytes control neuronal function.  
One of the most frequently proposed ways in which astrocytes control neuronal function is by 
inducing, increasing and/or promoting excitatory synaptogenesis and maturation. Numerous 
proteins either excreted or expressed by astrocytes have now been put forward, and are widely 
accepted, as mediating this astrocyte controlled excitatory synaptogenesis (Allen, 2013). As such, 
you might expect that a number of the neuronal genes upregulated by astrocytes may be associated 
with excitatory synapses. Unexpectedly, I found that at the level of gene expression there was no 
apparent effect of astrocytes on the excitatory synapse components at either DIV8 or DIV15 (see 
appendix A3). This includes both the vesicular glutamate transporter Slc17a6 (vGlut-2), with 
astrocytes previously reported to increase and stabilise vGlut-2 synapses, and the “mature” AMPA 
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receptor subunit, Gria2 (GluA2), which astrocytes are alleged to promote the expression of (Risher 
et al., 2014, Blanco-Suarez et al., 2018). Of course, this does not rule out the possibility that there is 
an increase in protein or surface expression of these synaptic elements in co-cultured cortical 
neurons, and that the astrocytic control of excitatory synapse formation is independent of the 
astrocytic control of neuronal gene expression. However, it seems surprising that virtually no 
excitatory synaptic elements were among the ~15% of astrocyte-controlled neuronal genes. The 
question remaining then is: if astrocytes are not controlling the expression of these synaptic genes, 
then what are they controlling?  
Interestingly, I found that the expression of the Kcnj family of genes was downregulated as a whole 
in the presence of astrocytes. These genes encode the KIR family of channels, with the two highest 
expressed subunits in my cortical neurons being Kcnj3 (KIR3.1) and Kcnj4 (KIR2.3), which were also 
amongst the most downregulated members by astrocytes. This downregulation in gene expression 
corresponded with a significant decrease in KIR3.1 protein level in cortical neurons grown with 
astrocytes (KIR3.1 is relatively specific to our neurons, whereas KIR2.3 is expressed in our cortical 
astrocytes, making it hard to differentiate between neuronal and astrocytic protein in a western 
blot). Therefore, as KIR channels can have a large impact on the membrane properties of cells, I 
hypothesised that this astrocytic control of KIR expression may have functional consequences on 
the cortical neurons and may even be involved in the extensively observed increase in neuronal 
activity in the presence of astrocytes (Djukic et al., 2007, Hibino et al., 2010, Nägler et al., 2001, 
Pfrieger and Barres, 1997). I decided to follow up on this hypothesis and focus my investigation on 
the astrocytic control of neuronal KIR expression.  
I note that the downregulation of KIRs in cortical neurons only represents a small fraction of the 
total effect of astrocytes on neuronal gene expression that were uncovered in this chapter. The bulk 
of the observed influence of astrocytes over neurons remains to be explored. 
4.12.4 Astrocytes control neuronal membrane properties and excitability, purportedly by 
KIR regulation 
Having seen that KIR channels are downregulated in cortical neurons by astrocytes I investigated 
whether there was a difference in neuronal properties in the presence of astrocytes. In particular, I 
hypothesised that due to the physiological properties of KIR channels, a reduction in their expression 
111 
 
would be expected to result in an increase in the membrane resistance of neurons, as well as a 
depolarisation in their RMP away from the K+ reversal. Both of these outcomes should lead to an 
enhancement of excitability: higher resistance means less current is required to cross the membrane 
to depolarise the cell by a given voltage (from Ohm’s law), and a depolarisation in RMP means the 
cell is closer to the action potential threshold, further reducing the current required to induce an 
action potential. As predicted, I showed that co-cultured DIV8 cortical neurons had higher 
membrane resistances and more depolarised RMP compared to neurons grown in the absence of 
astrocytes, along with a corresponding increase in their excitability. These findings supported the 
presence of reduced KIR expression in co-cultured neurons. Further connecting a decrease in KIR 
with the change in properties, I demonstrated that by partially blocking KIR in mono-cultured 
cortical neurons I was able to increase the membrane resistance and enhance neuronal excitability. 
This result is particularly interesting as it demonstrates a novel way in which astrocytes control 
neuronal function that had not been previously described. Furthermore, an increase in excitability 
may make neurons more likely to fire, and therefore more synaptically active. It is noteworthy that 
an enhancement in spontaneous activity due to astrocytes has been a consistent finding in many 
studies, and here I have found a potential and unsuspected mechanism that could explain this 
observation (Mauch et al., 2001, Pfrieger and Barres, 1997, Allen et al., 2012, Ullian et al., 2001, 
Christopherson et al., 2005). Peculiarly, the earliest paper demonstrating that astrocytes increase the 
activity of RGCs only explored the role of enhanced excitatory synaptogenesis in this increased 
activity – they did not investigate whether there was an increase in the excitability of RGCs grown 
with astrocytes that could also lead to these observations, even while noting that it was a possibility 
(Pfrieger and Barres, 1997). Ever since, although repeatedly finding that astrocytes increase activity, 
subsequent studies have neglected to investigate whether neuronal (or RGC) excitability is 
enhanced by astrocytes. In hindsight, this may have been an oversight.  
4.12.5 An astrocyte secreted protein is responsible for cortical neuronal KIR regulation 
I wished to uncover the signalling pathway by which astrocytes regulated neuronal KIR expression 
in order to undertake experiments that could confirm the role of KIR regulation in controlling 
neuronal excitability. Overall, the majority of astrocytic communication with neurons that has been 
previously described in literature has been mediated by astrocyte secreted factors, with occasional 
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exceptions such as astrocytic neuroligin-2 (Stogsdill et al., 2017). Taking the approach of other labs 
to investigate if an astrocyte secreted factor or physical contact mechanism was behind the 
downregulation of KIR, I grew cortical neurons in regular media or ACM and recorded these cells’ 
intrinsic properties. Concurrently, my colleague Dr Philip Hasel sent off samples of these cells for 
RNA-sequencing to explore the cortical neuronal genes regulated by astrocyte secreted factors 
compared to direct co-culture. I found that ACM was able to virtually replicate the effects of direct 
co-culture on neuronal membrane resistance, RMP and excitability, suggesting that a factor in 
ACM downregulates neuronal KIR expression. Happily, when we received the results from the 
RNA-seq of these ACM treated neurons I found that, as with direct co-culture, ACM treatment 
did indeed cause a reduction in Kcnj3 and Kcnj4 expression. These findings show that unlike the 
neuronal regulation of astrocytic EAAT expression that I uncovered in Chapter 3, astrocytes 
regulate KIR expression in neurons by a secreted factor. 
To further explore what this factor and downstream signalling pathway in neurons could be, I 
prepared and sent off both ACM and NCM samples for mass spectrometry analysis. Comparing 
the proteins present in both samples, I generated a list of proteins enriched in ACM over NCM. 
Convincingly, many of the previously reported astrocyte secreted factors involved in promoting 
neuronal activity and synaptogenesis were present and enriched in my ACM sample, including 
thrombospondin-1, glypican-4 and -6, sparc and SPARCL1 (Kucukdereli et al., 2011, Allen et al., 
2012, Christopherson et al., 2005). However, one of the most abundantly present proteins enriched 
in my ACM samples was apoE: although apoE was not found to increase activity, it can carry 
cholesterol which has previously been observed to increase activity in RGCs (Mauch et al., 2001). 
In experiments going forward I will need to confirm whether or not it is a protein or other factor 
(such as cholesterol) in ACM that reduces neuronal KIR expression, for example by protease 
treatment of the ACM to denature the proteins.  
4.12.6 Neurons require astrocytes for activity-dependent homeostatic plasticity of 
excitability 
From the initial RNA-seq data I observed that KIR expression increased in cortical mono-culture 
neurons from DIV8 to DIV15, which lead me to hypothesise that the effects of astrocyte co-culture 
on membrane properties and excitability would be even more pronounced by DIV15. 
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Unfortunately, this initial dataset did not include a DIV15 CC neuron sample, which would have 
shown that the effects of astrocytes on KIR repression are not as great at this time point. Instead this 
first became apparent following intrinsic property recordings of DIV15 MC and CC neurons, 
where I found no significant difference in membrane properties or excitability due to astrocytes. At 
this point I wondered whether this apparent lack of effect of astrocytes was due to homeostatic 
processes in the CC neurons induced by an increased level of activity in this condition that caused 
the effect of astrocytes to be obscured. To find out, I treated both MC and CC neurons with TTX 
to inhibit activity for 48 hours before recording. I discovered that after activity deprivation there 
was a pronounced effect of astrocytes on the membrane properties of neurons, uncovering a 
significant increase in neuronal excitability in these co-cultured cells. Most interestingly of all, 
activity deprivation had very little effect in MC neurons. In parallel, Dr Philip Hasel ran an RT-
qPCR for Kcnj3 (KIR3.1) for these four conditions, which supported my functional findings, 
showing a decrease in Kcnj3 expression following TTX treatment only in CC neurons. A 
subsequent RNA-seq data set (this time including DIV15 CC neurons) further supported these 
findings (see Appendices A4 & A5).  
Previous literature had established a role for astrocytes in mediating both LTP and LTD forms of 
plasticity, with one report additionally demonstrating astrocytic involvement in homeostatic 
plasticity of synaptic strength (Stellwagen and Malenka, 2006, Henneberger et al., 2010, Min and 
Nevian, 2012, Navarrete et al., 2012, Navarrete et al., 2019, Adamsky et al., 2018). My results in this 
chapter suggest that astrocytes are also involved and/or required for the homeostatic regulation of 
cell excitability. This is the first report of astrocytes’ involvement in this form of plasticity, and if 
confirmed could position astrocytes’ control of plasticity as one of their fundamental functions in 
the CNS, being involved with all of its flavours.     
4.12.7 Limitations and future work  
There are still several gaps in this work that need addressing. Firstly, much work still has to be done 
to identify the signalling pathway that drives the astrocyte induced decrease in KIR expression, 
starting with confirming if it is a protein or other factor present in ACM that is responsible for the 
induction. Once the factor and mediating pathway have been established, I will be able to better 
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address the remaining holes in this body of work, with the potential to extend the work into an in 
situ or in vivo model to investigate the relevance beyond this culture preparation.  
To begin with I will confirm whether it is a protein or other secreted factor that mediates the 
regulation of KIR, by treating ACM with protease to degrade the proteins present before applying 
to MC neurons. If there is still an effect of this protein depleted ACM on KIR expression the finger 
will be largely pointing towards a non-protein factor such as cholesterol, but if not then a protein 
detected from my mass spec results will be more likely. Next, I will run an RT-qPCR drug screen 
on ACM treated MC neurons treated with a variety of different inhibitors targeting 
pathways/receptors known to be activated by the top protein/non-protein candidates, as 
applicable. Once I have found a likely suspect, I will then apply the identified factor to MC neurons 
to see if said factor can repress KIR expression. If this is successful, I will record the 
electrophysiological properties of MC neurons treated with the factor and CC neurons treated with 
antagonists for the suspected factor’s receptors. If these recordings are successful, I will then seek to 
develop a mouse model with conditional astrocytic knockout of the suspected factor, or neuronal 
knockout of the target receptor/pathway in order to explore the relevance of this signalling pathway 
between astrocytes and neurons in an in vivo setting. 
Secondly, as yet I have not demonstrated beyond doubt that the astrocyte induced decrease in 
neuronal KIR mRNA and protein is responsible for the astrocyte mediated changes in neuronal 
membrane properties and excitability. First and foremost, I have not directly measured whether KIR 
currents themselves are reduced in the presence of astrocytes, I have only measured the secondary 
anticipated changes in membrane properties. Therefore, to begin with I will measure the KIR specific 
currents in MC and CC cortical neurons, by running a series of hyperpolarising current injection 
steps in the absence and presence of Ba2+ and/or the specific KIR3.1/2.3 blockers tertiapin 
Q/ML133, and measuring the elicited instantaneous and steady state currents. If there is less 
functional KIR in CC neurons, then I should observe a smaller drug-sensitive current component. 
Additionally, I intend to discover the signalling pathway involved in KIR mRNA repression, as 
described above. I can then investigate if simply by applying the factor identified as being 
responsible for causing the repression of KIR to MC neurons is able to reduce the KIR currents and 
alter the intrinsic properties of neurons in a similar manner to astrocytes. I can also then block the 
neuronal target receptors, or knockdown the expression of the suspected factor in astrocytes with 
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shRNA (before neuronal plate-down to ensure astrocyte specific removal) to see if this prevents the 
decrease in KIR expression in CC neurons. Given my results so far, it would be surprising if it did 
not turn out to be the case that astrocyte reduction of KIR mediates the changes in intrinsic 
properties, but never-the-less astrocytes do alter the membrane properties and increase excitability 
of cortical neurons – even in the unlikely scenario that this regulation does not involve KIR 
functional expression.    
Finally, although I have found that neuronal KIR appears to undergo activity-dependent 
homeostatic regulation, and that astrocytes are required for the homeostatic plasticity of neuronal 
excitability, I have not explored whether the regulation of KIR drives this form of plasticity, or if 
some separate mechanism is involved. Before finding the secreted factor, I can begin to investigate 
this by looking at the functional changes to excitability in DIV15 MC neurons treated with ACM 
± TTX. This experiment will allow me to see if astrocytes are actively involved in activity-dependent 
homeostatic plasticity, or if the emergence of this plasticity in neurons is due to a passive effect of 
astrocyte factors. If astrocytes actively respond to regulate KIR/excitability in response to changes in 
neuronal activity, then I should not see an effect of activity deprivation in ACM treated MC 
neurons on excitability. To further investigate the involvement of KIR in the observed homeostatic 
regulation in the presence of astrocytes, once I have isolated the astrocyte factor, I can inhibit the 
neuronal receptor or knockdown the factor in astrocytes to see if this prevents the activity 
dependent homeostatic regulation of excitability.  
4.12.8 Conclusion 
In this chapter I have presented the first report of the astrocytic control of cortical neuronal gene 
expression. This opens up the door for many future investigations on astrocytes’ control of 
neuronal functions, far beyond the scope of this thesis. Here I have begun by demonstrating that 
astrocytes control the functionally important KIR channels in cortical neurons by a secreted factor, 
and that astrocytic control leads to an increase in neuronal excitability. I have additionally shown 
that astrocytes allow these neuronal KIR channels as well as neuronal excitability to undergo activity-
dependent homeostatic plasticity.  A putative model for the astrocytic regulation of neuronal KIR 





Figure 4.13: Model of astrocytic control of neuronal KIR   
i) During development (and low neuronal activity levels) astrocytes secrete a factor that induces a pathway 
that represses the transcription of Kcnj, reducing functional KIR channel expression, leading to a 
depolarisation in the RMP and an increase in the RM of neurons. This causes an increase in action potential 
generation. ii) Under high activity levels a signalling pathway is activated that prevents the release of the 
astrocytic factor, preventing the repression of Kcnj transcription, causing an increase in functional KIR 




From the work in this chapter I hypothesised that neurons grown in the presence of astrocytes 
would show an increased amount of spontaneous activity, driven by this enhanced excitability. 
Given the previous literature documenting an effect of astrocytes on excitatory synapse formation, 
I further hypothesised that an increase in activity might be additionally driving the previously 
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Chapter 5 – Cortical neurons do not need cues from astrocytes to 
form synapses; astrocytes instead enhance network activity and 
plasticity 
5.1 Introduction 
In the previous chapter I showed that astrocytes increase the excitability of cortical neurons, by 
ostensibly decreasing neuronal expression of KIR channels. The question then is, does this change in 
excitability effect the activity of neurons, and if so how? There is a growing body of literature 
suggesting that astrocytes increase spontaneous activity, promote synaptogenesis and are required 
for certain forms of plasticity, including LTP and LTD (Adamsky et al., 2018, Henneberger et al., 
2010, Allen, 2013, Pfrieger and Barres, 1997). It is conceivable that alterations in neuronal 
excitability may interact, or be directly involved, with any of these processes, given that an increase 
in the global average excitability of cells would be predicted to result in an increase in the activity 
across the network. 
Astrocytes were shown to be able to increase neuronal activity in retinal ganglion cell cultures in the 
1990s (Pfrieger and Barres, 1997). The authors noted that by culturing purified RGCs with cortical 
astrocytes they were able to transform these otherwise rather silent cells into cells displaying robust 
spontaneous activity (Pfrieger and Barres, 1997). They went on to shown that the astrocytes were 
able to induce excitatory synapse formation in these prepared RGCs, leading to the hypothesis that 
astrocytes are required for synaptogenesis (Ullian et al., 2001, Nägler et al., 2001). A body of work 
has since been built on this, with several astrocyte secreted molecules having been shown to play a 
role in the excitatory synaptogenesis seen in RGCs (Chung et al., 2015, Baldwin and Eroglu, 2017). 
Unexpectedly, I did not see an increase in excitatory synapse associated genes in cortical neurons co-
cultured with astrocytes, but it is conceivable that the reported synaptogenic effect of astrocytes 
could be downstream of the increase in excitability: increased excitability may increase activity, and 
activity may drive synaptogenesis.  
A key feature of plasticity is the ability of neuronal networks to alter their responses following 
stimulation by either increasing or decreasing their responses to future stimuli (Rich and Wenner, 
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2007, Martin et al., 2000). I found in the previous chapter that co-cultured neurons were able to 
regulate their expression of KIR, along with their excitability, in response to changing activity levels, 
whereas mono-cultured neurons were not, suggesting astrocytes are required for homeostatic 
plasticity of neuronal excitability. Additionally, astrocytes have previously been reported to be 
required for homeostatic plasticity of synaptic strength (Stellwagen and Malenka, 2006). If this is 
also true of the cortical neurons in my preparation, then through the combination of these two 
forms of plasticity astrocytes would be predicted to exert extensive control over the homeostatic 
regulation of synaptic activity of neurons.    
In this chapter I explore these questions. First, I hypothesise that the decreasing KIR levels and 
increasing excitability of cortical cells grown with astrocytes leads to an increase in spontaneous 
activity of neurons. Second, I hypothesise that if there is an increase in activity in the presence of 
astrocytes, I will also see an increase in excitatory synapses. Finally, I hypothesise that there will be a 
homeostatic increase in synaptic strength resulting in an increase in the network activity of 
co-cultured neurons in response to activity deprivation, whilst there will be little effect of activity 
deprivation on mono-cultured neurons. As with Chapter 4, for the experiments in this chapter I 
used rat cortical neurons grown alone in mono-culture (MC) or grown on a bed of mouse 
astrocytes, referred to as co-culture (CC). 
5.2 KIR overexpression blocks spontaneous activity in cortical neurons 
To see if KIR expression could alter activity levels in neurons, I first transfected CC cortical neurons 
with either a globin-GFP plasmid or a KIR2.1-GFP plasmid, in order to generate neurons that 
overexpress KIR. I then recorded the spontaneous firing of these CC neurons in current-clamp. 
Globin transfected controls on average fired 55 ± 23 AP per minute (Fig 5.1 i & ii, n = 12), whereas 
KIR2.1 overexpressing neurons only fired an average of 1 ± 1 AP per minute (Fig 5.1 ii & iii, n = 12). 
In fact, most KIR2.1 overexpressing neurons were not observed to fire once over the duration of a 
5-10 minute recording. Not only did KIR2.1 overexpression reduce the likelihood of CC neurons 
spontaneously firing action potentials, it also significantly hyperpolarised their RMP compared to 
globin transfected controls (Fig 5.1 iv: mean RMP = -44.6 ± 2.6 vs -75.5 ± 3.2 mV, n = 12 and 12, 
for globin and KIR2.1, respectively, from 3 independent cultures). This demonstrates that 





Figure 5.1: KIR2.1 overexpression reduces spontaneous activity in co-cultured cortical neurons 
Cortical CC neurons were transfected with either a globin-GFP plasmid or a KIR2.1-GFP plasmid. The RMP 
was taken and the spontaneous firing of GFP-positive cells was recorded in current-clamp. i) Example trace 
of the spontaneous firing of a CC globin expressing cell compared to ii) a KIR2.1 positive cell. iii) Transfection 
with KIR2.1 reduced spontaneous firing of cortical CC neurons (p = 0.02, student t-test, n = 12 & 12, for 
globin and KIR2.1, respectively). iv) Transfection with KIR2.1 significantly hyperpolarises the RMP of CC 
neurons compared to control (p < 0.001, Student’s t-test, n = 12 & 12 for globin and KIR2.1, respectively). 





5.3 Spontaneous activity is higher in co-cultured cortical neurons 
I next investigated if the spontaneous activity of cortical neurons was higher in CC compared to 
MC cells. To do this I recorded the cells in voltage-clamp, and measured the spontaneous 
amplitude, frequency and charge transfer occurring over several minutes.  
 
 
Figure 5.2: Spontaneous activity is greater in co-cultured cortical neurons at DIV8 
Example traces of DIV8 i) mono-culture and ii) co-culture cortical neurons, voltage-clamped at -60 mV. 
Larger “network” burst firing events can be seen in CC compared to MC, which likely result from current 
generated by voltage-gated Ca2+ and Na+ channels. iii) & iv) There was no significant difference in frequency 
or amplitude of events between MC and CC, v) but the observed increase in large network events was 
represented by significantly greater charge transfer in neurons cultured with astrocytes compared to mono-




There was a clear increase in the number of spontaneous network events in CC cells compared to 
MC cells, characterised by large inward current bursts as seen in Figure 5.2 ii, which were nearly 
always absent in MC cells (Fig 5.2 i). The increase in network events with CC was not marked by a 
significant difference in the average amplitude or frequency of events, but instead it can be seen in 
the significant increase in charge crossing the membrane in CC cells (Fig 5.2 vi: mean = 25.8 ± 5.5 
and 235.8 ± 85.2 nC min-1, n = 19 and 24, MC and CC, respectively, from 11 independent 
cultures). 
5.4 There is no difference in TTX-insensitive (miniature EPSCs) event 
properties between mono- and co-cultured neurons  
As astrocytes increased the activity levels of cortical neurons, I next looked into whether there was 
an increase in excitatory synapse formation in CC by measuring miniature EPSCs (mEPSC). 
mEPSC are non-action potential dependent excitatory post-synaptic currents, and their frequency 
and amplitudes can be used as an indication of the number of established synapses present. 
Miniature EPSCs can be recorded in voltage-clamp whilst applying the NaV-channel blocker TTX 
to prevent action potential firing, and the GABA antagonist picrotoxin (PTX) to eliminate 
detection of non-action potential dependent release of GABA. 
Contrary to my expectations, I saw no difference between mEPSC recordings of MC (Fig 5.3 i) and 
CC (Fig 5.3 ii) cortical cells at DIV8. This is seen by a lack of difference in the amplitudes, 
frequencies and charge transfer between MC and CC cortical neurons (Fig 5.3 iii-v: n = 19 and 24, 
MC and CC, respectively, from 11 independent cultures). 
These recordings were done at DIV8 – at this stage in primary rat culture spine formation has yet 
to begin, and it may be too early to see an effect of astrocytes on excitatory synapse formation. As 
such I repeated the experiment at DIV15, by which point my rat primary neurons had developed 
spines, to see if there was an astrocytic induction of excitatory synapse formation later in 
development.  
As was observed at DIV8, there was still no difference in any mEPSC property between MC and 






Figure 5.3: TTX-insensitive currents (mEPSCs) in DIV8 cortical neurons are unaltered by 
astrocytes 
Co-culture with astrocytes had no effect on TTX-insensitive mEPSC events. i-ii) Example traces of mEPSC 
recordings. All cells were voltage-clamped at -60 mV and recorded in the presence of 300 nM TTX and 
50 μM PTX. iii-v) Neither the frequency (p = 0.9, LME ANOVA, df = 46), amplitude (p = 0.7) or charge 
(p = 0.8) of mEPSC events were altered by co-culture with astrocytes. n = 19 & 24 for MC & CC, respectively, 
11 independent cultures. 










Figure 5.4: TTX-insensitive currents (mEPSCs) in DIV15 cortical neurons are unaltered by 
astrocytes 
At the later developmental timepoint of DIV15, no difference in mEPSCs had arisen between MC and CC 
cortical neurons. i) & ii) Example mEPSC recordings in MC and CC DIV15 neurons. iii-v) There was no 
difference in the frequency (p = 0.7, LME ANOVA, df = 42), amplitude (p = 0.8) or charge transfer (p = 0.5) 
of mEPSC events between MC and CC neurons (n = 22 & 22 for MC & CC, respectively, 7 independent 




5.5 There is no difference in synapse numbers between mono- and co-cultured 
cortical neurons 
Although I saw an increase in activity in CC neurons, I did not find this to be accompanied by an 
increase in mEPSCs. This suggests that there is no astrocytic promotion of excitatory synapse 
formation in these cortical cells. To confirm that this was the case, I used immunohistochemistry 
to visualise the number of excitatory synapses in MC and CC cells.  
Due to the density of the cells in the culture preparation, it is hard to identify single dendrites from 
each other in order to be able to count the synapse numbers along a single branch. To get around 
this problem I sparsely transfected the cortical neurons with EF-GFP on DIV4, in order to visualise 
single cells. On DIV15 the cells were fixed and stained for antibodies against the post-synaptic 
marker Homer-1, the excitatory pre-synaptic marker Synapsin-1, and GFP.  
Three separate dendrites, located approximately 100 μm from the soma, were imaged for each 
GFP-positive cell (Fig 5.5 i & ii). Co-localised pre- and post-synaptic markers along these 
GFP-positive dendrite stretches were manually selected for puncta overlap and their numbers 
counted. The average number of synapses per 10 μm was then calculated per dendrite and per cell.  
There was no difference in the number of excitatory synapses (co-localised pre- and post-synaptic 
puncta) between DIV15 MC and CC cells (Fig 5.5 iii: mean synapses 10 μm-1 = 2.76 ± 0.25 and 
2.45 ± 0.30 per cell, n = 15 and 14 cells for MC and CC, respectively, from 3 independent cultures). 
These results support the functional observation of no difference between the mEPSCs recorded in 
MC and CC cortical cells. 
I’ve shown in the last two sections that my cortical astrocytes are either a) not able or b) not required 








Figure 5.5: Co-localised pre- and post-synaptic markers appear with the same frequency in mono- 
and co-cultured cortical neurons 
Co-localised pre- and post-synaptic markers along GFP-positive dendrites were counted (3 dendrites per 
cell). i & ii) example of MC and CC dendrites. Co-localised puncta staining is seen along both MC and CC 
dendrites. iii) There was no difference in the average number of synapses over a given length of dendrite 
between MC and CC cortical neurons. Astrocytes do not increase the number of structural synapses in 
cortical neurons (p = 0.1, LME ANOVA, df = 25, 3 independent cultures). Scale = 5 μm; pre-synapse 
(Synapsin-1) = blue channel, post-synapse (Homer-1) = red channel, GFP = green channel. Pink-purple = 




5.6 Lack of astrocytic influence on synaptogenesis not due to an inefficiency 
of our cortical astrocytes; synaptogenesis can be induced in RGCs 
Substantial evidence has shown that astrocytes are needed for excitatory synapse formation in 
purified RGC cultures (Ullian et al., 2001, Nägler et al., 2001, Pfrieger and Barres, 1997). It has 
been largely suggested that this function of astrocytes is conserved throughout different brain 
regions, although there is little direct evidence that astrocytes are required for excitatory 
synaptogenesis in cortical cells.  
My results showing that astrocytes have no effect on excitatory synapse formation therefore raise 
several questions. Firstly, is it a deficiency of my astrocyte preparation that lends them unable to 
induce synapse formation? This seems unlikely, given that I do see robust synaptic activity in my 
MC preparations, along with plentiful co-localised puncta. Secondly, is the lack of effect due to a 
difference in media, that is, is there some factor in my media that is supporting synaptogenesis, 
masking the role of astrocytes? 
To address these questions, I established purified retinal ganglion cell culture preparations. As there 
is ample evidence to show astrocytes have a significant effect on RGCs, this allowed me to check 
that my astrocytes were able to induce synaptogenesis in these cells and confirm it wasn’t the mouse 
astrocytes that were the problem. This also allowed me to check that it wasn’t my media inducing 
synaptogenesis, masking an astrocytic effect. 
I prepared rat RGCs from P5 pups, and plated the isolated cells directly onto coverslips, or else onto 
a bed of standard mouse astrocytes. Importantly, I fed the RGCs with my standard 1% NBA growth 
media – including rat serum and B27 (with the addition of BDNF, CNTF and forskolin that is 




Figure 5.6: Spontaneous activity in retinal ganglion cells cultured alone or with mouse astrocytes 
Retinal ganglion cells were recorded at DIV12. Compared to RGCs grown alone (i) there is a large induction 
of spontaneous activity in RGCs cultured on a bed of mouse astrocytes (ii). This increase is seen both in the 
average amplitude of events (p = 0.002, LME ANOVA, df = 28) and in the frequency of events (p < 0.001). 
v) Co-culture with astrocytes increased the proportion of cells that displayed spontaneous activity. From 




Figure 5.7: Astrocytes increase the proportion of retinal ganglion cells with synaptic activity and 
the frequency of mEPSC events  
i) & ii) Example mEPSC recordings of RGCs. Cells were voltage-clamped at -70 mV and recorded in the 
presence of 300 nM TTX and 50 μM PTX. iii-iv) The addition of astrocytes increased the frequency (p = 0.05, 
LME ANOVA, df = 26) of mEPSC events in RGCs, but not the amplitude of events. v) Astrocytes increased 
the proportion of RGCs that were observed to have mEPSCs. iv) Of the RGC cells that displayed mEPSCs, 




To begin with I looked at the spontaneous activity of MC and CC RGCs. There was very little 
spontaneous activity in RGCs grown alone (Fig 5.6 i) compared to RGCs grown with astrocytes 
(Fig 5.6 ii). This was reflected by a significant increase in both the amplitude (Fig 5.6 iii: 
mean = 12.4 ± 2.8 and 27.1 ± 5.5 pA, n = 16 and 17, for MC and CC, respectively) and the 
frequency of spontaneous events (Fig 5.6 iv: mean = 31.7 ± 12.0 and 182.1 ± 37.6 events min-1, MC 
and CC, respectively). Most impressively, only half of the MC RGCs displayed any form of 
spontaneous activity, whereas spontaneous activity was seen in all RGCs grown on astrocytes 
(Fig 5.6 v). 
I next looked at the mEPSC activity in RGCs. Unlike cortical cells, RGCs cultured with astrocytes 
had significantly more mEPSC events (Fig 5.7 iv: mean = 15.1 ± 7.4 and 96.1 ± 40.5 events min-1, n 
= 16 and 15, MC and CC, respectively). Similar to spontaneous events, nearly all RGCs cultured 
with astrocytes had mEPSC events, whereas mEPSCs were seen in under half of the MC RGCs (Fig 
5.7 iv).  
From this I see that my astrocytes are able to replicate the results found in earlier studies, that is they 
increase both the spontaneous and mEPSC activity of RGCs. Importantly, astrocytes increase the 
proportion of RGCs that display both spontaneous and mEPSC activity, showing that they do 
indeed induce synaptogenesis in RGCs. Furthermore, I have ruled out that it is some factor in my 
media masking the synaptogenic effect of astrocytes in my cortical cells.  
5.7 Homeostatic increases in synaptic strength after activity deprivation are 
only seen in co-culture 
It has been well documented that 24-48 hours of activity deprivation results in a homeostatic 
increase in synaptic strength of neurons (Turrigiano et al., 1998). I showed in Chapter 4.7 that the 
excitability of cortical neurons undergoes homeostatic regulation in response to activity 
deprivation, but that this only occurs in neurons grown with astrocytes. In this section I investigate 
whether the synaptic strength, as measured by mEPSC frequency and amplitude, of mono-cultured 
neurons is able to undergo this documented form of homeostatic plasticity, or whether co-culture 




Figure 5.8: Blocking activity in DIV15 co-cultured neurons increases mEPSC frequency, but has no 
effect on mono-cultured neurons 
The homeostatic increases in synaptic strength known to occur with activity deprivation are only observed 
in cortical neurons cultured with astrocytes. Mature cortical cultures had their activity blocked with 48 hrs of 
TTX treatment (300 nM) from DIV13. i) & ii) show example recordings from DIV15 MC and CC neurons, 
respectively, that had undergone activity blockade for 48 hrs. All recordings were done in the presence of 
300 nM TTX and 50 μM PTX. iii) A homeostatic increase in event frequency due to activity deprivation is 
seen in CC neurons (p = 0.04, LME ANOVA, df = 56). There was no effect of activity deprivation on the 




I recorded mEPSCs from DIV15 MC and CC neurons which I had previously applied TTX to for 
48 hours in order to block activity. There was no effect of activity deprivation on either the 
frequency or amplitude of mEPSC events on MC cells treated with TTX for 48 hours compared to 
control MC cells (Fig 5.8, iii: mean amplitude = 16.0 ± 1.5 and 13.8 ± 1.7 pA, for MC and 
MC +TTX, respectively, mean frequency = 412.7 ± 75.0 and 417.2 ± 110.7 events min-1, for MC 
and MC +TTX, respectively; n = 23 & 13 cells, 4 independent cultures).  
On the other hand, in co-cultured neurons there was a significant increase in the frequency of 
mEPSC events after activity deprivation (Fig 5.8 iii: mean = 381.3 ± 43.4 and 631.7 ± 105.1 events 
min-1, n = 22 and 14, CC and CC +TTX, respectively). As with MC cells, there was no effect on 
the amplitude of mEPSC following activity deprivation (mean = 16.9 ± 2.3 and 16.6 ± 2.1 pA, for 
CC and CC +TTX, respectively). This shows that astrocytes are required for the activity-dependent 
homeostatic regulation of synaptic strength, as well as excitability. 
5.8 Homeostatic regulation of neuronal activity only seen in co-cultured 
neurons 
I showed in Chapter 5.3 that there was significantly greater activity in CC neurons compared to MC 
neurons at DIV8. At this time point there was also significantly greater excitability in CC, which I 
hypothesised to be driving the observed increase in activity. By DIV15 I saw little difference in 
excitability between MC and CC neurons, so I next investigated whether there was a corresponding 
reduction in the difference of spontaneous network activity between DIV15 MC and CC cells.  
I found that by DIV15 there was only a slight difference in spontaneous activity between MC and 
CC cortical neurons, with CC neurons seen to have just over twice the charge crossing the 
membrane as MC neurons (Fig 5.9 v: mean charge min-1 = 50.0 ± 14.9 and 116.8 ± 26 nC, n = 23 
and 22, for MC and CC respectively, n = 7 independent cultures). By comparison, at DIV8 there 
was an ~10-fold increase in charge transfer in cortical neurons by co-culture with astrocytes, from 
~25 nC min-1 in MC to ~235 nC min-1 in CC (Fig 5.2). This decrease in spontaneous activity with 







Figure 5.9: There is still a difference in spontaneous activity between MC and CC neurons by DIV15 
Example traces of spontaneous activity recorded in DIV15 i) MC and ii) CC cortical neurons. iii & iv) There 
was no significant difference between the frequency and amplitude of spontaneous events between MC and 
CC neurons at DIV15. v) By DIV15 the difference in charge transfer of spontaneous events between MC and 
CC had diminished but was still significantly greater in CC neurons (p = 0.01, LME ANOVA, df = 37). From 






As I have shown both excitability and synaptic strength are upregulated in CC neurons following 
activity deprivation at DIV15, I then investigated the spontaneous network activity in response to 
activity deprivation at this time point, predicting that there would be an increase in activity 
specifically in CC neurons. As in the previous section, I applied TTX from DIV13 to block action 
potential driven activity in MC and CC neurons and recorded the spontaneous activity on DIV15 
following TTX washout. 
In activity-deprived MC neurons (MC +TTX) I saw very few large “network” events (Fig 5.10 i) 
following TTX removal, similar to untreated DIV8 and DIV15 MC neurons. This is marked by an 
insignificant difference in spontaneous activity following activity deprivation compared to 
untreated control MC neurons (Fig 5.10 iii: mean charge min-1 = 90.7 ± 64.6 nC, n = 13 for 
MC +TTX from 4 independent cultures). 
Following TTX removal from CC neurons I saw robust regular network events (Fig 5.10 ii), in 
striking contrast to MC neurons. This was measured by a significant increase in the charge between 
activity-deprived MC and CC neurons (Fig 5.10 iii: mean charge min-1 = 90.7 ± 64.6 vs 1,710.6 ± 
304.9 nC, n = 13 and 14, for MC +TTX and CC +TTX, respectively, 4 independent cultures), as 
well as a nearly 15-fold significant increase above the activity I saw in untreated control CC neurons.  
By DIV15 there was little difference in spontaneous activity between MC and CC neurons but 
following 48 hours of activity deprivation there was a dramatic increase in network activity in 
cortical neurons grown with astrocytes. This activity-dependent homeostatic plasticity of network 
activity is not observed in the absence of astrocytes and is more pronounced than the homeostatic 





Figure 5.10: Removing TTX after 48hrs of activity inhibition induces robust neuronal network 
activity in co-culture, with limited effect in the absence of astrocytes 
Removing TTX from DIV15 neurons after 48 hrs induces robust network firing events, with currents likely 
generated by voltage-gated Ca2+ and Na+ channels, in CC neurons. i) Example recordings of spontaneous 
activity in two DIV15 MC neurons following removal of TTX. Often there were no large events, as seen in the 
first trace. ii) Spontaneous activity of two DIV15 CC neurons following removal of TTX. Unlike MC cells, large 
burst events were seen in all CC neurons following TTX removal. iii) There is a significant increase in the 
network activity, as measured by charge transfer, in CC neurons following activity deprivation (CC +TTX) 
compared to both activity-deprived MC neurons (MC +TTX) and to untreated CC neurons (p < 0.001 
compared to MC, MC +TTX and CC conditions, LME ANOVA, df = 55). There was no difference in charge 




5.9.1 Summary of findings 
In this chapter I have shown that, consistent with an astrocyte-mediated increase in cortical 
neuronal excitability, there is an increase in spontaneous activity of cortical neurons grown in the 
presence of astrocytes. I further demonstrated this link with excitability, as by DIV15 the difference 
in activity between MC and CC neurons has largely disappeared, as I had observed the difference 
in excitability to do in Chapter 4. Unexpectedly, I found that under baseline activity conditions 
there was no increase in excitatory synapse numbers in cortical neurons cultured with astrocytes. In 
fact, I demonstrated that cortical neurons can develop extensive excitatory synapses in the absence 
of astrocytes. This is contrary to documented findings in RGCs, which I was able to replicate using 
my cortical astrocyte preparation, suggesting synaptogenesis in RGCs occurs via a different 
underlying mechanism to cortical neurons. However, I do find that astrocytes are able to regulate 
cortical excitatory synapses in an activity-dependent manner, showing that following activity 
deprivation there is a significant increase in excitatory synaptic strength only in cortical neurons 
grown with astrocytes. As I have shown astrocytes to be involved in the homeostatic regulation of 
excitability in Chapter 4, and now in this chapter to be involved in homeostatic regulation of 
synaptic strength, I investigated the total effect of astrocytes on the homeostatic plasticity of 
neuronal activity. I showed that astrocytes control neuronal activity levels overall, mediating a 
robust increase in cortical neuronal activity in response to activity deprivation.   
5.9.2 Astrocytes increase the activity of neurons in a way consistent with an enhancement 
of excitability due to downregulation of KIR 
In this chapter I began by showing that increasing KIR expression can decrease spontaneous firing 
of cortical neurons, demonstrating that, in principle, astrocytic control of KIR expression could 
affect neuronal activity. As hypothesised from the increase in excitability seen in DIV8 neurons 
grown with astrocytes in Chapter 4, I showed that at DIV8 there were significantly higher 
spontaneous activity levels in CC cortical neurons. Furthermore, by DIV15 this difference in 
spontaneous activity had largely decreased. I predicted this to occur if the increase in activity seen at 
DIV8 was mediated by a decrease in KIR expression and increase in excitability, as I had shown in 
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Chapter 4 that by DIV15 KIR expression had increased in CC and there was no longer a difference 
in excitability between MC and CC cortical neurons. 
The increase in activity due to astrocytes that I saw in this chapter supports many previous findings 
in RGCs. The consistent finding across the literature investigating the effects of astrocytes on 
RGCs has been that either astrocytes or astrocyte conditioned media is able to increase activity in 
RGCs (Allen et al., 2012, Ullian et al., 2001, Pfrieger and Barres, 1997, Christopherson et al., 2005, 
Mauch et al., 2001). As I mentioned in Chapter 4, none of these previous studies investigated 
whether astrocytes caused an increase in the excitability of RGCs that might explain this increase in 
spontaneous activity – they only investigated whether there was an increase in excitatory synapses 
and synaptic activity. I have shown in this chapter that for cortical neurons the increase in 
spontaneous activity is consistent with the changes of excitability seen in neurons due to astrocytes, 
suggesting that alterations in RGC excitability may also be contributing to the previously reported 
effect of astrocytes on activity in these cells.   
5.9.3 Cortical neurons do not need astrocytes for the formation of excitatory synapses 
under baseline conditions 
Although I did not find any effect of astrocytes on the gene expression of excitatory synapse-
associated components in cortical neurons in Chapter 4, I hypothesised that the increase in activity 
might play a role in the previously reported astrocytic promotion of excitatory synaptogenesis, for 
example by increasing the intrinsically expressed pre- and post-synaptic puncta components’ 
membrane formation and co-localisation. To see if the astrocyte-induced increase in activity was 
involved in astrocyte-mediated synaptogenesis, I started off by recording mEPSC events in DIV8 
MC and CC neurons to confirm that there was a difference in excitatory synapses due to astrocytes. 
To my great surprise I found no difference in mEPSC events between MC and CC cortical neurons. 
Given the wealth of literature to the contrary (Mauch et al., 2001, Nägler et al., 2001, Pfrieger and 
Barres, 1997, Allen et al., 2012, Blanco-Suarez et al., 2018, Farhy-Tselnicker et al., 2017, 
Kucukdereli et al., 2011, Eroglu et al., 2009, Singh et al., 2016, Stogsdill et al., 2017, Risher et al., 
2018) I began to consider why I could not replicate this finding, and what I must be doing wrong.  
The first thing I considered was the age of the cells. I was recording at DIV8, and at this point the 
cultured rat cortical neurons are still quite immature, being before the point of spinogenesis. Work 
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by the lab of Eroglu and colleagues on the effect of hevin and excitatory synapse formation saw that 
this factor was required to prevent multiple synaptic inputs coalescing on a single spine (Risher et 
al., 2014). I reasoned then that it was possible the synapse promoting effect of astrocytes was 
happening later in development during spine formation. Therefore, I repeated my experiment at 
DIV15, by which point my cultured rat neurons had developed spines, to see if there was an 
excitatory synapse promoting effect of astrocytes apparent by this later stage. But, yet again, I failed 
to see a difference in mEPSCs between MC and CC neurons.     
Up until now I had been using electrophysiological read-outs as a proxy for excitatory synapse 
number. To confirm the lack of difference I was observing in mEPSCs was representative of 
underlying excitatory synapse numbers I turned to immunohistochemistry to visual co-localised 
excitatory puncta in DIV15 neurons. Even so, I still saw no difference in co-localised pre- and post-
synaptic excitatory puncta. As such, all evidence appears to suggest that astrocytes are not required 
for excitatory synaptogenesis in cortical neurons (and by extension that my hypothesis that the 
astrocyte-induced increase in activity may drive excitatory synapse formation was wrong). 
5.9.4 Astrocyte induced synaptogenesis is still observed in RGCs: RGC synaptogenesis is 
separate to cortical synaptogenesis 
Although my results above appear to suggest astrocytes are not involved in cortical synaptogenesis, 
it remained possible that either my astrocytes were somehow deficient in their ability to induce 
synaptogenesis, or else something in my media, for example the serum, was masking the astrocyte 
mediated effect on synaptogenesis. The most convincing demonstrations of astrocyte involvement 
in synaptogenesis have all been conducted using purified RGC cultures (Ullian et al., 2001, Pfrieger 
and Barres, 1997, Christopherson et al., 2005, Allen et al., 2012, Kucukdereli et al., 2011). 
Therefore, to rule out either of these possibilities I turned to RGCs to find out if I could replicate 
the well-established findings of astrocyte induced synaptogenesis in these cells using my astrocytes 
and media.   
Consistent with previous reports I found that there was a significant increase both in spontaneous 
activity and mEPSC frequency in RGCs grown in the presence of my cortical astrocytes, that were 
fed with the same media as my cortical preparation. Also similar to earlier studies, I found that my 
astrocytes significantly increased the proportion of RGCs that displayed spontaneous activity, 
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finding spontaneous activity in 50% of MC RGCs and in 100% of CC RGCs; this is comparable to 
the findings of Pfrieger and Barres (1997) who observed spontaneous activity in 63% of their MC 
RGCs and 100% of RGCs grown with glia.  
Therefore, the lack of effect of astrocytes on excitatory synapse numbers in my cortical neurons was 
not due to problems with my astrocytes, nor due to occluding factors in my media. Instead, the 
astrocyte-induced excitatory synaptogenesis reported in RGCs appears to be separate to the 
induction of excitatory synapse formation in cortical neurons. This should not be too surprising: as 
discussed in Chapter 1.8.2.5, RGCs may not be the best model for the neuron-astrocyte 
involvement in synapse development of the wider CNS. Importantly, RGCs do not normally form 
synapses with each other in vivo, so the lack of synapse formation observed in cultures consisting 
solely of purified RGCs may simply be due to an absence of their physiological synaptic partners, 
and not necessarily due to a lack of astrocytic factors. Supporting this, Pfrieger and Barres (1997) 
even reported that purified neurons from one of the RGC axon target areas, the superior colliculus, 
had the same pro-activity and synapse-inducing effects as astrocytes, which suggests that even for 
RGCs astrocytes may not necessarily be needed for excitatory synaptogenesis. My findings in this 
chapter that cortical neurons grown alone can develop synapses to the same extent as their 
counterparts grown on astrocytes, contrary to RGCs, highlights the potential shortcomings of 
using RGCs as a general model for neurons beyond the retina. Given that it is now possible to grow 
neurons from other CNS regions in the absence of glia it would be beneficial for future work 
attempting to draw conclusions about astrocyte-neuron interactions in other brain regions to utilise 
culture models using neurons from these regions instead of RGCs.  
5.9.5Astrocytes do regulate excitatory cortical synapses in an activity-dependent manner 
Although I do not find that astrocytes are required for excitatory synapse formation under baseline 
conditions, I do see that they are required for homeostatic increases in synaptic strength following 
activity deprivation, and thus can mediate an increase in excitatory synapses. Given that I had found 
that astrocytes were required for the homeostatic plasticity of neuronal excitability in Chapter 4, 
and that previous work had also demonstrated their involvement in homeostatic plasticity of 
synaptic strength in hippocampal neurons (Stellwagen and Malenka, 2006), in this chapter I 
investigated their involvement in this form of homeostatic plasticity in cortical neurons. I found 
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that following 48 hours of activity deprivation of mature cortical neurons there was a robust 
increase in mEPSC frequency only in neurons grown in the presence of astrocytes, with no such 
homoeostatic increase in synaptic strength in MC cortical neurons. My finding suggests that 
astrocytes are also required for homeostatic plasticity of synaptic strength in cortical neurons, along 
with their documented role in this form of plasticity in hippocampal neurons. While I have shown 
that the astrocytes’ homeostatic control of excitability is presumably mediated in part by changes in 
KIR expression, I have not investigated whether this is true for the regulation of synaptic 
strengthening, or if this is mediated by a different astrocytic signalling pathway, for example the 
previously proposed astrocytic factor TNF-α involved in hippocampal plasticity (Stellwagen and 
Malenka, 2006). 
My findings in this chapter show that astrocytes can promote excitatory synapse formation in an 
activity dependent manner. Thus, it is possible that some of the astrocytic factors found to be 
involved in RGC synapse formation are instead physiologically involved in the homeostatic 
regulation of synaptic strength in cortical cells.    
5.9.6 The combined ability to regulate excitability and synaptic strength gives astrocytes 
significant control over the activity-dependent homeostasis of neurons 
The spontaneous activity of neurons is mediated both by their excitability and their synaptic 
strength. As I saw in Chapter 4 that the difference in neuronal excitability between MC and CC 
neurons had largely disappeared by DIV15, and as I saw no difference in synaptic strength between 
MC and CC cortical neurons, I hypothesised that the enhanced spontaneous activity in CC 
neurons I saw at DIV8 would have largely disappeared by DIV15. I demonstrated that this was 
indeed the case, with the enhancement of synaptic activity in CC neurons compared to MC 
neurons greatly diminished by DIV15. This reduction in spontaneous activity of CC neurons is 
quite clear to see when you compare the example traces of spontaneous activity from DIV8 to 
DIV15, with a disappearance of the large “action potential” events (Fig 5.2 ii & Fig 5.9 ii). 
The forms of homeostatic plasticity that control excitability and synaptic strength that I have 
discussed in this and the previous chapter are both mechanisms with the ultimate purpose of 
regulating the activity of neurons in response to pathological activity levels. That is, in response to 
pathologically high levels of activity in the network they work together to bring activity down to 
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stable levels, whilst in response to an absence of activity they drive activity up (Stegen et al., 2011, 
Davis, 2013). As I have now demonstrated that astrocytes are required for the homeostatic increase 
of both excitability and synaptic strength in response to reduced activity, I predicted that this 
combined control would result in a robust increase in neuronal activity of CC neurons following 
activity deprivation. I found that this was the case: following 48 hours of activity deprivation there 
was a dramatic induction of neuronal network activity in neurons grown with astrocytes. 
Furthermore, in the absence of astrocytes there was no significant increase in activity, supporting 
my findings that neither excitability nor synaptic strength are upregulated following activity 
deprivation in the absence of astrocytes. My work here demonstrates that astrocytes are essential 
players in the homeostatic upregulation of cortical neuronal activity.   
5.9.7 Limitations and future work 
As was discussed in Chapter 4, a major limitation with this work is that it does not conclusively link 
astrocyte regulation of neuronal KIR function to the increase in activity. Much of the future work I 
will do to determine this link has been outlined in the previous chapter, for example directly 
measuring the KIR currents and determining the signalling pathway responsible for the reduction in 
cortical neuronal KIR mRNA. Once I have found the pathway, I will investigate whether inhibiting 
it in CC neurons prevents the increase in neuronal activity, or whether activating the pathway in 
MC neurons boosts activity. In the meantime, I will investigate whether chronic partial inhibition 
of KIR, for example with tertiapin Q and ML133, in MC neurons is able to boost activity in these 
cells.  
Aside from this previously discussed gap, I have not yet investigated the effect of a stimulated 
increase in activity on the homeostatic responses of neurons. It is possible the baseline levels of 
activity in MC neurons were so low that activity deprivation had next to no effect, hence no 
homeostatic response was observed. Stimulating activity in MC and CC neurons, for example by 
application of the GABA receptor antagonist bicuculline and/or the voltage-activated K+ channel 
blocker 4-Aminopyridine, to trigger homeostatic downregulation of activity would be one way to 
investigate this possibility further. Furthermore, this will also allow me to investigate whether 
astrocytes are involved in the reverse homeostatic downregulation of activity.  
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Additionally, as I have seen that activity deprivation of DIV15 CC neurons, but not MC neurons, 
leads to an increase in mEPSC events, I wish to see whether there is an associated increase in 
co-localised synaptic puncta in TTX-treated CC neurons. To do this I will repeat the 
immunohistochemistry experiments in DIV15 MC and CC neurons that have been treated with 
TTX and count the number of excitatory synapses present. 
Lastly, all my work to date is in primary cortical culture preparations. Some of the criticism raised 
regarding the pitfalls of using purified RGCs as a model to study synapse formation and 
development could also be levelled at this model. For example, many of these cortical cells would 
physiologically receive input from areas beyond the cortex, such as the thalamus. Indeed, Eroglu 
and colleagues have demonstrated that the putatively astrocyte-secreted protein hevin appears to 
work to stabilise and increase the number of vGlut2-thalamocortical excitatory synapses – an effect 
my cortical preparation would miss (Singh et al., 2016, Risher et al., 2014). Once I have determined 
the signalling pathway mediating the decrease in KIR/increase in excitability, the final part of my 
future work will look to generate a mouse model to study the relative importance of this astrocyte-
to-neuron signalling pathway on excitability and network activity in an in situ and in vivo setting.      
5.9.8 Conclusion 
I have shown here that astrocytes are involved in controlling cortical neuronal activity. Intriguingly, 
I do not see that astrocytes are required for the induction of cortical neuronal excitatory 
synaptogenesis, questioning the suitability of RGCs as a model for neuron-astrocyte interactions in 
synapse formation. Despite this, I find that astrocytes can control excitatory synapses in cortical 
neurons in an activity-dependent manner, showing that astrocytes are required for the homeostatic 
upregulation of synaptic strength following activity deprivation. In combination with my findings 
that astrocytes are required for the homeostatic upregulation of excitability, I demonstrate that 
astrocytes exert a large control over the activity of cortical neurons and are required for activity-
dependent homeostatic plasticity in these cells. This work adds to astrocytes known roles in other 

















Chapter 6 – Concluding remarks 
Neurons and astrocytes share an intimate bidirectional relationship with each other within the 
CNS. However, traditionally it has been difficult to determine exactly how one cell type affects the 
other. Considering this, our lab has come up with a mixed species co-culture approach that allows 
us to ascertain how one type of cell regulates the gene expression of another. In my thesis I have used 
this approach to explore the extent of the reciprocal relationship between neurons and astrocytes. I 
first demonstrated that neurons play an important role in determining astrocyte function, before 
showing that astrocytes in turn have control over neuronal gene expression and activity. 
Using our lab’s mixed species co-culture setup, in the first half I showed how cortical neurons 
control the gene expression of the two astrocytic glutamate transporters, Slc1a2 and Slc1a3, 
through the contact dependent Notch signalling pathway, and how this control leads to an 
induction of the astrocytic ability to clear glutamate. Astrocytic clearance of glutamate is a 
fundamentally important aspect of CNS function, with impairments in this clearance leading to 
epilepsy and excitotoxic cell death. It is intriguing to find that this ability, being one that so often 
characterises astrocytes and their function, is not innate to astrocytes and is instead controlled by 
neurons, highlighting the complex entwined relationship between these two cell types. My 
demonstration that Notch signalling from neurons is required to maintain the expression of these 
transporters suggests ways in which the breakdown in communication between these two cell types 
can have important consequences for the development of neurodegenerative disease. For example, 
a lack of Notch signalling will reduce astrocytic EAAT function, which could lead to excitotoxic 
neuronal death, which could cause a further reduction in contact and Notch signalling, a further 
reduction in glutamate clearance, and a potentiation of toxicity. An interesting avenue for future 
research would be to investigate the role impaired Notch signalling in astrocytes plays in the 
development of, for example, Alzheimer’s disease – given familial cases of the disease often involve 
mutations in the γ-secretase complex.  
In the second half of my thesis I presented our lab’s RNA-seq results on the astrocytic regulation of 
neuronal gene expression, finding that astrocytes extensively control cortical neuronal gene 
expression. This is the first study revealing how astrocytes control neuronal gene expression and is 
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an important finding on its own. Among these astrocyte-controlled genes I discovered that the Kcnj 
family of genes was downregulated in cortical neurons by astrocytes. As these genes encode the KIR 
channel subunits I hypothesised that this astrocytic control would have functional consequences 
for the neurons. I showed that this was the case, with astrocytes altering the membrane properties 
of neurons, increasing neuronal excitability, and in turn increasing neuronal activity. Finding the 
signalling mechanism behind this astrocyte control of Kcnj expression is the next key step for this 
work. A summary of two proposed candidate mechanisms and their pharmacological targets for my 
experiments going forward are depicted in Figure 6.1. 
 
Figure 6.1: Proposed astrocyte signalling mechanisms leading to the repression of neuronal Kcnj  
The primary targets for my work going forward are 1. the potential role of ApoE/cholesterol signalling leading 
to an inhibition of Kcnj3/4 transcription and 2. whether the astrocytic downregulation of Kcnj is mediated by 
epigenetic repression of these genes in neurons. To investigate these possibilities, I will initially use 
pharmacological interventions to inhibit these two signalling pathways, for example by application of PCSK9 
to reduce low density lipoprotein receptor (LDLR) expression, or DNA methyltransferase (DNMT) and histone 
deacetylase (HDAC) inhibitors to prevent epigenetic repression.    
 
Contrary to previous findings espousing the requirement of astrocytes for excitatory synaptogenesis 
I did not find genes associated with excitatory synapses to be regulated by astrocytes. In agreement 
with the RNA-seq dataset I found that there was no increase in excitatory synapse formation under 
baseline conditions in the presence of astrocytes. I proved that my astrocytes and media conditions 
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allowed for astrocyte induced synaptogenesis of RGCs, suggesting the results of previous studies 
using purified RGCs may not be generalisable to cells beyond that preparation.  
Despite not seeing an increase in excitatory synapses in the presence of astrocytes, it was observed 
that the kinetics of the mEPSC events may be different between the two conditions. Specifically, 
the duration of the events appeared to be longer in the presence of astrocytes, as seen in Figure 5.8. 
This could indicate that there is a difference in the AMPA receptor subunit composition, with 
mono-culture neurons possessing more kinetically fast Ca2+-permeable AMPA receptors compared 
to co-culture. This would be consistent with the observations of Allen and colleagues, who found 
that astrocytes promote the formation of Ca2+-impermeable AMPA receptors in neurons (Blanco-
Suarez et al., 2018). In the future it would be of interest to investigate this possibility further, for 
example by using Naspm, a Ca2+-permeable AMPA receptor antagonist, to investigate whether 
there is a reduction in these receptors in the presence of astrocytes. 
The major finding from the second half of my thesis was that astrocytes were required for activity-
dependent regulation of neuronal excitability and synaptic strength. I showed that the regulation 
of these two mechanisms of activity-dependent homeostatic plasticity endowed astrocytes with a 
profound ability for the homeostatic regulation of neuronal activity. It has been established that 
astrocytes are closely involved in the forms of plasticity associated with memory, LTP and LTD, 
with one study also suggesting a role in the homeostatic plasticity of synaptic strength. The results 
from my thesis firmly cement astrocytes as players in the various aspects of homeostatic plasticity 
and suggests a major function of astrocytes in the CNS may be the regulation of neuronal plasticity.  
In experiments going forward it will be desirable to investigate the relevance of these findings in a 
more physiologically intact setting. One interesting possibility would be to set up a dark rearing 
experiment to see if the expression of these KIR channels decreases in the visual cortex in the absence 
of light and increases upon exposure to light. If this is the case, I would then investigate whether 
impairing the astrocyte-to-neuron signalling cascade could prevent these changes, which could 




Overall, in my thesis I have elucidated some of the reciprocal signalling mechanisms and associated 
functional control that neurons and astrocytes exert over each other. This work is just the 
beginning, providing a glimpse of the complex relationship that is becoming increasingly apparent 
between these two major cell types. Future work will then need to explore how the other glial cells, 
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Figure A1: Involvement of the Notch signalling pathway between neurons and astrocytes 
All figures are taken from Hasel et al., 2017, with data acquired by Dr. Philip Hasel. i) Relative expression of 
Notch ligands and Notch receptors in neurons vs. astrocytes. It can be seen that neurons are particularly 
enriched for the ligands, whilst astrocytes are enriched for the receptors. ii) Luciferase assay of the Notch 
effector, CBF1. There is greater Notch activity in astrocytes grown with neurons, and this activity can be 
blocked by inhibiting the cleavage of the NICD with DAPT. iii) Relative expression of the two Notch genes, 
Hes5 and Hey2, along with the glutamate transporter Slc1a2 in mouse astrocytes ± rat neurons. Neuronal 
inducement of gene expression is blocked for all three genes by application of the γ-secretase inhibitor DAPT 
to prevent Notch signalling. iv) Expression of the constitutively active Notch effector mutant causes an 






Figure A2: Tubulin expression in MC and CC cortical neurons (DIV8)  
Tubulin gene expression is significantly greater for the majority of the tubulin gene family in rat cortical 
neurons grown in the presence of mouse astrocytes. Tuba1a, Tubb2b, Tubb3 and Tubb5 were some of the 
highest expressed genes in CC neurons, and amongst the most significantly upregulated by co-culture with 
astrocytes. Samples prepared by Dr Jing Qio and Dr. Philip Hasel, bioinformatic analyses undertaken by Dr 





Figure A3: Gene expression of excitatory synapse associated genes for MC and CC cortical 
neurons at DIV8 and DIV15 as assessed from RNA-sequencing 
Co-culture with astrocytes had very little effect on gene expression for excitatory synapse associated 
proteins, including pre-synaptic, post-synaptic and ionotropic glutamate receptor subunit proteins in cortical 
rat neurons. This was the case both early on in culture (DIV8), and also later on in development at DIV15, 
after the formation of spines had occurred. Samples prepared by Dr Jing Qiu and Dr Philip Hasel, 







Figure A4: RNA-sequencing data of KIR gene expression in cortical rat neurons is decreased in the 
presence of mouse astrocytes 
Expression of KIR channel genes in cortical neurons grown alone (MC) or in the presence of mouse astrocytes 
(CC) at DIV8 and DIV15. There is a pronounced reduction in expression at DIV8, which is somewhat reduced 
by DIV15. The largest effects are on the two most abundantly expressed members, Kcnj3 (KIR3.1) and Kcnj4 
(KIR2.3). At DIV15 there is still a significant reduction of these two genes in the presence of astrocytes. 
Samples prepared by Dr Jing Qiu and Dr Philip Hasel, bioinformatic analyses undertaken by Dr Owen Dando 












Figure A5: Activity dependent changes in KIR expression in DIV15 cortical rat neurons 
i) Relative expression of Kcnj3 in cortical rat neurons ± mouse astrocytes with and without activity deprivation 
(by TTX application) at DIV15 as assessed by RT-qPCR (data courtesy of Dr Philip Hasel). Activity deprivation 
has little effect on Kcnj3 expression in neurons in the absence of astrocytes. In the presence of astrocytes 
Kcnj3 expression appears to be further reduced. ii) RNA-seq dataset of DIV15 MC and CC rat neurons 
(samples prepared by Dr Philip Hasel, bioinformatic analysis by Dr Owen Dando and Dr Xin He). Blocking 
activity for 48 hours with TTX treatment had little effect on the gene expression of K IR channels in MC rat 








Figure A6: Activity regulation of KIR channels in pure mouse neurons vs mixed mouse cells 
RNA-seq data for Kcnj gene expression in mouse primary culture. Mouse neurons were either purified with 
AraC treatment from DIV0 (-glia), or else grown without to allow growth and proliferation of glial cells, 
including astrocytes (+glia). As with the rat data, there is a reduction in Kcnj expression in mouse samples 
containing glia. Increasing activity by application of bicuculline causes an increase in Kcnj3 and Kcnj4 only 
in the presence of astrocytes. Conversely, reducing activity with TTX treatment causes a robust decease in 
these channels’ expression in the mixed sample, supporting our findings in rat preparations. NB: specific 







Figure A7: Regulation of KIR genes in DIV3 rat neurons by ACM treatment 
RNA-seq data for Kcnj gene expression for MC rat neurons, grown in standard media or supplemented with 
ACM for three days. ACM treatment significantly reduced the expression of both Kcnj3 and Kcnj4, replicating 
the effects of direct astrocyte co-culture on these genes. Samples prepared by Dr Philip Hasel, bioinformatics 



















Figure A8 (4/4) 
 
Figure A8: Relative expression of proteins enriched >2-fold in ACM over NCM 
Mean ACM is the average of relative protein abundance in 6x mouse ACM samples (3x samples in NBA 
media, 3x samples in DMEM media – protein expression was comparable between media conditions). Mean 
NCM is the average of relative protein abundance in 3x rat NCM samples. Proteins detected (with relative 













Figure A9: Astrocytes alter the membrane properties of mouse neurons at DIV8, appearing similar 
to rat neurons at DIV15  
Mouse neurons were seeded instead of rat neurons and the intrinsic properties recorded at DIV8 to check 
for the effects of mixed species. At DIV8 there was no apparent difference between MC and CC mouse 
neurons. However, treatment with TTX for 48hrs saw an emergence of an effect of astrocytes. i) There was 
a significant difference between CC +TTX neurons and both MC and MC +TTX neurons (p = 0.046 and p = 
0.008 for MC and MC +TTX, respectively, LME ANOVA, df = 60). ii) CC +TTX neurons had a slight but 
insignificant increase in RM compared to MC +TTX (p = 0.02 and p = 0.1, respectively). iii) CC neurons 
treated with TTX have a slight leftward shift in their FI relationship compared to other conditions. iv) With TTX 
treatment CC neurons have significantly lower rheobase compared to both MC and MC +TTX neurons, and 
a slight but insignificant reduction compared to untreated CC (p < 0.001, p = 0.03, and p = 0.06, compared 





Figure A9 (accompanying text) 
 
One question arising from the experimental set-up using mixed species (mouse astrocytes and rat neurons) 
is whether the effects of astrocytes on neurons is due to an effect of different species on gene expression, 
rather than different cell type. The results of the labs’ RNA-sequencing on mixed mouse preparations shown 
in appendix Figure A6 suggest that this is not the case, but to address this concern, I created a same species 
set-up, using mouse cortical neurons grown on mouse astrocytes. I then recorded the membrane properties 
and excitability in these same species MC and CC cells. As mouse primary neurons typically develop slightly 
faster than rat neurons, I additionally created samples of MC and CC mouse neurons that had been 
incubated in TTX for 48 hrs prior to recording. This was to control for any homeostatic masking of differences 
in properties, as described in the previous section, that may occur at an earlier time point in mouse cells. 
 
At DIV8 there was no significant difference in RMP, RM, or excitability between untreated MC and CC mouse 
neurons. However, in TTX-treated cells differences emerged. There was a significant depolarisation in RMP 
between in CC +TTX treated cells compared to MC +TTX (Fig A9 i: mean = -48.4 ± 1.8 and -40.8 ± 2.4 mV, 
n = 17 and 17, for MC +TTX and CC +TTX, respectively), as well as a slight but insignificant increase in RM 
(Fig A9 ii: mean = 493.6 ± 56.2 and 659.3 ± 103.4 MΩ for MC +TTX and CC +TTX, respectively, p = 0.1). In 
terms of excitability, activity-deprived CC neurons additionally had a slight but insignificant leftward shift in 
their FI relationship, with significantly lower rheobase than TTX-treated MC mouse neurons (Fig A9 iii & iv: 
mean input current = 86.5 ± 11.3 and 48.8 ± 8.9 pA, n =17 and 17, for MC +TTX and CC +TTX, respectively).  
 
Although there are shifts in developmental stage and speed, it appears that the effects of astrocytes on 
neuronal properties are not species specific, with mouse neurons also benefiting from an increase in 
















Figure A10: Both Notch pathway and astrocytic EAAT transporter genes are downregulated with 
age in humans 
On average, downstream Notch genes as well as genes for the Notch receptors, γ-secretase complex and 
Notch effector complex show lower expression in brain samples from humans >40 years old (n = 6) 
compared to samples from humans <40 years old (n = 6), suggesting that there is a decrease in Notch 
signalling activity with age in humans. Additionally, a similar decrease in the expression for the astrocytic 
glutamate transporters SLC1A2 and SLC1A3 is likewise observed in humans with age. Data from Zhang et 
al., 2016. 
